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Understanding Gene Regulation In Development And Differentiation Using Single
Cell Multi-Omics
Abstract
Transcriptional regulation is a major determinant of tissue-specific gene expression during development.
My thesis research leverages powerful single-cell approaches to address this fundamental question in
two developmental systems, C. elegans embryogenesis and mouse embryonic hematopoiesis. I have also
developed much-needed computational algorithms for single-cell data analysis and exploration. C.
elegans is an animal with few cells, but a striking diversity of cell types. In this thesis, I characterize the
molecular basis for their specification by analyzing the transcriptomes of 86,024 single embryonic cells. I
identified 502 terminal and pre-terminal cell types, mapping most single cell transcriptomes to their exact
position in C. elegans’ invariant lineage. Using these annotations, I find that: 1) the correlation between a
cell’s lineage and its transcriptome increases from mid to late gastrulation, then falls dramatically as cells
in the nervous system and pharynx adopt their terminal fates; 2) multilineage priming contributes to the
differentiation of sister cells at dozens of lineage branches; and 3) most distinct lineages that produce the
same anatomical cell type converge to a homogenous transcriptomic state. Next, I studied the
development of hematopoietic stem cells (HSCs). All HSCs come from a specialized type of endothelial
cells in the major arteries of the embryo called hemogenic endothelium (HE). To examine the cellular and
molecular transitions underlying the formation of HSCs, we profiled nearly 40,000 rare single cells from
the caudal arteries of embryonic day 9.5 (E9.5) to E11.5 mouse embryos using single-cell RNA-Seq and
single-cell ATAC-Seq. I identified a continuous developmental trajectory from endothelial cells to early
precursors of HSCs, and several critical transitional cell types during this process. The intermediate stage
most proximal to HE, which we termed pre-HE, is characterized by increased accessibility of chromatin
enriched for SOX, FOX, GATA, and SMAD binding motifs. I also identified a developmental bottleneck
separates pre-HE from HE, and RUNX1 dosage regulates the efficiency of the pre-HE to HE transition. A
distal enhancer of Runx1 shows high accessibility in pre-HE cells at the bottleneck, but loses accessibility
thereafter. Once cells pass the bottleneck, they follow distinct developmental trajectories leading to an
initial wave of lympho-myeloid-biased progenitors, followed by precursors of HSCs. During the course of
both projects, I have developed novel computational methods for analyzing single-cell multi-omics data,
including VERSE, PIVOT and VisCello. Together, these tools constitute a comprehensive single cell data
analysis suite that facilitates the discovery of novel biological mechanisms.
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ABSTRACT

UNDERSTANDING GENE REGULATION IN DEVELOPMENT AND DIFFERENTIATION USING
SINGLE CELL MULTI-OMICS

Qin Zhu
Kai Tan and Junhyong Kim

Transcriptional regulation is a major determinant of tissue-specific gene expression
during development. My thesis research leverages powerful single-cell approaches to
address this fundamental question in two developmental systems, C. elegans
embryogenesis and mouse embryonic hematopoiesis. I have also developed muchneeded computational algorithms for single-cell data analysis and exploration.
C. elegans is an animal with few cells, but a striking diversity of cell types. In this
thesis, I characterize the molecular basis for their specification by analyzing the
transcriptomes of 86,024 single embryonic cells. I identified 502 terminal and preterminal cell types, mapping most single cell transcriptomes to their exact position in C.
elegans’ invariant lineage. Using these annotations, I find that: 1) the correlation
between a cell’s lineage and its transcriptome increases from mid to late gastrulation,
then falls dramatically as cells in the nervous system and pharynx adopt their terminal
fates; 2) multilineage priming contributes to the differentiation of sister cells at dozens of
lineage branches; and 3) most distinct lineages that produce the same anatomical cell
type converge to a homogenous transcriptomic state.
Next, I studied the development of hematopoietic stem cells (HSCs). All HSCs
come from a specialized type of endothelial cells in the major arteries of the embryo
called hemogenic endothelium (HE). To examine the cellular and molecular transitions
v

underlying the formation of HSCs, we profiled nearly 40,000 rare single cells from the
caudal arteries of embryonic day 9.5 (E9.5) to E11.5 mouse embryos using single-cell
RNA-Seq and single-cell ATAC-Seq. I identified a continuous developmental trajectory
from endothelial cells to early precursors of HSCs, and several critical transitional cell
types during this process. The intermediate stage most proximal to HE, which we termed
pre-HE, is characterized by increased accessibility of chromatin enriched for SOX, FOX,
GATA, and SMAD binding motifs. I also identified a developmental bottleneck separates
pre-HE from HE, and RUNX1 dosage regulates the efficiency of the pre-HE to HE
transition. A distal enhancer of Runx1 shows high accessibility in pre-HE cells at the
bottleneck, but loses accessibility thereafter. Once cells pass the bottleneck, they follow
distinct developmental trajectories leading to an initial wave of lympho-myeloid-biased
progenitors, followed by precursors of HSCs.
During the course of both projects, I have developed novel computational
methods for analyzing single-cell multi-omics data, including VERSE, PIVOT and
VisCello. Together, these tools constitute a comprehensive single cell data analysis suite
that facilitates the discovery of novel biological mechanisms.
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CHAPTER 1 INTRODUCTION

During development, a fertilized egg undergoes repeated cell divisions to produce an
embryo that contains distinct cell types. This sequence of cell divisions is called the
organism’s cell lineage. Each cell in the lineage expresses a different set of genes in
various quantities (the cell’s transcriptome), thus directing cells to differentiate into
specific cell types. It is not yet fully understood how cells control its gene expression
during differentiation, and how cells interact with each other to form complex tissue
structures.
Historically, researchers have studied gene expression during development
through analysis of pooled population of cells from different developmental time points.
These “bulk” methods were able to capture global expression changes over time and
upon perturbation, but often fail to address the heterogeneous change and response of
each individual cell type. Therefore, it is extremely difficult to study the development of
rare cell types such as hematopoietic stem cells (HSCs). The emergence of single cell
technology made it possible to simultaneously profile the molecular state of almost every
cell in a multi-cellular organism. Unlike bulk methods, single-cell approach does not
require purification of cell population or synchronization of the developing organism.
Instead, by sampling cells across tissues and developmental stages, methods like single
cell RNA sequencing (scRNA-Seq) are able to capture transcriptomes of various cell
types and differentiation states (1, 2), bringing unprecedented resolution to the study of
development. Recent technologies such as single cell ATAC (Assay for Transposase
Accessible Chromatin) sequencing (scATAC-Seq) (3, 4) can identify active DNA
elements that likely promote or inhibit gene expression, thus facilitating mechanistic
1

understanding of gene regulatory program. Furthermore, multiplexed cytometric imaging
techniques such as CODEX (CO-Detection by indEXing) (5) imaging made it possible to
visualize the spatial distribution of different cell types in the tissue microenvironment and
investigate cell-cell interactions. Such interactions play critical roles in cell fate
specification and tissue patterning during normal development, and mediate pathological
processes such as immune cell infiltration and tumor metastasis in cancer.
This technological revolution provides exciting opportunities to study
development, but also poses challenges in data analysis and visualization. For
developmental biology, it is particularly important to model the differentiation trajectory
and characterize the underlying gene regulatory network. Novel methods are required to
integrate different data modalities, such as scRNA-Seq and scATAC-Seq data, to gain
mechanistic understanding of cell differentiation. The rapid growth of single cell data also
requires robust software environment for easy and fast data exploration to bridge the
gap between data generation and biological discovery.

Development and differentiation
C. elegans embryogenesis
Caenorhabditis elegans (C. elegans) is a simple, transparent organism with only 558
somatic cells upon hatching and 959 somatic cells in its adult hermaphroditic form.
Unlike many complex organisms, the cell lineage of C. elegans is invariant across
different individuals and has been fully resolved (6, 7), making it an ideal organism to
study cellular differentiation and organismal development. C. elegans is the first
multicellular organism whose genome gets completely sequenced, revealing a small
2

genome size of 97Mb and about 19,000 genes in total (8). The self-fertilization capability
of the hermaphrodites enables easy genetic screening to recover recessive mutants and
identify genes critical to the developmental process. Cross-fertilization could also
happen between males and hermaphrodites and will produce over 1000 fertilized eggs.
Fertilization initiates the embryogenesis process, which takes about 14 hours to
transform a single zygote into a moving L1 larva.
Embryogenesis of C. elegans can be divided into several stages, including
fertilization, proliferation, gastrulation, morphogenesis, elongation, quickening and
hatching (Figure 1.1) (9). Upon fertilization, anterior-posterior axis is established based
on the entry position of the sperm. The sperm pronucleus is pushed to the nearest end
of the elongated oocyte, making it the posterior pole (10). In the first 150 min post
fertilization, a series of asymmetric division happens to establish a set of founder cells,
including AB, MS, E, C and D (Figure 1.2). Each founder cell undergoes subsequent
divisions to give rise to cells that will differentiate into various cell types. Gastrulation
happens in conjunction with the proliferation of the founder cell lineages, where the AB
and C lineages produce ectoderm and pharynx, MS descendants form mesoderm and
pharynx, and E descendants form endoderm. Towards the end of gastrulation, the
majority of cells start terminal differentiation and organize into various tissues, while the
rest of cells undergo programmed cell death. Elongation occurs in parallel with tissue
morphogenesis, and the embryo grows about three-fold to adopt its long worm-like
shape. The embryo can be seen moving inside the egg about 650 minutes postfertilization, and hatches with about 600 cells 14 hours post-fertilization.
The simplicity of the organism makes it possible to experimentally perturb the
developmental process to gain insight into cellular differentiation and tissue
3

development. For example, individual cells in the early developing embryo can be
destroyed via laser ablation to reveal its developmental potential (7, 11, 12). Using this
approach, it has been shown that every single cell in the early embryo is indispensable
for normal development, and their fate is determined either autonomously or
conditionally. Autonomous fate specification means the intrinsic cellular factors
determine the fate of the cell and its progenies, and no extrinsic signaling is required.
The determination of P1 lineage is autonomous as it can generate the posterior part of
the embryo without the presence of AB (11). After P1 divides, one of its daughter cells,
EMS, also have the capacity to produce pharyngeal tissues in isolation. The maternal
protein SKN-1 is likely a key intrinsic factor that specifies the fate of EMS.
Hermaphrodites with skn-1 mutation produce embryos without pharyngeal mesoderm
and endoderm, but with extra skin and muscle cells (13). When EMS cell divides, the
specification of the E cell lineage (endoderm) is conditional, as it requires interaction with
the P2 blastomere through Wnt signaling (14, 15). Without contact with P2, which
expresses Wnt ligands mom, EMS cell will produce two MS cells but no intestine will be
formed (15). Similarly, specification of the ABp cell fates depends on the contact
between ABp and P2 through Notch signaling (16). The Notch receptor GLP-1 protein
can be found in both ABa and ABp cells, but only ABp contacts P2 which has the Notch
ligand APX-1. This signaling asymmetry cause ABp to adopt a different fate from its
sister, thus establishing the dorsal-ventral axis of the embryo.
In recent years, omics technologies have enabled profiling of hundreds and
thousands of gene expression patterns in the C. elegans embryo, allowing systematic
characterization of gene regulatory pathways. For example, using fluorescent reporters,
Murray et al. traced expression of 127 genes across cell lineages and developmental
4

time points (17). They identified several genes downstream of the Wnt signaling
pathway, which interact with the transcription factor POP-1 to generate diverse lineagespecific expression patterns. One of the earliest scRNA-Seq technologies, CEL-Seq,
was first applied to study C. elegans embryogenesis (18). By comparing the gene
expression profile of daughter cells with the mother cell, the researchers found
transcription factors are highly enriched among daughter-cell-expressed genes,
suggesting their critical roles in early lineage specification. Similarly, using scRNA-Seq,
Tintori et al. profiled gene expression in the early embryo up to the 16-cell stage (19).
They observed a global similarity in gene expression between AB descendants, except
for a few genes including known Notch targets, hlh-27, ref-1, and tbx-38. Therefore,
Notch signaling may be one of the key discriminating factors that drives different fate
choice of early AB lineage cells.
Despite all these efforts, it largely remains a mystery how the fate of every single
cell is robustly specified throughout embryonic development. Comprehensive gene
expression profiling of single cells during C. elegans embryogenesis could provide the
first step towards mechanistic understanding of this process. In Chapter 2, I describe our
efforts to construct a lineage-resolved molecular atlas of the C. elegans embryo, which
includes 86,024 single-cell gene expression profiles covering 87% of the embryonic
lineages. Using this dataset, we modeled the differentiation trajectories of the cells and
identified developmental patterns that are prevalent across embryonic lineages.

5

Embryonic origin of blood
Development of the blood system is a highly conserved process across vertebrates, and
has been extensively studied in chicken, zebrafish, and mouse (20). The mouse
hematopoiesis system shares a lot of similarity with that of human and therefore has
been used as a model system for studying mammalian blood development. During early
embryogenesis, there are multiple waves of blood cell progenitor formation (21). The first
wave occurs around embryonic day (E) 7 in the extra-embryonic yolk sac of mouse,
where a group of mesodermal progenitor cells differentiate into erythrocyte,
megakaryocyte, and macrophage progenitors (22-24). These cells are transiently
produced to support fetal development and will not last until adulthood, thus were termed
the “primitive wave” of blood formation. The second wave originates from the
vasculature of yolk sac around E8.25 (25). A subset of the endothelial cells in the blood
vessel undergoes “endothelial to hematopoietic transition” (EHT), and form erythromyeloid progenitors (EMPs) (26, 27). The second wave also involves generation of
lymphoid progenitors from the yolk sac, dorsal aorta, vitelline arteries, and umbilical
arteries, which will differentiate into T cells and B cells (28-30).
Hematopoietic stem cells (HSCs) first emerge from the aorta-gonadmesonephros (AGM) region between E10.5 to E11.5 during the third “definitive wave” of
blood formation (31, 32). These cells have both self-renew capability and the potential to
differentiate into all blood cell types. Formation of HSCs involves multiple differentiation
steps and several intermediate cell types (20, 33). Around E9.5, a subset of endothelial
cells in the dorsal aorta is specified as hemogenic endothelial (HE) cells, which can be
distinguished by the expression of the transcription factor Runx1 (34). The HE cells
undergo EHT to give rise to hematopoietic stem and progenitor cells (HSPCs) that
6

accumulate in intra-arterial clusters (IAC) (35). Limiting dilution analysis revealed that at
E10.5, fewer than 10% of the several hundred IAC cells are HSC precursors, or preHSCs (36, 37). Pre-HSCs cannot engraft adult mice directly, but can mature in vivo or ex
vivo into HSCs that can engraft (38). All pre-HSCs at E10.5 lack the pan-hematopoietic
marker CD45, and are called type I pre-HSCs (38). At E11.5, the IACs contain type I
pre-HSCs, CD45+ type II pre-HSCs that have matured from type I pre-HSCs, and ~1
HSC (36). CD45+ cells are also found in the IACs at E10.5, but these cells cannot be
matured into HSCs and hence are not pre-HSCs (38). The lineage relationship between
the CD45+ IAC cells that appear at E10.5 and the CD45+ type II pre-HSCs at E11.5 is
unknown. Pioneering scRNA-seq analyses identified type I and II pre-HSCs within IACs
(39, 40), but the overall composition of the IACs was not described due to the small
number of cells that were previously analyzed. The pre-HSCs eventually detaches from
the blood vessel and migrates to fetal liver, where they undergo rapid expansion and
further maturation before colonizing the bone marrow to support adult hematopoiesis
(33).
Formation of pre-HSCs from the arterial endothelium is regulated by multiple
transcription factors and signaling pathways. The transcription factor Runx1 is a critical
regulator of the definitive waves of hematopoiesis (33, 41, 42). Runx1-deficient embryos
dies by E12.5 with severe anemia due to the lack of blood production from the last two
waves (33). Conditional knock-out of Runx1 in vascular endothelial cells shows Runx1 is
essential for the generation of pre-HSCs and formation of the IACs (41). But Runx1 is
not required to maintain the hematopoietic cell identity as conditional knock-out of Runx1
in the hematopoietic cells does not cause embryonic lethality (41). Previous studies
show Runx1 functions in HE to recruit hematopoietic regulators, Tal1 and Fli1 to induce
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the transition towards hematopoietic fate (43). Direct targets of Runx1 include Spi1 and
Gfi1 (33, 44), both are essential for EHT and are used in a transduction cocktail along
with Runx1 and Fosb to reprogram endothelial cells to hematopoietic cells in vitro (45).
Besides Runx1, Gata2 is another transcription factor essential for EHT (46).
Haploinsufficiency of Gata2 results in severe reduction of HSC production in the AGM
region (47). Gata2 expression is induced by Notch1 signaling, which is transiently
required for the specification of HE (48). The Notch ligand, Dll4 and Jag1 are both
expressed in the dorsal aorta. When in contact with Dll4, Notch activity is upregulated
and promotes the arterial fate of endothelium (49). When bound by Jag1, Notch activity
is restricted, permitting the induction of hematopoietic program (49). Other signaling
pathways involved in HE specification and EHT includes retinoid acid signaling (50),
BMP signaling (51), cytokine signaling (52) and fluid shear stress (53). However, due to
the technical difficulties in isolating the rare cell population involved in EHT, little is
known about the interplay between these pathways and the transcriptional regulatory
network downstream of the signaling pathways.
In Chapter 3, I describe our effort to map a continuous developmental trajectory
from endothelial cells to early precursors of HSCs by analyzing ~40,000 rare single cells
from early developing mouse embryos. Through joint analysis of scRNA-Seq and
scATAC-Seq data, I identified a developmental bottleneck regulated by Runx1 dosage,
and a distal enhancer of Runx1 with transient activity at the bottleneck. I also identified
pathways with increased activities at the bottleneck. Once cells pass the bottleneck, they
follow distinct developmental trajectories leading to an initial wave of lympho-myeloidbiased progenitors, followed by precursors of HSCs.
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Single cell technologies
The past decade has witnessed rapid development of single cell technology. The
following section reviews several key methodology innovations that enable measuring
molecular phenotypes of cells in a high-throughput fashion.

Single cell RNA sequencing (scRNA-Seq)
Single cell RNA sequencing enables measurement of mRNA transcript abundance
across thousands of cells simultaneously. Figure 1.3 shows an overview of the general
procedure of scRNA-Seq. First, biological samples are harvested and are dissociated
into a single cell suspension. Cells of interest are then loaded onto a single cell isolating
device which captures each cell in e.g., a droplet. After cells are lysed, reverse
transcription and cDNA amplification are performed to generate libraries for sequencing.
Sequencing reads are analyzed to obtain mRNA abundance measure of each gene in
every cell, which can be further analyzed to gain biological insights.
scRNA-Seq technology has evolved a lot over the past years and several major
breakthroughs were made to improve the throughput and robustness of the method. For
example, the utilization of microfluidic device enables sorting cells into separate oil
droplets, beads, or wells (54, 55). Each of the cells were lysed and labeled with a unique
molecular barcode, such that they can be pooled for library construction and
sequencing. The Fluidigm® C1 system was one of the earliest microfluidic-based
technology which allows capturing of 96 to 800 cells (2). Since then, technologies such
as inDrop, Drop-Seq and Next GEM from 10x GenomicsTM were developed, enabling
partitioning and labeling of thousands of single cells (54-56). A different strategy to
increase the throughput is using combinatorial barcoding, which is implemented in the
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SPLiT-Seq and sci-RNA-Seq protocols (57-59). The methods randomly distribute fixed
cells into wells and label the cells with well-specific barcodes. With several rounds of
random splitting, barcoding, and pooling, the overall complexity of the ligated barcodes
will be high enough to uniquely label almost every single cell, allowing 1-2 million cells to
be sequenced in a single experiment. Such approaches significantly reduce the cost for
library preparation but may not robustly capture lowly expressed genes in the cell due to
limitations in sequencing depth. For certain biological questions, medium cell number
and high read coverage per cell may be preferred, as many key regulatory genes, such
as transcription factors, are present in small amount in each cell but have global
regulatory effects.
The limited materials in each single cell also require robust library preparation
methods, such that technical variations do not distort the biological signal. To this end,
linear amplification protocols such as in vitro transcription (IVT) have been developed
(18, 60, 61), which avoids the uncontrolled scaling by exponential amplification methods.
To make the counting of mRNA molecules even more accurate, a unique molecular
identifier (UMI) can be attached to each molecule, such that after amplification the reads
can be readily de-multiplicated (62). Technologies such as IVT and UMI have been
incorporated into modern single cell platforms such as the 10x Genomics Chromium
system, allowing robust quantification of single cell gene expression.

Single cell ATAC sequencing (scATAC-Seq) and single-cell multi-omics
Gene expression in development is regulated by both cis-acting DNA elements and
trans-acting factors. ATAC-Seq uses the hyperactive transposase Tn5 to insert
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sequencing adaptors to accessible chromatin regions, enabling identification of active
DNA regions and potential trans-factor binding sites (63) (Figure 1.4). The successful
application of microfluidic device for scRNA-Seq inspired development of single-cell
ATAC sequencing. Using the Fluidigm® C1 system, Buenrostro et al. developed a single
cell ATAC-Seq protocol allowing simultaneous measurement of chromatin accessibility
in hundreds of cells (3). Although the data are very sparse, it shows that scATAC was
able to capture cell-type-specific epigenetic features and global chromosome
compartments. Around the same time, Cusanovich et al. developed a different scATACSeq protocol using combinatorial indexing (4). Like sci-RNA-Seq, the sci-ATAC-Seq
protocol uses two rounds of splitting and pooling of cells on a 96-well plate to introduce
unique combination of barcodes for each single cell. The method is capable of profiling
1500 cells in a single run but have ∼11-12% collision rate. Recently, scATAC-Seq using
the 10x Chromium platform has gained much popularity due to its high throughput
(thousands of cells) and low collision rate (0.8-4%). After nuclei suspension is made and
incubated with Tn5 transposase, the Chromium device encapsulates each cell in a Gel
bead-in EMulsion (GEM), where cell barcoding and linear amplification happens. The
GEMs are then pooled and broken to release the barcoded DNA fragments for library
construction and sequencing. A study by Satpathy et al. used this technology to profile
more than 200,000 single cells from human blood and tumor microenvironment. They
were able to reconstruct the trajectory of multiple immune cell lineages using this
dataset, demonstrating that scATAC is a valuable tool to understand gene regulatory
programs in development and differentiation (64).
Recently, several methods were developed to jointly profile mRNA level and
chromatin accessibility in the same cell, such as sci-CAR (65), Paired-Seq (66), SNARE11

seq (67) and SHARE-seq (68). Besides these, other types of multi-omics methods were
developed for joint assay of transcriptome and epitopes (69), chromosome conformation
and methylomes (70), transcriptome and histone modification (71), and even three
different modalities (72, 73). These assays show lots of promises for understanding
hierarchical gene regulatory program during development and differentiation. For
example, using SHARE-Seq, Ma et al. observed during skin development, domains of
regulatory chromatin (DORCs) became accessible before many fate-specific genes are
expressed, suggesting chromatin accessibility is predictive of cell fate decisions (68).
This dynamic relationship between chromatin accessibility and gene expression, which
they termed “chromatin potential”, can be quantified to estimate the time scale of fate
commitment, and to facilitate the discovery of key lineage-determining genes.

Single cell imaging technologies
Although scRNA-Seq and scATAC-Seq provide quantitative readout of key molecular
features of each cell, the sequencing-based technologies alone are unable to resolve the
spatial location and dynamical changes of the cell. Such information is critical for
understanding the interaction between the cell and its surrounding environment, which
plays a pivotal role in cell fate specification during development and differentiation.
The development of reporter genes and microscopy technology has made it
possible to visualize gene expression in living organism at single cell resolution (74). For
example, using confocal microscopy and fluorescent reporter constructs, Murray et al.
measured reporter expression of more than one hundred genes in the C. elegans
embryo on a cell-by-cell basis (17, 75). With this cellular-resolution compendium of gene
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expression, the researchers identified interesting spatial expression patterns such as
left-right-asymmetric gene expression, as well as temporal expression cascades that
define cell fates in a sequential manner. The GFP-based single cell imaging technique
has also been applied to other model organisms such as Drosophila (76), but has
fundamental limitation in throughput due to overlapping fluorophore emission spectra.
Multiplexed in situ fluorescent imaging, such as CODEX (CO-Detection by
indEXing) (5), DEI (DNA Exchange Imaging) (77) and t-CyCIF (Tissue-based cyclic
immunofluorescence) (78), circumvents this limitation by repeated imaging of the same
specimen over multiple cycles. For example, the CODEX technology (5) uses DNAconjugated antibodies to stain the cells. In each cycle, three fluorophores tagged with
complementary DNA sequence were introduced and bound to matched antibodies,
allowing imaging of three proteins at the same time. The fluorophores were then washed
away to start another cycle of imaging. With repeated cycling, CODEX is able to capture
fluorescent images of up to 45 proteins for a single tissue section. Using this technology,
researchers were able to identify spatial distribution of different cell types and infer cellcell communication network in normal and diseased tissues (5, 79).
Besides measuring protein abundance at single cell level, direct imaging of single
RNA molecules in the cell has been made possible through single-molecule
fluorescence in situ hybridization (smFISH) (80, 81). Several variations of this technique
have been developed to increase the throughput and robustness of the method, allowing
thousands of mRNA species to be measured at cellular or sub-cellular resolution (8286). For example, Long Cai’s group developed seqFISH (sequential Fluorescence In
Situ Hybridization) technology (82, 87-89), which uses sequential rounds of hybridization
and fluorescent imaging to read out the temporal barcode for each mRNA transcript.
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seqFISH enables in situ quantification of gene expression that preserves spatial gene
expression pattern (87), as well as direct read out of lineage barcodes introduced using
CRISPR/Cas9-based targeted mutagenesis (88). Another technology, multiplexed errorrobust FISH (MERFISH) (84), also enables transcriptome-scale quantification of RNA
species, and has been extended to DNA imaging to enable simultaneous capture of the
3D organization and transcription activity (90). Compared to scRNA-Seq, smFISH data
contain additional information about cellular and sub-cellular localization of individual
mRNA species. Therefore, smFISH offers critical insight into many developmental
processes that are regulated by mRNA localization, such as embryonic patterning, cell
fate specification, cell migration and synapse development of neurons.

Lineage tracing
A cell’s developmental history could involve multiple rounds of cell division, cell migration
and programmed cell death. During cell division, a parental cell gives rise to two
daughter cells with same identity, or with completely different cell fates. Methods such as
scRNA-Seq and scATAC-Seq capture snapshots of each cell’s molecular state but
cannot record the consecutive cell divisions which represents a cell’s lineage history.
The cell lineage history, although by nature is tree-like, may be reflected in the molecular
state space as several disjoint clusters, bifurcating trajectories, or loops. Therefore,
tracking a cell’s lineage history and mapping it back to the state space could help
researchers understand how cells traverse the molecular state space to reach its
terminally differentiated state.
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In the past, lineage tracing was done using microscopy on simple, transparent
organisms such as ascidians (91) and C. elegans (7). Recent in toto confocal
microscopy technique enables cell tracking in more complicated organisms such as
zebrafish (92) and mouse (93). In addition, it is possible to label cells with dyes,
radioactive tracers, or reporter genes at an early embryonic stage, and track the fate of
its descendants (94). Although these methods were able to reconstruct partial or full cell
lineage tree, they cannot be readily used in conjunction with single cell omics methods to
link a cell’s lineage with its molecular state.
With high-throughput sequencing, it is possible to use DNA or RNA sequences
as lineage labels, which can be directly read out using single cell sequencing methods.
For example, using naturally occurring mutations in mitochondria genome, Ludwig et al.
was able to identify subclones in human cell lines and human colorectal cancer and
simultaneously measure chromatin accessibility using scATAC-Seq (95). Genetic
modification can also be introduced using recombination (96), transposition (97), and in
vivo editing of DNA targets by CRISPR-Cas9 (40, 88, 98, 99). Through consecutive
editing of a lineage-recording barcode, CRISPR-Cas9 based methods such as
scGESTALT (98) and ScarTrace (40) enables tracking cell lineage history and
measuring transcriptome at the same time. However, resolution of such methods is
limited by the editing efficiency and barcode detection rate, thus not every cell lineage
can be confidently resolved.
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Computational methods for single cell analysis of development and
differentiation
Identifying cell types and cell states
A multicellular organism is composed of various cell types that are functionally
specialized and morphologically distinct. Although the definition of cell type is
controversial, scRNA-Seq offers a unique way to relate a cell’s identity with its
transcriptomic profile, which is inherently associated with morphology and function (100,
101). Furthermore, scRNA-Seq enables detailed characterization of different molecular
states of the same cell type as cell cycle, circadian rhythm, aging and disease often
cause altered gene expression pattern (102-104). To robustly group and annotate cells
as different cell types and cell states, numerous computational methods have been
developed, which can be grouped into two major categories – the unsupervised
clustering-based approach and the supervised reference-based approach.
Clustering algorithms have long been developed in the field of statistics and
computer science. However, most of these methods cannot be readily applied to single
cell data due to several important limitations. One of such limitations is the sparsity of
the data, as current single cell technologies sometimes fail to capture transcripts of lowly
expressed genes, leading to zeros in the data matrix (105). This “dropout” effect distorts
the true gene expression pattern, leading to biases in the downstream analysis. To
reduce the effect of dropouts, many groups have developed algorithms to impute the
missing values (106-110). Others take a slightly different approach by explicitly modeling
the dropout events. For example, the ZIFA algorithm uses zero-inflated factor analysis to
impute the cell coordinates in a low dimensional latent space (111). A similar algorithm,
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ZINB-WaVE, uses zero-inflated negative binomial model on the count data, and
observed tighter, biologically meaningful clusters (112).
Another challenge for single cell clustering is the curse of dimensionality, which
refers to the instability of distance metrics in high dimensional space (113). Therefore, a
common procedure prior to clustering analysis is to reduce the dimensionality of the
data. Principal component analysis (PCA) is one of the most extensively used linear
dimensionality reduction method. By successively maximizing the variance in each
principal component (PC), the method projects cells into a low-dimensional space where
many clustering methods, such as K-means clustering and density-based clustering, can
be readily applied. Furthermore, each PC represents a linear combination of genes that
contribute to the separation of the clusters, thus can be biologically interpreted. In one
single-cell study on metastatic melanoma, the researchers observed different partition of
cells along each PC, which suggests transcriptional heterogeneity associated with cell
cycle, spatial context and drug resistance program (114). In another study on the
development of early C. elegans embryo, iterative PCA was applied to identify distinct
cell lineages arising from asymmetric divisions, where each PC corresponds to lineagespecific transcription programs (19).
Although linear methods like PCA enable visualization and clustering of high
dimensional gene expression data, biological data are intrinsically nonlinear. In recent
years, several nonlinear dimensionality reduction methods, such as t-distributed
stochastic neighbor embedding (t-SNE) (115) and uniform manifold approximation and
projection (UMAP) (116, 117) have gained much popularity. The t-SNE algorithm creates
an embedding of cells that preserves the probability distribution of neighbors around
each cell, such that cells close to each other in the high dimensional space have high
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probability being close together in the low dimensional embedding. With t-SNE, distinct
cell types often appear as disjoint islands in the embedding, making it easy to identify
rare cell types. For example, with t-SNE performed on ~7000 single cells from the airway
epithelium, Montoro et al. discovered the presence of a rare CFTR-expressing cell type
(96). These cells are found to be the primary source of the cystic fibrosis transmembrane
conductance regulator CFTR, and their dysfunction leads to phenotypes that are
characteristic of cystic fibrosis (96). The discovery was also made independently by
another group using a non-linear, graph-based algorithm, SPRING, which uses forcedirected layout to preserve the nearest-neighbor relationship of cells (118, 119). The
UMAP algorithm was recently favored by many biologists, as it not only preserves local
nearest neighbor structure like t-SNE, but also preserves the global distance relationship
to some degree (116, 117). In this way, dissimilar cells are often segregated into clusters
that are far away from each other, making it ideal to apply density-based clustering
algorithms, such as DBSCAN (120), or graph-based community detection algorithms,
such as the Louvain method (121).
To further improve accuracy and robustness of the clustering result, several
methods explore different metrics of cell-cell similarity. For example, SIMLR uses multikernel learning to generate a similarity matrix with an approximate block-diagonal
structure, which can be visualized with t-SNE and clustered using spectral method (122).
Similarly, the SC3 algorithm performs K-means clustering with various distance metrics
and performs consensus clustering on top of the K-means results (123). Other clustering
approaches aim to improve the flexibility of single cell clustering by allow varying
resolutions, such that cell types, subtypes and states can be hierarchically explored. To
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this end, several graph-based clustering methods have been developed, such as PAGA
(124) and Toomanycells (125).
Currently, annotation of clusters heavily relies on cell-type marker genes curated
from past literatures, and there is no gold standard for evaluating the accuracy of
clustering and cell type annotation. This paradigm may soon change due to the influx of
well-annotated single cell data, such as those from the Human Cell Atlas project (126)
and the Human BioMolecular Atlas Program (HuBMAP) (127). For developmental
biology, transcriptional atlases have also been created for multiple species (see Table
1.1 for a list of published datasets). Therefore, it is possible to train a cell type classifier
using large-scale reference datasets and predict cell type labels for newly profiled single
cells. Many methods have adapted classification algorithms such as random forest,
elastic net and neural network for this purpose, which has been extensively reviewed by
Pasquini et al (128). One limitation of such approaches is the accuracy of the classifier
heavily relies on the quality of the reference data. If a rare cell type or a transient cell
type is missing from the reference data, the algorithm may fail to identify it and may
classify it into a close cell type. Therefore, for analysis described in this thesis, I mainly
used unsupervised clustering to discover various cell types and cell states. In addition, I
compared data from this study to published datasets using enrichment of cell-type
signatures and projection method, which further validates our cell type annotations.

Modeling of differentiation trajectory, velocity, and potential
Single cell RNA-Seq provides a powerful way to investigate the sequential transcriptional
regulatory events during differentiation. To recapitulate the temporal sequence of gene
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regulation, a trajectory inference algorithm can be applied to order cells based on their
transcriptome similarity. Trajectory inference algorithms differ in their assumption about
the temporal structure of the underlying process, and the resulting trajectory can be
linear, cyclic, tree-like or of mixed types. For example, Wanderlust constructs K-nearest
neighbor (KNN) graphs based on cosine similarity between cells and draws shortest
path on the graph to obtain a single linear trajectory (129). The algorithm was applied to
model the B cell development and revealed a rare B cell precursor marked by its unique
pSTAT5 response to the cytokine IL-7. However, for complex developmental systems,
algorithms that allow branching and cyclic trajectories may be preferred, as cell cycle
and fate bifurcation occur recurrently throughout development. One of the earliest
trajectory inference method uses the PQ-tree algorithm to model the time-series
microarray data such as the cell cycle of bacteria (130), and was later adapted for single
cell data (131). Many other graph-based or tree-based algorithms for modeling
differentiation trajectory have been developed in recent years (124, 132-134) and have
been extensively reviewed by Saelens et al. (135).
Like single cell clustering, trajectory inference methods often rely on
dimensionality reduction techniques to obtain a low dimensional representation of the
“manifold” of transcriptomic states. Besides the widely used PCA, t-SNE and UMAP,
diffusion map (136) is another popular method for modeling differentiation as a diffusionlike dynamical process and has been successfully applied to complex developmental
systems such as the differentiation hierarchy of HSCs (137). A flexible trajectory
inference method, Slingshot (138), allows user to input custom dimensionality reduction
results and use principal curve analysis to fit linear or bifurcating trajectories. Slingshot is
one of the top ranked methods in terms of accuracy, stability and usability based on a
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recent comparison of trajectory inference methods (135). Therefore, it is used to
reconstruct the developmental trajectory of HSCs in this thesis, as described in Chapter
3.
With the inferred trajectory, “pseudo-time” can be assigned for each cell to reflect
its relative position along the differentiation trajectory. This enables differential
expression analysis to derive temporally differentially expressed genes that may be
responsible for cell fate specification. For example, one can apply the switchde algorithm
to find switch-like genes along single-cell trajectories (139), or use the BEAM method to
discover genes that are differentially activated at branching points (132).
Trajectory inference methods connect cells across developmental stages but
cannot determine the direction and rate of differentiation. To model the velocity of
transcriptome change during differentiation, the Velocyto algorithm exploits the RNA
splicing dynamics (140). When a gene is up-regulated, transcription initiation produces
large amount of unspliced mRNAs. The immature mRNAs undergo alternative splicing
and degradation, which brings the system to a steady state. Conversely, when a gene’s
expression is repressed, reduction of unspliced mRNA precedes the downregulation of
spliced mRNA, leading to a fast drop of unspliced versus spliced mRNA ratio. The RNA
dynamics can be modeled with a set of ordinary differential equations (ODEs), solving
which gives estimation of the rate of transcriptome change, or “RNA velocity”, for each
cell. Using the RNA velocity, one can extrapolate the future state of the cell, and project
that onto a dimensionality reduction plot. The projected velocity field enables automatic
identification of start and end point of differentiation and allows investigation of the cell
fate choices at bifurcating points. With RNA velocity estimated for the developing mouse
hippocampus, the authors identified radial glia cells as the root of the lineage tree of the
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hippocampus and observed fate biases before the trajectory branches into CA and
granule fate. One limitation of Velocyto is that it assumes the induction and repression of
gene expression last long enough to reach steady state, which is often not true for
transient cell populations in development. Therefore, a recent method scVelo was
developed to address this limitation by solving the full gene-wise transcriptional
dynamics (141). The concept was further extended to account for the protein translation
kinetics, such that protein velocity and acceleration can be estimated with joint profiling
of proteins and RNAs (142).
Lastly, during development, cells may have multiple differentiation potentials
before committing to a terminal fate. For example, scRNA-Seq and lineage tracing
experiment reveals that the hematopoietic stem and progenitor cells (HSPCs) exhibit a
continuum of transcriptome states with different fate biases (143). To computationally
resolve the fate potential of early progenitor cells, several algorithms, such as FateID
(144), Waddington-OT (145), and population balance analysis (146) have been
developed. Weinreb et al. benchmarked these methods using the HSPC lineage tracing
data and observed all three methods were able to resolve lineage potential for late-stage
cells but performed poorly on early-stage progenitors (143). Nevertheless, these
algorithms, combined with lineage tracing, provides important information about fate
specification mechanisms in early progenitors. By comparing the progenitors with
different fate biases, factors that drive fate choices can be derived and functionally
tested.
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Identifying transcriptional regulatory network
Transcriptional regulatory network (TRN) describes the regulatory relationship between
genes and provides systematic understanding of transcriptional regulation. However,
multiple challenges exist for the robust reconstruction of TRN with single cell data. For
example, currently, the state-of-art TRN algorithms for bulk gene expression data has a
precision of ~50% for prokaryotes, and performs poorly for eukaryotic organisms (147).
The technical noise and high dropout rate of single cell data adds to the variance, so the
performance of these bulk algorithms, if applied directly to single cell data, would be
even worse.
Despite of these caveats, single cell data presents unique opportunities for
accurate and robust inference of TRN. First, gene correlation analysis using single cell
data yields much more accurate estimation of co-expression relationship compared to
bulk methods, as the latter may suffer from Simpson’s Paradox (148). With single cell
clustering analysis, individual cell types can be identified and cell-type-specific TRNs can
be constructed. Second, trajectory inference and velocity analysis give temporal ordering
to the gene expression profiles, making causal inference of gene regulatory relationship
possible. Finally, other single cell data modalities such as scATAC-Seq provide
important information about active DNA regulatory elements, which can be used to infer
the cis- and trans-regulatory relationship. Indeed, many recently developed single cell
network analysis methods exploit these unique properties of single cell data and have
been successfully applied to several developmental systems (149-153).
In one of the earliest single cell study of blood stem and progenitor cells, celltype-specific TRN was constructed using expression profiles of 18 transcription factors
with known important roles in hematopoiesis (154). The authors observed that although
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most regulatory connections remain stable across cell types, some show clear
differences. For example, strong negative correlation between Gfi1 and Gata2 was only
observed in HSCs, and the correlation between Gata1 and PU.1 was strongly dependent
on the cell type, consistent with their switch-like function in controlling erythroid and
myelomonocytic fates (155, 156). Several single cell TRN inference methods, such as
LEAP (149), SINCERITIES (150), SCODE (151) and SCRIBE (152), explicitly uses time
information in their model. SINCERITIES first computes the Kolmogorov-Smirnov (KS)
distance to measure the differences in marginal gene expression distributions between
two consecutive time points (150). Regulatory connections were then inferred using
Granger causality, where the changes in transcription factor (TF) expression were used
to predict changes in its target genes. SINCERITIES were benchmarked using timestamped single cell data of monocytic THP-1 human myeloid leukemia cell differentiation
and gave much better predictions compared to methods that do not use time
information. To further improve the accuracy of TRN inference, several algorithms utilize
TF motif enrichment in active regulatory DNA elements. For example, the SCENIC
method (157) first infers TRN using expression-based methods, GRNBoost (157) and
GENIE3 (158), and then refines the TRN using motif enrichment analysis on promoters
of co-expressed genes. A recently developed method, CellOracle (153), uses scATACSeq data and motif enrichment analysis to assemble a “base” TRN, and then uses
scRNA-Seq data to convert the base TRN into cell-type specific TRNs. CellOracle was
used to map the network structure during hematopoiesis and correctly predicts the effect
of Gata1 knock-out on myeloid cell identity. Finally, it is worth noting that a newly
emerged single cell technology, Perturb-Seq (159, 160), enables profiling of thousands
of cells with genome-scale CRISPR perturbations, therefore presenting a new
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opportunity for causal TRN inference. So far, only a few TRN inference methods have
been developed for this type of data (159, 161).

Integrative analysis of single cell transcriptome and epigenome
The fast development of single cell technology has enabled profiling of various types of
molecular features at single cell resolution. The collection of multimodal single cell data
can be performed separately using biological replicates, or parallelly on one sample with
true multi-omics technologies (65-68). In the first case, both features and cells are
different across modalities, while in the second case, various types of features are
measured for the same set of cells. Statistical challenges for each of these cases are
different. At the time of the study described in this thesis, only the first type of technology
is commercially available. Therefore, I will focus on reviewing integrative analysis
methods for separately collected scRNA and scATAC data. However, it is worth noting
that several methods have been recently developed for integrative analysis of true multiomics datasets (162, 163).
One important challenge of integrative analysis of transcriptome and epigenome
data is that the correspondence between the features is unclear. For example, the
association between chromatin accessibility and gene expression is not completely
understood, thus there is no simple transformation that maps cells from gene expression
space to chromatin accessibility space, and vice versa. However, such relationship can
be learned if cells collected for both modalities have the same underlying distributions of
molecular states, which can be achieved through collection of biological replicates. The
MATCHER algorithm makes a simple assumption that single cell measurements are
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made from cells changing unidirectionally along a one-dimensional manifold, and for
each data modality cells are sampled from the same population, process, and cell type
(164). Given these assumptions, MATCHR performs manifold alignment to project cells
of different data modalities onto a shared 1D pseudo-time space. The authors applied
MATCHR to jointly analyze gene expression and DNA methylation changes during
human induced pluripotent stem cell (iPSC) reprogramming and observed an overall
trend that DNA methylation changes lag behind gene expression changes.
Several integration algorithms do not have strong assumption on the latent
manifold structure, but make certain assumptions about feature correspondence. For
example, LIGER leverages the well-established negative relationship between genebody methylation and expression to integrate single cell methylome and transcriptome of
mouse cortical cells (165, 166). Joint embedding of the two data modalities were learned
using integrative nonnegative matrix factorization and revealed multiple cell populations
that could not be identified using the methylation data alone. The Seurat v3 algorithm
builds upon a gene activity matrix, which can be computed by summing the scATAC-Seq
fragments in the gene body and promoter region (167). Canonical correlation analysis
(CCA) is applied to the gene activity matrix and gene expression matrix to obtain a joint
dimensionality reduction of both data modalities. Next, Mutual nearest neighbors (MNNs)
are identified and used as “anchors” for computing a set of correction vectors.
Subtracting these vectors from one dataset allows the two datasets to be merged and
jointly analyzed. GLUER (168) and scDART (169) also requires a pre-defined gene
activity matrix and utilizes the deep learning framework to learn a joint latent
representation of the cells.
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The technological development presents a unique opportunity for investigating
the association between transcriptome and epigenome during development and
differentiation. For example, Cao et al. (65) used a linear regression model to predict
gene expression from chromatin accessibility data and found that accounting for
accessibility at distal sites improved prediction by four-fold compared to using promoter
accessibility alone. One limitation of such method is that it can only be applied to true
multi-omics dataset. In Chapter 3, I developed a computational framework for joint
analysis of paired scRNA-Seq and scATAC-Seq data. The method first learns feature
correspondence from the data by matching differentially accessible peaks with
differentially expressed genes, then uses Seurat v3 to obtain a joint embedding of
scRNA and scATAC cells. Using paired meta-cells, I performed linear regression to
identify enhancer-promoter links that are important for the endothelial to hematopoietic
transition.
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Figures

Figure 1.1 C. elegans embryogenesis.
Reprinted from WormAtlas (9). Horizontal axis shows approximate time in minutes after
fertilization at 20-22°C. The stages, number of nuclei, marker events and DIC images of
the embryos and larva are shown above the axis. Yellow bars indicate period of early
cell migration. Blue bar shows gastrulation period (between 270 and 330 minutes). Red
bar indicates elongation of the embryo between 400 and 640 minutes.
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Figure 1.2 Cell lineage tree of C. elegans embryogenesis.
Only cells with birth time before 500 mins are shown. Lineage tree reproduced from
WormAtlas (9) and Sulston et al. (7) using VisCello.celegans (170). Length of each edge
is proportional to the lifespan of the cell, and the color represents the birth time of the
cell.

Figure 1.3 Single-cell RNA sequencing.
Created with BioRender.com. Biological samples are harvested and are dissociated into
a single cell suspension. Single cells are then isolated with a cell isolating device. Once
cells are isolated and lysed, sequencing library is prepared by reverse transcription and
cDNA amplification. After sequencing, the reads are aligned and quantified for
downstream data analysis.
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Figure 1.4 Single-cell ATAC sequencing.
Created with BioRender.com. Depending on the protocol, the order of single nuclei
isolation and tagmentation can be reversed. Single nuclei isolation can be performed
using methods such as microfluidics technology. Tagmentation involves using Tn5
transposase to insert sequencing adaptors to open chromatin regions. The resulting
DNA fragments are then amplified and indexed for sequencing.
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Tables
Table 1.1 List of large-scale single cell datasets for developmental biology.
SPECIES
Mus musculus
Mus musculus
Mus musculus
Drosophila
melanogaster
Xenopus
tropicalis
Danio rerio
(Zebrafish)
Danio rerio
(Zebrafish)
Hydra
Schmidtea
mediterranea
Spongilla
lacustris
Schmidtea
mediterranea
Ciona
intestinalis
Caenorhabditis
elegans

DEV. STAGE TECHNOLOGY
CELL# REFERENCE
E6.5-8.5
10x Genomics
116,312
(171)
E8.5-E9.5
10x Genomics
22,264
(172)
E9.5-13.5
sci-RNA-seq3 2,072,011
(59)
Embryo

Drop-seq

7,975

(173)

Embryo

InDrop

136,966

(174)

Embryo

inDrop

92,000

(97)

Embryo

Drop-seq

38,731

(175)

Adult

Drop-Seq

25,000

(176)

Adult

Drop-seq

21,612

(177)

Juvenile

10x Genomics

39,552

(178)

Adult

Drop-seq

66,783

(179)

Embryo

10x Genomics

90,579

(180)

Embryo

10x scRNA

86,024

(170), this
thesis

32

CHAPTER 2 A LINEAGE-RESOLVED MOLECULAR ATLAS OF C. ELEGANS
EMBRYOGENESIS AT SINGLE-CELL RESOLUTION

The contents of this chapter have been previously published as:
Packer JS*, Zhu Q*, Huynh C, Sivaramakrishnan P, Preston E, Dueck H, Stefanik D,
Tan K, Trapnell C, Kim J, Waterston RH, Murray JI. A lineage-resolved molecular atlas
of C. elegans embryogenesis at single-cell resolution. Science. 2019 Sep
20;365(6459):eaax1971.
* These authors contributed equally
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Introduction
To understand how cell fates are specified during development, it is essential to know
the temporal sequence of gene expression in cells during their trajectories from early
uncommitted precursors to differentiated terminal cell types. Gene expression patterns
near branch points in these developmental trajectories can help identify candidate
regulators of cell fate decisions (181). Single cell RNA sequencing (sc-RNA-seq) has
made it possible to obtain comprehensive measurements of gene expression in whole
animals (58, 177, 179, 182-184) and embryos (19, 59, 97, 171, 173-175). sc-RNA-seq
profiling of multiple developmental stages in a time series can be particularly informative,
as algorithms can use the data to reconstruct the developmental trajectories followed by
specific cell types. However, confounding factors can generate misleading trajectories.
For example, progenitor cell populations with distinct lineage origins may be conflated if
their transcriptomes are too similar, and abrupt changes in gene expression can result in
discontinuous trajectories. Thus, information from independent assays is necessary to
conclusively validate an inferred trajectory as an accurate model of development.
Here, we comprehensively reconstruct and validate developmental trajectories
for the embryo of the nematode worm Caenorhabditis elegans. C. elegans develops
through a known and invariant cell lineage from the fertilized egg to an adult
hermaphrodite with 959 somatic cells (6, 7), which creates the potential for a truly
comprehensive understanding of its development. Using sc-RNA-seq, the known C.
elegans lineage, and imaging of fluorescent reporter genes (17, 185), we produce a
lineage-resolved single cell atlas of embryonic development that includes trajectories for
most individual cells in the organism. Our atlas expands on previous studies of the
earliest embryonic blastomeres (18, 19), covering 87% of embryonic lineage branches.
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We use this dataset to quantitatively model the relationship between the cell
lineage and the temporal dynamics of gene expression. We find that during gastrulation,
lineage distance between cells is a strong predictor of transcriptome dissimilarity. The
strength of this correlation increases from the middle to the end of gastrulation. After
gastrulation, expression patterns of closely related cells diverge as they adopt their
terminal cell fates. Body wall muscle, hypodermis, and the intestine are exceptions to
this trend, as they are produced by semi-clonal lineage clades that maintain within-clade
transcriptomic similarity. In the ectoderm, the final two rounds of cell division produce
distinct neuron and glia cell types, which rapidly differentiate, often resulting in
discontinuities in computational reconstructions of their developmental trajectories. In
several cases, the transcriptomes of distant lineages converge as they adopt the same
terminal cell fate, and at the same time diverge from their close relatives in the lineage.
Our ability to reconstruct these complex gene expression dynamics highlights
both the utility of the known C. elegans lineage and the challenges that will be faced
when trying to use single cell RNA sequencing to reconstruct the lineages of other
organisms.

Results
Single-cell RNA-seq of C. elegans embryos
We sequenced the transcriptomes of single cells from C. elegans embryos with the 10x
Genomics platform. We assayed loosely synchronized embryos enriched for preterminal cells as well as embryos that had been allowed to develop for ~300, ~400, and
~500 minutes after the first cleavage of the fertilized egg. We processed the datasets
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with the Monocle software package (132). After quality control, the final integrated
dataset contained 86,024 single cells, representing a more than 60x oversampling of the
1,341 branches in the C. elegans embryonic lineage.
We estimated the embryo stage of each cell by comparing its expression profile
with a high-resolution whole-embryo RNA-seq time series (186) (Supplemental Figure
2.1). We then visualized the data with the Uniform Manifold Approximation and
Projection (UMAP) (116, 187) algorithm, which projects the data into a low-dimensional
space and is well suited for data with complex branching structures (187). We found that
trajectories in the UMAP projection reflect a smooth progression of embryo time (Figure
2.1A), with cells collected from later time points usually occupying more peripheral
positions (Figure 2.1B). Unique transcripts per cell, as estimated with Unique Molecular
Identifiers (UMIs), decreased with increasing embryo time throughout the period of
embryonic cell division, consistent with decreasing physical cell size (Supplemental
Figure 2.2). These observations suggest that UMAP trajectories corresponded to
developmental progression and that embryo time estimates are a reasonable proxy for
developmental stage for most cells. Approximately 75% of the cells recovered (64,384
cells) were from embryos spanning 210-510 minutes post first cleavage, corresponding
to mid-gastrulation (~190 cell stage) to terminal differentiation (3-fold stage of
development) (Figure 2.1C); however, cells were also recovered from earlier embryos (<
210 minutes, 9,886 cells), and later embryos (> 510 minutes, 11,754 cells).
We clustered cells in the UMAP using the Louvain algorithm (121) and annotated
clusters with cell type identities using marker genes from the literature on C. elegans
gene expression (188). Markers used for each annotation are listed in Table 2.1. The
global UMAP arranges cells into a central group of progenitor cells and branches
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corresponding to eight major tissues (Figure 2.1A, Supplemental Figure 2.3):
muscle/mesoderm, epidermis, pharynx, ciliated neurons, non-ciliated neurons,
glia/excretory cells, intestine, and germline. While some individual cell types were
identifiable in this global UMAP, many were not, especially progenitor lineages. To gain
resolution, we hierarchically created separate UMAPs of each tissue (Supplemental
Figures 2.4-2.13). These “sub-UMAPs” better resolved specific cell types, allowing us to
make extensive, fine-grained annotations.
A combination of marker genes, lineage assignments, and developmental time
allowed us to locate 112 specific terminal anatomical cell types, including every lineage
input to body wall muscle, every distinct subtype of pharyngeal muscle (pm1-2, pm3-5,
pm6, pm7, and pm8) and hypodermis (hyp1-2, hyp3, hyp4-6, hyp7, hyp8-11, seam, and
P cells), and every non-neuronal cell type in the mesoderm. We identified 69 of 82 nonpharyngeal neuron types and 9 of 12 glial cell types present in the embryo. We could not
identify 12 of 14 pharyngeal neuron types. A cluster corresponding to the most
differentiated pm3-5 pharyngeal muscle cells had a low level of expression of neuronspecific genes, suggesting that we failed to dissociate the neurons that innervate these
muscles in late embryos.
We successfully annotated 93% of cells in our dataset with a cell type (for
terminal cells) or a cell lineage (for progenitor cells, discussed below) (Figure 2.1D). The
number of cells annotated for each cell type was variable but roughly fit the expectation
on the basis of the number of cells of that type present in a single embryo (Figure 2.1E, r
= 0.64, p = 2.4e-13, t test).
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Mapping single cells to known C. elegans cell lineage tree
The structure of the global and single-tissue UMAPs was dominated by trajectories of
terminal cell differentiation. We hypothesized that closely related lineages could be
better resolved by separately analyzing progenitor cells prior to terminal differentiation.
Thus, we ran UMAP with only cells with embryo time <= 150, 250, or 300 minutes and
found branching patterns that reflect lineage identities (Figure 2.2, Supplemental Figures
2.14-2.16). Intestine and germline cells commit to their terminal fates very early and
have very divergent expression that distorts the projections, so they were removed and
analyzed separately (Supplemental Figures 2.7, 2.12). The 300-minute UMAP contained
several large quasi-connected groups corresponding approximately to major founding
lineages, roughly organized by the major fates produced by each founder cell lineage
(MS muscle, MS pharynx, C/D muscle and AB-derived lineages that produce either
pharynx, neurons/glia, or hypodermis). We were able to resolve additional details by
recursively making sub-UMAP projections of these cell subsets.
To annotate progenitor lineages, we exploited lineage marker genes from the
literature and the EPiC database, which contains single cell resolution expression
profiles extracted by cell tracking software from confocal movies of C. elegans embryos
expressing fluorescent reporters (17). In addition to the 180 previously described
patterns (17, 189), we have collected movies for 71 additional genes, increasing the total
number of patterns in EPiC to 251 genes. We annotated branches with lineage identities
between the 28-cell and 350-cell stages by finding genes that were differentially
expressed both between sister lineages in the EPiC data and between branches of the
sub-UMAP trajectories in a concordant manner (Figure 2.2, Supplemental Figures 2.142.16). For example, expression of ceh-51 is restricted to the MS (mesoderm-producing)
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lineage (190), allowing us to label the single group of ceh-51(+) cells in 150-minute
UMAP as part of the MS lineage (Figure 2.2A, B). Within this lineage, we used
expression of pha-4 to annotate the anterior granddaughters of MS (MSaa and MSpa)
and hnd-1 to annotate the posterior granddaughters (MSap and MSpp) (Figure 2.2C).
We applied this same logic iteratively across the different UMAPs and lineage marker
genes to annotate each branch with its lineage identity.
In most cases, branches in the progenitor lineage UMAPs corresponded directly
to sister cells in the lineage (Figure 2.2D, E), but some branches were unclear or
misleading, and marker gene expression was critical to annotate lineages correctly. For
example, ABpxpaaaa and ABpxpaapa are cousin lineages, but appear to branch as
sisters in the UMAP trajectory, and the same is true for their sisters (ABpxpaaap and
ABpxpaapp) (Figure 2.2D). In other cases, such as the ABpxppap lineage (Figure 2.2D),
marker gene combinations were required to annotate lineages that were not contiguous
with their parent or sister lineages in the UMAP. These misleading branches
demonstrate the importance of having independent expression or lineage data to
correctly interpret trajectories visualized in low-dimensional embeddings of sc-RNA-seq
data.
To complete our annotations, we used UMAPs of selected subsets of cells with
embryo time <= 350 or 400 minutes to reconstruct trajectories leading from the
grandparents and parents of terminal cells to their terminal descendants (Supplemental
Figure 2.17). Most terminal cell types were thus identified by two methods: first using
marker genes for the differentiated cell type, and second by following UMAP trajectories
from the cell’s progenitors. Notably, in all cases, the cell type predictions of these two
mostly independent methods were concordant.
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In total, we annotated 502 distinct cell lineages. Most lineage annotations
correspond to a symmetric pair of cells, with the exception of some terminal cell types in
which 3-18 cells converge to a homogenous transcriptomic state and could not be
further resolved. Our annotations account for 1,068 out of 1,228 individual branches in
the C. elegans embryonic lineage (Supplemental Figure 2.18), excluding the 113
branches that lead to programmed cell death. Combined with the dataset of Tintori et al.
(19), which profiles the 1- to 16-cell stages, we now have a near-complete molecular
atlas of C. elegans embryogenesis.
The lineages included in our atlas partially overlap with the Tintori et al. dataset
(19) at the 16-cell stage. Gene expression profiles for lineages annotated in both
datasets were concordant (Supplemental Figure 2.19). Additionally, gene expression
profiles for terminal cells in our data were concordant with previously published
microarray data (191) (Supplemental Figure 2.20).

Bifurcating cell fates and multi-lineage priming
Developmental trajectories in which a parent cell divides to produce two terminal
daughter cells of different cell types are a basic type of cell fate decision. Bifurcations
like these are common in neuronal lineages in C. elegans, such as those that produce
ciliated neurons. To examine the molecular basis for such developmental decisions, we
used recursive UMAP projections of ciliated neurons (Figure 2.3A) to identify
developmental trajectories for all but one of the 22 ciliated neuron types and their
parents, missing only the PHA phasmid neurons. The distinction between neuroblasts
and terminal neurons was supported by embryo time estimates consistent with terminal
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cell division times (192), by the expression patterns of cell cycle associated genes and
transcription factors (Figure 2.3B), and by the structure of the UMAP projection. A 3D
version of the UMAP featured better continuity for several trajectories, including those
connecting the ASG-AWA, ADF-AWB, and ASJ-AUA neuroblasts with their daughter
cells, as well as the branching of the laterally asymmetric left and right ASE neurons
(Supplemental Figure 2.21).
To identify potential regulators of cell fate decisions, we identified genes that
were differentially expressed between the branches of each bifurcating ciliated neuron
lineage. The lineage of the ASE, ASJ, and AUA neurons (spanning embryo time ~215650 minutes) serves as a representative example (Figure 2.3C). About 3-4 TFs are
specific to each terminal neuron type in this lineage (Figure 2.3D). Similar numbers of
branch-specific TFs were observed for other lineage bifurcations (Supplemental Figure
2.22). Beyond these simple cases, we also found several TFs that were expressed in a
parent cell and had expression selectively maintained in one daughter but not the other.
For example, the TFs ceh-36/37/43/45, ham-1, and hlh-3 are all co-expressed within
single ASE-ASJ-AUA neuroblast cells. ceh-36/37 and hlh-3 expression was maintained
in only one daughter of this neuroblast, the ASE parent, while ceh-43/45 and ham-1
expression was maintained only in the other daughter, the ASJ-AUA neuroblast
(Supplemental Figure 2.23).
This pattern, where a progenitor cell co-expresses genes specific to each of its
daughters, has been termed “multilineage priming” and has been observed in several
organisms and developmental contexts (174, 193-198). Our transcriptomic atlas of the
C. elegans cell lineage allows us to provide an unbiased quantification of the prevalence
of multilineage priming throughout the organism’s ectoderm and mesoderm (we lack
41

sufficient resolution in our annotations of the endoderm, which produces only one cell
type, the intestine). There are 172 instances in which we have data for a parent cell and
both of its distinct daughters. Of these, 52% exhibit multilineage priming. Multilineage
priming events are distributed throughout several generations of both the ectoderm and
mesoderm (Supplemental Figure 2.24), demonstrating that it is a common and pervasive
mechanism of gene regulation. The expression patterns of many TFs involved in
multilineage priming, e.g. hlh-3 (Supplemental Figure 2.23D), are confirmed by the
movies in EPiC (17).
Transcription factors that are both required for neuron type specification and
have expression maintained throughout the lifetime of the neuron are referred to as
“terminal selectors” (198). To identify potential terminal selectors, we looked for
transcription factors that were 1) expressed in a neuron type but not its sister in the
embryo and 2) expressed in the same neuron type at the L2 stage. This analysis
replicated 23 known neuron-TF associations (198) and identified 116 novel associations.
Other known associations may have been missed due to the extreme sparsity of the L2
stage data, and the fact that many terminal selectors are expressed at low levels in fully
differentiated neurons, or are expressed in both daughters of a terminal division. In
cases where a neuron’s sister undergoes programmed cell death, we looked for TFs that
are both enriched in the terminal cell’s most recent ancestor that has a surviving sister
cell (compared to that sister), and also have expression maintained throughout the
lifespan of the terminal neuron. This revealed novel associations, including ceh-6 for
AVH, ceh-8 for RIA, unc-62 for RIC, and lin-11 for RIC and RIM, in which the putative
terminal selector TF is expressed in a neuroblast before the terminal cell is produced,
suggesting that these lineages commit to a cell fate early.
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Only two neurons (ASE and AWC) are known to have left-right asymmetric gene
expression (199, 200). For both neuron types, the lineages of the left and right neurons
diverge in the early embryo at the 4-cell stage (< 50 minutes). Asymmetric gene
expression in our data, however, emerges only much later in embryogenesis. The
transcriptomes of ASEL and ASER diverged in our UMAP at ~650-700 minutes, with lim6 expressed specifically in the ASEL branch, consistent with previous studies (201, 202).
AWC left/right asymmetry occurs stochastically, with one neuron becoming “AWC-ON”
and the other becoming “AWC-OFF” (200). We identified a small cluster in the UMAP
with embryo time >700 minutes as AWC-ON based on srt-28 expression (Figure 2.3A)
(203). AWC-OFF is putatively part of the main AWC trajectory. No evidence of left/right
asymmetry was observed in neurons besides ASE and AWC.

Transcriptional convergence of co-fated lineages
While most bilaterally symmetric cells were not distinguishable by UMAP (as expected),
several cell types with >2-fold symmetry are produced by multiple non-symmetric lineage
inputs. These lineage inputs tended to cluster separately in our progenitor cell UMAPs,
while in our late-cell tissue UMAPs, we saw almost no evidence of heterogeneity within
the terminal cell types that they produce. This difference suggested that the
transcriptomes of these co-fated lineages were converging during differentiation.
One example of apparent molecular convergence of cells from distinct lineages
was the IL1-IL2 neuroblasts. The six IL1 and six IL2 neurons are produced by three
symmetric pairs of neuroblast lineages. Each neuroblast pair produces a pair of
bilaterally symmetric IL1 neurons, and likewise a pair of IL2 neurons. A UMAP of IL1/2
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neurons and progenitors revealed trajectories for these neuroblasts that converge
gradually over their lifespan (Figure 2.4A). The transcription factor ast-1 was transiently
expressed at extremely high levels (>10,000 TPM) during this process, suggesting that it
might play a role in homogenizing the IL1/2 neuroblast transcriptomes (Figure 2.4B).
Correspondingly, expression of genes differentially expressed between the input
lineages decreased over time, while expression of genes specific to terminal neurons
increased (Figure 2.4C-D). We observed similar lineage convergence via continuous
gene expression trajectories for other cell types, including hypodermis (Supplemental
Figure 2.8), head body wall muscle (Supplemental Figure 2.17), and GLR cells
(Supplemental Figure 2.17).
Like the IL1/2 neurons, IL socket glia (ILso) are produced by three symmetric
pairs of lineages. In contrast to the examples discussed above, trajectories formed by
the ILso progenitors and their terminal descendants were discontinuous in UMAP space
(Supplemental Figure 2.25). Discontinuous trajectories were also observed for several
other cell types from multiple tissues, including other glia, several neuron types, the
excretory gland, coelomocytes, and somatic gonad precursors (Z1/Z4) (Supplemental
Figure 2.25). Several lines of evidence suggest that these discontinuities reflect sudden
changes in the transcriptome rather than technical artifacts of sc-RNA-seq or UMAP.
Discontinuous trajectories had more genes differentially expressed between the parent
and daughter cells than continuous trajectories (Supplemental Figure 2.26). Almost all
discontinuous trajectories were observed in lineages where a parent cell gives rise to
two daughters of different broadly-defined cell types, e.g. a glia and a non-glial cell, or a
ciliated neuron and a non-ciliated neuron (Supplemental Figure 2.26). These
discontinuities were seen in both the global and the tissue-specific UMAPs, and with
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different UMAP parameters. Finally, for most discontinuous trajectories, cells had a
continuous distribution of embryo times (Supplemental Figure 2.27). However, a few
trajectories, such as that of the BAG neuron, had gaps in the embryo time distribution
indicative of potential sampling bias.
Body wall muscle (BWM) was exceptional in that lineage-related heterogeneity
persisted throughout differentiation. BWM is produced by multiple distinct lineages (C, D,
MS) and occupies a wide range of positions along the anterior-posterior (A-P) axis of the
animal. A UMAP of BWM cells identified distinct trajectories for the 1st row of head BWM
vs. all other BWM (Figure 2.4E). The non-1st-row trajectory was formed by input
trajectories that corresponded to lineages and progressed in parallel along the temporal
axis. Using marker genes that are expressed in domains along the A-P axis (17, 204206), we divided BWM cells in the UMAP into six “bands” (Figure 2.4E) and identified the
specific anatomical cells present in each band (Figure 2.4F). We found that the JensenShannon (JS) distance, a measure of transcriptome difference, between the
transcriptomes of posterior BWM (C lineage) vs. both the 1st and 2nd rows of BWM
(D/MS lineage) did not decrease over time (Figure 2.4G), indicating that BWM
heterogeneity persists throughout differentiation.

Temporal dynamics of the lineage-transcriptome relationship
The presence of discontinuities between progenitor cells and terminal cells in the UMAP
projections suggested that the terminal division could mark a shift from lineagecorrelated to fate-correlated gene expression. We asked how well the distance between
two cells in the lineage predicts the difference between their transcriptomes (as defined
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with the JS distance). We focused on the AB lineage, which produces mostly ectoderm
and accounts for ~70% of the terminal cells in the embryo. The AB lineage undergoes
roughly synchronized cell divisions, allowing us to group cells by generation. For
example, we refer to the 32 cells produced by 5 divisions of AB as “AB5” and so on.
In AB5 (early/mid-gastrulation; 50-cell stage), the earliest stage where our
lineage annotations were near-complete, sister cells were more similar than distant
relatives, but the difference was not large (Figure 2.5A). In AB6 (mid-gastrulation; 100cell stage) and AB7 (late gastrulation; 200-cell stage), the transcriptomes of sister cells
become more similar than in AB5, while those of distant relatives become more
divergent, resulting in a strong correlation between transcriptome distance and lineage
distance. In AB8 (350-cell stage), most epidermal cells exit the cell cycle and begin
terminal differentiation, while neuron/glia progenitors continue for 1-2 more cell divisions.
AB8 thus features a bimodal distribution of transcriptome JS distances: terminal
epidermal cells become highly distinct from neuron/glia progenitors, but cells within each
group are more similar (Supplemental Figure 2.28). Finally, most neuron/glia progenitors
in AB8 produce two terminal daughters in AB9 that have distinct cell fates and a much
weaker lineage-transcriptome correlation than in earlier generations.
Together, these statistics suggest that progenitor cells develop strong expression
signatures of their lineage identity, and that these signatures are rapidly lost or
overshadowed by new expression at the time of the terminal division. An analysis of
cells from the mesoderm (MS lineage) replicated the trends observed in the ectoderm
(Supplemental Figure 2.29A).
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To summarize the strength of the lineage-transcriptome correlation in a cell
generation as a single number, we developed a statistic analogous to the concept of
pseudo-R2 in generalized linear regression models. Consistent with the above analysis,
we find that the extent to which lineage predicts the transcriptome increases throughout
gastrulation, peaks at 55% in AB7, and then falls to 18% after terminal differentiation in
AB9 (Figure 2.5B). Next, we asked how much of the total pseudo-R2 for one cell
generation was attributable to gene expression signatures associated with each
preceding cell generation. For cells in AB5-8, the largest contributor to pseudo-R2 was
the identity of their ancestor in the AB3 generation (Supplemental Figure 2.30). This is
interesting because many of the clades formed at AB3 share a broadly-defined tissue
fate. For example, the clade founded by the cell ABala produces only neurons and glia,
while the clade founded by the cell ABarp produces mostly (but not exclusively)
epidermal cells. The second largest lineage signal was from the identity of a cell’s parent
in the preceding generation (i.e. the tendency of sister cells to be more similar than
cousins). Thus, both broad and fine-grained structure in the lineage contribute towards
shaping the transcriptome.
To investigate the potential regulatory mechanisms that differentiate sister cells,
we identified transcription factors (TFs) that distinguish each cell in AB5-9 from its sister.
The median number of these “lineage signature TFs” per cell increased over time,
ranging from 1.5 in AB5 to 14 in AB9 (Figure 2.5C). A substantial number of lineage
signature TFs (~40-50%) had expression selectively maintained in only one of a cell’s
two daughters (Figure 2.5D). In other words, TFs that distinguish a cell from its sister in
one generation are frequently re-used to distinguish that cell’s daughters from each
other. Sister cells are also differentiated by the expression of new TFs not present in
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their parents. The proportion of lineage signature TFs that are newly expressed ranged
from 33-61% and increased over time in AB6-9 (Figure 2.5E). Temporal dynamics of
lineage signature TFs were similar in the mesoderm (Supplemental Figure 2.29).
Taken together, these results highlight the incremental nature of cell fate
decisions: every terminal cell is the result of a series of lineage bifurcations, each of
which, on average, involves multiple differentially expressed TFs.

Global patterns of gene expression and transcriptome specialization
Hierarchical clustering of expression levels in all annotated lineages and cell types
provides a global view of expression dynamics for all genes in our dataset. A heatmap of
pre-terminal lineage expression profiles (Supplemental Figure 2.31) does not reveal
large clusters of genes specific to specific lineages, other than one cluster of genes
specific to the early C and D lineages. Similarly, most marker genes used for lineage
annotation are not part of large clusters of co-expressed genes. The clusters that do
form are composed of early tissue-specific genes. The lack of cluster structure in the
heatmap suggests that differential fates for tissue sub-lineages are specified by relatively
small sets of genes. By contrast, a heatmap of terminal cell type expression profiles
(Supplemental Figure 2.32) has more obvious structure. Cells in each major tissue
express ~500-1500 tissue-enriched genes. There is little reuse of tissue-enriched genes
between tissues other than hypodermis, which shares many genes with glia and
intestine. Neuron subtypes and other specialized cells (such as the hmc or M cell) are
typically distinguished from other cells within their tissue by expression of <20-300
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genes. Finally, there are substantial temporal changes in expression, especially in
muscle and hypodermis.
We observed substantial variation between cells in the Gini coefficient, which
measures how unequally different genes are expressed in a given cell type
(Supplemental Figure 2.33A). Hypodermis, seam cells, and the pharyngeal gland
express small sets of cell type specific genes at very high levels (high Gini coefficient),
while the intestine and germline feature diverse gene expression patterns (low Gini
coefficient). In several cell types, such as the pharyngeal gland, increases in Gini
coefficient over time coincide with decreases in the number of TFs expressed per cell
(Supplemental Figure 2.33B). Families of TFs also exhibit differential expression
patterns over time and across lineages. Nuclear hormone receptors (NHRs) are on
average activated later in development than other TF families, such as Forkhead and
Homeodomain TFs (Supplemental Figure 2.33C). Hypodermis and intestine express
many distinct NHRs, while expression of Sox family TFs is largely restricted to neurons,
glia and pharynx (Supplemental Figure 2.33D).

Discussion
The cells of C. elegans are limited in number and invariant in lineage and cell fate,
making it feasible to conduct comprehensive, whole-organism investigations. Yet within
this limited repertoire of cells exists an impressive diversity of cell types, which work
together to produce complex anatomical structures and behaviors. This study and our
previous work (17, 58) have shed light on the molecular basis for the specification of
these cell types, but are only the first step toward a comprehensive understanding of the
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molecular basis of development. We hope that this resource will help guide future
projects in the C. elegans community.
In contrast to developmental sc-RNA-seq datasets from other species, this
dataset links gene expression trajectories to the exact cell lineages they correspond to,
allowing steps in the process of differentiation to be associated with specific cell division
events. Thus, our data provide a quantitative portrait of Waddington’s landscape (207)
for a whole organism. The abruptness of many cell fate decisions in C. elegans, with
many distinct terminal cell types becoming distinguished only in the final embryonic cell
division, contrasts, however, with the smooth landscape in Waddington’s illustrations
and warrants further investigation.
We observe convergence of gene expression patterns in many instances where
distinct cell lineages produce identical or related cell types. Data from a recent atlas of
mouse organogenesis (59) suggests that this phenomenon is also prevalent in
vertebrates. For example, myocytes in the mouse atlas are produced by two convergent
trajectories, and excitatory neurons are produced by several trajectories.
Our analysis highlights two important challenges that will be faced by efforts to
reconstruct the cell lineages of other organisms using single cell RNA-seq. First is the
difficulty of accurately connecting developmental trajectories that start after the
convergence of lineages with similar cell fates to trajectories that span earlier stages of
development. A naive interpretation of the UMAP projection of the full dataset (Figure
2.1A) could lead to inferred trajectories that are inconsistent with the correct lineage (for
example, incorrectly concluding that hypodermis and seam cells are produced from a
common ancestor that previously diverged from the progenitors of neurons). Second is
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the difficulty of constructing continuous trajectories for lineages that undergo abrupt
changes in gene expression. In our data, progenitor cells that give rise to glia, excretory
cells, and non-ciliated neurons were more often than not disconnected to their terminal
daughters in UMAP space (Supplemental Figure 2.25, Supplemental Figure 2.26),
reflecting the fact that many of these lineages only commit to a terminal fate after their
final cell division.
Due to these challenges, we anticipate that constructing end-to-end trajectories
of vertebrate organogenesis will require single cell RNA-seq to be integrated with
experimental lineage tracing methods (208). It will also require improved computational
methods that can model heterogeneity among poorly-differentiated progenitor cells and
highly-differentiated cell types in an integrated manner.
Between this study, our previous study of the L2 stage (58), and earlier studies of
the 1 to 16-cell stage embryos (18, 19), a large portion of the early C. elegans life-cycle
has now been profiled by single cell transcriptomics. However, more datasets will be
needed to complete missing stages, including other larval stages and the adult soma
and germline. In the future, single cell profiling of different strains or species will be a
useful approach to examine the evolution of cell types and their expression programs. All
of these datasets will ideally be integrated into a single visualization platform, such as
VisCello (170), to allow full tracking of cell trajectories from fertilization through the end
of life. A greater challenge will be to discover the precise mechanisms that produce
transcriptomic outputs. Single cell transcriptome analysis of mutants will likely need to be
integrated with new single cell multi-omic technologies (209) to bring mechanistic studies
to a whole-organism scale.
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Materials and Methods
Sample preparation
To obtain a broad range of embryo ages, including early stages, roughly
synchronized C. elegans adults (N2 strain) were obtained by releasing embryos with
standard hypochlorite treatment and letting the L1 larvae hatch and undergo growth
arrest on unseeded plates. Starved L1s were transferred to NGM plates seeded with E.
coli OP50 bacteria. Embryos were released from these synchronized young adults using
hypochlorite treatment followed by three washes with L15-10 media. To generate cell
suspensions, embryos were then treated with 0.5 mg/ml chitinase at room temperature
until the shells were dissolved (30-40 minutes at ~22 °C) followed by dissociation of the
cells using a 3 ml syringe fitted with a 21 gauge 1¼ inch needle until >80% of embryos
were disrupted. The cell suspension was then passed through a 10 µm filter, washed in
phosphate buffered saline (PBS) and finally resuspended in PBS. An estimated 14,000
cells were loaded immediately onto a 10x Chromium instrument. The trypan blue
negative viable cell count was estimated using a hemocytometer and was >84% for all
samples.
To sample later stages more deeply, more tightly synchronized embryo
populations (used for the 300-minute, 400-minute, and 500-minute time series shown in
Figure 2.1B) were obtained through two cycles of bleaching adult worms (strain VC2010,
a strain derived from N2 that has been completely sequenced). On the first round of
synchronization, populations of mixed stage embryos recovered by hypochlorite
treatment of mixed populations were hatched overnight in egg buffer (118 mM NaCl, 48
mM KCl, 3 mM CaCl2, 3 mM MgCl2, 5 mM HEPES pH 7.2) with gentle shaking. The
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hatched L1s were plated onto 150 mm peptone rich NGM plates seeded with E. coli
NA22 at no more than 100,000 worms per plate. When worms reached the adult stage,
the number of embryos inside the adults was monitored until most had about 4 embryos
on each gonad arm. The adult worms were collected and treated with hypochlorite to
release embryos. The embryos were again allowed to hatch in the absence of food at 20
°C for 12 hours yielding a more tightly synchronized population of L1 worms. Around
250,000 L1 larvae were plated onto four 100 mm petri plates seeded with NA22 bacteria
and allowed to develop at 20 °C. As the worms reached the young adult stage, the
population was closely monitored. When about 20-30% of the adults had a single
embryo in either arm of the gonad, worms were subjected to hypochlorite treatment. The
time hypochlorite was added to the worms was considered t = 0 (see Warner et al. (210)
for typical age distributions). The capture time was taken as when the cells were loaded
onto the 10x Chromium instrument. The embryos were allowed to develop in egg buffer
until one hour prior to capture time. The embryos were collected by centrifugation,
resuspended in 0.5 ml egg buffer and 1 ml chitinase (1 U/ml), and transferred to 30 mm
petri dishes. The degradation of eggshell was monitored; after ~20 min (when about half
the eggs had lost the shell), the suspension was transferred to a 15 ml falcon tube and
centrifuged at 200 g for 5 min. The chitinase solution was aspirated; a solution of 200 ul
pronase (15 mg/ml) together with 0.5 ml egg buffer was added to the embryo pellet. The
vitelline membrane was disrupted and the cells released by repeated passage through
21 gauge 1¼ inch needle attached to a 1 ml syringe. When sufficient single cells were
observed, the reaction was stopped by adding 1 ml of egg buffer containing 1% BSA.
Cells were separated from intact embryos by centrifuging the pronase treated embryos
at 150 g for 5 min at 4 °C. The supernatant was transferred to a 1.5 ml microcentrifuge
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tube and centrifuged at 500 g for 5 min at 4 °C. The cell pellet was washed twice with
egg-buffer containing 1% BSA.
Single cell capture and library preparation followed 10x Genomics published
protocols. For each channel, 14,000 C. elegans cells were mixed with reverse
transcriptase reaction solution and loaded immediately onto the capture chip to minimize
the time that the cells spent in the reverse transcription cocktail. The exception was the
first 500 minute sample, when three channels were loaded with 14,000, 4,666, and
1,555 cells respectively.

Read mapping and gene expression quantification
The single cell RNA-seq data was processed using the 10x Genomics CellRanger
pipeline. Reads were mapped to the C. elegans reference transcriptome from
WormBase (188), version WS260. We noticed that many 3’ UTR annotations in the
reference transcriptome were too short, causing genic reads to be called as intergenic,
affecting gene expression quantification. To address this, we also mapped reads to
modified versions of the WS260 transcriptome in which all 3’ UTRs were extended by
either 100, 200, 300, 400, or 500 bp (these 3’ UTR extensions were cut short if the
extended UTR would overlap with a downstream gene).
We then defined a set of criteria that specified for each gene whether it was
beneficial to extend the 3’ UTR for that gene, and if so, by how much. For each gene, we
counted the number of reads across the entire dataset mapped to that gene for each
version of the reference. We computed the ratio of the read counts from the 500 bp 3’
UTR extended reference to the baseline reference. If this ratio was < 1.2, or if the total
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read count for the gene in the 500 bp 3’ UTR extended reference was < 20, we used the
baseline 3’ UTR annotation for that gene. Otherwise, we used the shortest 3’ UTR
extension (100, 200, 300, 400, or 500 bp) that gave at least 90% of the read count gain
that was given by the 500 bp 3’ UTR extension.
We repeated this process with reads from our previous study on L2 worms (58).
If a gene met our criteria for extending the 3’ UTR based on embryo reads, we used the
extension length determined by the embryo reads. If a gene did not meet our criteria for
extending the 3’ UTR based on embryo reads but did meet the criteria based on L2
stage reads, we used the extension length determined by the L2 stage reads. After
deciding on how much to extend each gene’s 3’ UTR, we made a final reference
transcriptome incorporating all of the per-gene 3’ UTR extension lengths. We then used
this final reference transcriptome as input to the CellRanger pipeline to generate geneby-cell UMI count matrices.

Criteria for distinguishing cells from empty droplets
The default barcode filtering algorithm in the 10x CellRanger pipeline can fail for
experiments where the cells profiled are highly variable in size, resulting in a non-normal
distribution of UMIs per cell. This is the case for our data. The total volume of the C.
elegans embryo remains constant as cells divide within it, making cells of later
generations smaller than those from earlier generations. Additionally, some cell types
are more prone to damage and mRNA leakage than others. Neurons in particular usually
have lower UMI counts than other cell types. To account for these factors, we manually
set UMI count thresholds to distinguish cell barcodes from empty droplet barcodes on a
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sample-by-sample basis, based on the knee plots reported by CellRanger. The UMI
count thresholds ranged for 700-1100.
While performing downstream analyses, we noticed that several neuronal, glial,
rectal, and excretory cell types were missing from our data. We discovered that this was
due to cells with extra low UMI counts (< 700 UMIs) being excluded by our UMI count
thresholds. Lowering the UMI count threshold for all cells, however, would include lowquality, potentially damaged cells for other cell types where the average UMIs/cell is
higher. To integrate the low-UMI count cells, we:
1. made a set of all cells with UMI count >= 500 (vs. the previous threshold of 700)
2. ran UMAP dimensionality reduction (described below) on this set of cells
3. identified clusters of cells corresponding to neurons (using the pan-neuronal
marker genes sbt-1 and egl-21) or glia, rectal, and excretory cells (using a variety
of markers, see Table 2.1)
4. made new UMAPs from just neurons, just glia and excretory cells, or just rectal
cells
5. filtered putative doublets (i.e. cells also expressing markers of non-neuronal cell
types in the neuron UMAP, or cells also expressing markers of nonglia/hypodermal cell types in the glia UMAP)
6. made whitelists of the remaining cells
These whitelisted low-UMI count cells were then included when generating the final
tissue UMAPs presented in this paper (Figure 2.3A, Supplemental Figures 2.9-2.11,
2.13). They are not included in the original global UMAP (Figure 2.1A).
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Dimensionality reduction
For each dimensionality reduction (both for the global analysis of all cells and the tissue
specific analyses), the first step was to perform PCA and adjust the PCA results to
correct for batch effects. We performed PCA on the size-factor corrected, log
transformed expression matrix, typically with 50-100 PCs depending on the dataset.
For batch effect correction, we noted that the predominant source of batch
effects in our data appeared to be background contamination where RNA from lysed or
damaged cells enters droplets in the 10x sc-RNA-seq apparatus that contain intact cells,
causing each cell to receive reads from exogenous RNA. For each experimental sample,
we computed the gene expression distribution of this background RNA by summing the
read counts for cell barcodes that had < 50 UMIs, i.e. empty droplets. We transformed
the background RNA count vector for each sample as if it were the count vector for a
cell, and projected this vector into the PCA space computed from real cells. We then
computed the dot product of each real cell PCA coordinate vector with each sample’s
background vector, calling this the “background loading” of a given cell for a given
sample (each cell actually comes from exactly one sample, but computing each cell’s
loading for each sample’s background made the next step
mathematically/computationally simpler). Next, we fit a linear regression model, real cell
PCA coordinate matrix ~ cell background loadings, and called its residuals the
“background corrected PCA matrix.” This background correction method is similar to, but
developed independently of, a recently published method (211).
We found that the UMAP (116, 187) algorithm, which provides a way to project
the data into a low-dimensional space, better maintains the topology of the dataset
compared to the commonly used t-SNE algorithm. In our dataset, UMAP often creates
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long, continuous trajectories, while t-SNE clusters distinct cell types but does not clearly
show the relationships between them. UMAP and t-SNE have been compared in the
context of sc-RNA-seq by Becht et al. (187), but this paper focuses on the empirical
performance of the algorithms and does not explain precisely how and why the
mathematical differences between the algorithms underlie their qualitatively different
results. We chose UMAP over t-SNE based on our subjective evaluation of how the two
algorithms’ results compared to our expectations given the known C. elegans lineage.
We reduced the dimensionality of the background corrected PCA matrix to 2 or 3
dimensions using UMAP, using the wrapper function for this algorithm provided by the
Monocle software package, version 3 alpha (the reduceDimension function). The UMAP
parameters were: metric = “cosine”, min_dist = 0.1, n_neighbors = 20.
Lastly, cells in the UMAP space were clustered using the Louvain algorithm
(121). The Louvain algorithm is one of several algorithms that group nodes in a
weighted, undirected graph into clusters in a way that seeks to maximize a statistic
called “modularity.” Modularity is essentially the difference between the total edge weight
between nodes assigned to the same cluster and the expectation of the total withincluster edge weight if all edges were randomized. Exact optimization of modularity is
computationally intractable for large graphs, so the Louvain algorithm uses a heuristic. In
the context of our study, the graph used for the Louvain algorithm is a k-nearest
neighbor graph (k = 20) constructed from cell coordinates in UMAP space.
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Doublet identification
We used two complementary methods to identify doublets. The first method involved
identifying clusters of doublets in iterated UMAP projections of the data on the basis of
co-expression of high-confidence cell type specific marker genes, reported in WormBase
(188), for >1 cell type (e.g. a cluster expressing the muscle markers myo-3 and pat-10
along with the neuron markers egl-21 and sbt-1 was considered a muscle-neuron
doublet cluster). We applied this simple approach to a global UMAP of all cells and
iterated UMAPs of tissues / related groups of cells from the global UMAP (e.g. muscle,
intestine, ciliated neurons, etc.).
The second approach involved logistic regression models, one for each broadlydefined terminal cell type (e.g. body wall muscle, intestine, ciliated neurons, non-ciliated
neurons, etc.), that predict whether a cell is part of that cell type or not. We fit one such
model for each broadly-defined cell type and used the models to score each cell for the
probability of it being a member of each broadly-defined cell type. Cells that had >= 2
cell types with a >= 20% predicted probability of the cell being a member of that cell type
were considered doublets. Clusters in the UMAP projections that were enriched for cells
considered doublets by these regression models were manually examined, and in some
cases manually filtered.
Due to the abundance of cell type specific marker genes, we estimate that we
were able to filter out almost all terminal cell type doublets. Residual expression of
genes from one cell type in a cluster corresponding to another cell type appears to be
driven by background RNA contamination, not doublets. Our approach is less likely to
catch doublets between progenitor cells that do not yet express marker genes of
differentiated terminal cell types. For earlier-stage embryos however, the cell
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dissociation protocol works more reliably than for late-stage embryos, so we expect the
doublet rate to be close to the reported rate for the 10x Genomics Chromium platform,
which is low (~4.5% given ~9k cells loaded per lane).
While performing downstream analyses, we noticed that a few cell types were
missing from our data, including rectal epithelial and gland cells, the excretory duct and
pore, and the T cell. These were erroneously excluded by our doublet filter due to coexpressing genes that were enriched in two or more tissues (e.g. co-expressing
hypodermis-enriched genes with pharynx-enriched genes). We used marker genes to
identify these cells in a non-doublet-filtered global UMAP, whitelisted them, and included
them in the appropriate tissue UMAPs (Figure 2.3A, Supplemental Figures 2.9-2.11,
2.13). These cells are not included in the global UMAP (Figure 2.1A).

Embryo time estimation
For each cell, we estimated the age of the embryo that the cell came from (“embryo
time”) based on Pearson correlation of its transcriptome with bulk RNA-seq time series
data from Hashimshony et al. (18). Their data show that the majority of genes that
change expression over time in any given lineage are not lineage specific. Thus, we first
defined a list of genes with time-dependent expression patterns, requiring an autocorrelation greater than 0.6 and standard deviation greater than 1.5 across bulk RNAseq time points (units = log TPM). Pearson correlation was then computed between logscaled single cell and bulk data using only the time-dependent genes. We observed for
non-multiplet cells, the Pearson correlation across time shows a strong peak pattern
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(Supplemental Figure 2.1A). Thus, by fitting a Loess regression curve and finding its
maximal point, we were able to assign each cell with its most correlated bulk time point.
Embryo times estimated based on data from Hashimshony et al. (18)
approximately agree with embryo collection times from our experimental design
(Supplemental Figure 2.1B), and also have a strong correlation with embryo times
estimated based on data from Boeck et al. (212) (Supplemental Figure 2.1C). To further
validate our embryo time estimates, we computed for each anatomical cell in the C.
elegans embryonic lineage the 5th percentile of the embryo times for the set of sc-RNAseq cells that we annotated as corresponding to that anatomical cell. This effectively
estimates the birth time of the anatomical cell. These cell birth time estimates correlated
well with cell birth time estimates derived from live imaging (192) (Supplemental Figure
2.1D).
In the Waterston lab samples, embryos were incubated for a specific amount of
time after hypochlorite treatment. However, each sample has some outlier cells with
abnormally low embryo time estimates, i.e. lower than the incubation time. There are
several biological and technical factors that could produce these outlier cells. The
developmental rate of C. elegans embryos can vary by over 2-fold depending on
temperature, and may also be influenced by differences in crowding, hypoxia, or the
effects of hypochlorite and chitinase treatment. Consistent with this, embryo times
estimated using data from Boeck et al (212), which was collected using methods more
similar to those used in this study, were systematically later than embryo times
estimated using data from Hashimshony et al. (18) (Supplemental Figure 2.1C).
Alternatively, some cells may have embryo time estimates that are lower than the true
developmental age of the embryo they came from. Sparsity in the single cell data
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contributes to noise in the estimates. Finally, the most extreme outlier embryo time
estimates in each sample are for germline cells. The germline maintains expression of
many genes that turn off during early embryogenesis in all other cells. This causes
embryo time estimates based on correlation to bulk RNA-seq to be inaccurate for this
cell type.

Per-cell background correction and filtering
Our method for correcting for background RNA contamination, described in the section
above titled “Dimensionality reduction”, works solely on the level of PCA coordinates and
does not change the underlying gene-by-cell expression matrices. We used a separate
background correction method to adjust these gene expression matrices on a per-cell
basis for purposes of making plots of gene expression.
Our per-cell background correction method relies on a panel of cell-type specific
marker genes that are assumed, based on the literature (and confirmed empirically in
our data), to be specific to either hypodermis (including seam and P cells) or body wall
muscle (BWM). The hypodermis-specific genes were: sqt-3, dpy-17, dpy-14, dpy-10,
dpy-7, dpy-2, dpy-3, bus-8, wrt-2, and noah-1. The BWM-specific genes were: pat-10,
mlc-3, cpn-3, clik-1, ost-1, mlc-1, mlc-2, tni-1, ttn-1, unc-15, and myo-3.
The gene expression distribution for the background contamination of each
biological sample was estimated by aggregating the reads for cell barcodes that had <
50 UMIs, which were assumed to correspond to empty droplets in the 10x sc-RNA-seq
apparatus. The expression level of each gene in the panel was computed for each
sample’s background, measured in transcripts per million (TPM). Similarly, the
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expression level of each gene in the panel was computed for each cell, also measured in
TPM. The background fraction of a cell was estimated as the sum of the expression of
panel genes in the cell divided by the sum of the expression of panel genes in the
background distribution for the sample that cell came from. For cells annotated as
hypodermis, glia, or potential progenitors of those cell types, hypodermis-specific genes
from the panel were excluded from the computation. Likewise, for cells annotated as
body wall muscle, intestinal/rectal muscle, or a non-pharyngeal mesoderm cell type, as
well as progenitors of those cell types, BWM-specific genes from the panel were
excluded from the computation. For all other cells, all genes from the panel were used.
The median estimated background fraction across all cells in the dataset was
17.7%. Putatively damaged cells with an estimated background fraction >= 75% (8.3%
of all cells, see Supplemental Figure 2.34A) were filtered entirely from all subsequent
plots and analyses. For the remaining cells, the cells’ gene expression profiles were
corrected to subtract the contribution from background. A cell’s raw gene expression
vector (UMI counts) was converted to transcripts per million by dividing each entry by the
sum and multiplying by one million. The background-corrected TPM value for each gene
was computed according to the formula:
background-corrected TPM =
max(raw TPM - background fraction * background TPM, 0)
where background TPM is the expression of the given gene in the background
distribution for the biological sample that the cell came from. The background-corrected
TPM values were then rescaled to sum to 1,000,000 and then converted back to
(pseudo-)counts based on the total UMI count of the cell. Fractional count values were
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rounded probabilistically (i.e. a value of 2.7 was rounded to 3.0 with a 70% chance and
to 2.0 with a 30% chance).
After background correction, cells with low background fractions and cells with
high background fractions have near-identical average gene expression profiles
(Supplemental Figure 2.34B). This indicates that non-background gene expression
observed in high background cells is not systematically biased compared to low
background cells.

Differential expression analysis for Figure 2.3D and Supplemental Figure 2.22
We included four classes of transcription factors (TFs) in the heatmaps of Figure 2.3D
and Supplemental Figure 2.22. Both figures consider differential expression of TFs
between different ciliated neuron lineages. For the division of a parent neuroblast into
two daughter cells, the four TF classes of interest were:
1. TFs enriched in one daughter vs. the parent and vs. the other daughter
2. TFs depleted in one daughter vs. the parent and vs. the other daughter
3. TFs enriched in the parent vs. both daughters and vs. other neuroblasts of the
same cell generation
4. TFs enriched in parent vs. other neuroblasts of the same cell generation; and in
both daughters vs. other terminal cells
We considered a TF “enriched” in cell set A vs. cell set B if the expression in A was at
least 3-fold higher than in B; and if the difference in expression was statistically
significant with q-value < 0.01. We considered a TF “depleted” in cell set A vs. cell set B
if it was “enriched” in B vs. A. q-values were computed using the Monocle (version 3
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alpha) function “differentialGeneTest”. Differential expression tests were performed for
all genes, not just TFs-the non-TF results were discarded, but this was done to produce
more conservative q-values compared to considering only TF DE tests. Cells with
embryo time >650 minutes were excluded from all comparisons. Due to limited figure
space, some TFs that matched the criteria of the four TF classes but had low absolute
expression levels were excluded from the figure heatmaps.

Derivation of lineage specific and terminal cell type specific genes for Figure
2.4D
Lineage specific genes were derived by one vs. rest differential expression analysis on
the three input branches based on Louvain clustering results and annotations from
Supplemental Figure 2.15, using “sSeq” (213), as implemented in the cellrangerRkit
package. Genes associated with IL1/IL2 terminal cell types were derived by comparing
IL1/IL2 cells to all other ciliated neurons in Figure 2.3A. For each of the gene sets, the
average TPM across all genes in the set was computed for cells from each of the three
input branches, binned in 30-minute intervals up to 390 minutes, where the branches
can no longer be distinguished from each other in the UMAP. Values in each heatmap
were linearly rescaled to be within the range of 0 to 1.

Pseudo-R2 statistic
For each anatomical cell annotated in our dataset, we compute an aggregate gene
expression profile from all of the sc-RNA-seq cells that we annotated as corresponding
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to that anatomical cell. This procedure is described in above section titled, “Computing
aggregate gene expression profiles for cell types and lineages.” The result is that each
anatomical cell is associated with a vector of relative gene expression values. We refer
to this vector as the anatomical cell’s “transcriptome.”
In Figure 2.5B and Supplemental Figure 2.29B, we seek to estimate the extent to
which the transcriptomes of cells in a given generation of the AB or MS lineages are
predicted by the lineage. To do this, we have defined a statistic that measures how
much more similar, on average, are the transcriptomes of sister cells compared to
random pairs of cells. Specifically, we compute:
average Jensen-Shannon divergence between the transcriptomes
of pairs of sister cells in the cell generation
1 - ——————————————————————————————————————————————————————————————
average Jensen-Shannon divergence between the transcriptomes
of random pairs of cells in the cell generation
In the main text and figures, we refer to our statistic as a pseudo-R2 statistic. The
so-called pseudo-R2 statistics are a family of statistics that have been proposed in the
context of generalized linear regression models (214) and aim to have similar properties
to the coefficient of determination, R2, that is commonly used in the analysis of ordinary
linear regression models. Similarly, the statistic we have defined aims to have similar
properties to R2, despite not being mathematically comparable to it in a rigorous sense.
Below, we discuss the similarities between our pseudo-R2 statistic and R2.
One of several equivalent definitions of R2 for an ordinary linear regression model
is:
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mean squared error of the regression model’s predictions
1 - ————————————————————————————————————————————————————————
overall variance of the response variable
This formula for R2 and our formula for pseudo-R2 are both expressed in terms of a
fraction subtracted from one. The numerator in our formula for pseudo-R2, which we
defined in terms of the Jensen-Shannon divergence, can be re-expressed as the
average prediction error of a certain regression model, analogous to the numerator of
regular R2.
Specifically, the numerator in our pseudo-R2 is equivalent to the average
prediction error of a model that:
1. seeks to predict a cell’s transcriptome based on the identity of its parent.
2. measures the deviation between its predicted transcriptome and the observed
transcriptome for a cell using the Kullback-Leibler (KL) divergence.

Methods used in Supplemental Figure 2.30
In Supplemental Figure 2.30, we estimate the extent to which the ability of lineage to
predict the transcriptome in a given cell generation, “generation N”, is a consequence of
gene expression signatures associated with each of the preceding cell generations 1 to
N-1. We compute the overall ability of the lineage to predict the transcriptome in
generation N using the pseudo-R2 statistic described in the previous section. To
compute the contribution of the parent generation N-1 to the total pseudo-R2 for
generation N, we use the formula:
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(average JS divergence between cells that share a grandparent average JS divergence between sisters)
———————————————————————————————————————————————————————————————
average JS divergence between random pairs of cells
This formula evaluates how much more similar are cells that share a parent (i.e. sisters)
than cells that share a grandparent (i.e. cousins or sisters), and scales this relative to the
average dissimilarity of random pairs of cells in the same generation.
Generalizing this formula, we estimate the contribution of the generation N - M
as:
(average JS divergence between cells with lineage distance <= M+1 average JS divergence between cells with lineage distance <= M)
——————————————————————————————————————————————————————————————————
average JS divergence between random pairs of cells
where the lineage distance between two cells is the number of cell divisions since their
most recent common ancestor (1 for sisters, 2 for cousins, etc.).
Using this formula, the sum of the contributions of each ancestor generation 1 to
N-1 simplifies to:
(average JS divergence between cells with lineage distance <= N-1 average JS divergence between cells with lineage distance <= 1)
———————————————————————————————————————————————————————————————————
average JS divergence between random pairs of cells
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All cells in generation N have lineage distance <= N-1, so the first term in the numerator
is equal to the average JS divergence between random pairs of cells (same as the
denominator). Furthermore, the only cells with lineage distance <= 1 are sisters. Making
these substitutions, we get:
(average JS divergence between random pairs of cells average JS divergence between sisters)
—————————————————————————————————————————————————————
average JS divergence between random pairs of cells
Which simplifies to our original statistic for total pseudo-R2:
average JS divergence between sister cells
1 - —————————————————————————————————————————————————————
average JS divergence between random pairs of cells
This equivalence is a consequence of the following:
1. When tasked to predict the transcriptomes of two sister cells, a model that
predicts a cell’s transcriptome based on the identity of its parent effectively
guesses the midpoint of the two sister cells’ transcriptomes.

2. Therefore, if one measures the deviation between the model’s predictions and
the observed transcriptomes using KL divergence, then the mean prediction error
of the model, when applied to pairs of sister cells, is simply the average KL
divergence between each cell’s transcriptome and the midpoint of it and its
sister’s transcriptomes.
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3. By the definition of Jensen-Shannon (JS) divergence, this is the same as the
average JS divergence between each pair of sister cells’ transcriptomes, which is
the numerator used in our pseudo-R2.

The denominator of our formula for pseudo-R2, the average JS divergence
between the transcriptomes of random pairs of cells, is a measure of the overall
variability in the transcriptomic data. This is analogous to the denominator of regular R2,
which is also a measure of the overall variability (i.e. the variance) of the response
variable in an ordinary linear regression model.
Thus, both the numerator and the denominator in our formula for pseudo-R2
are qualitatively similar measurements to the numerator and denominator of regular R2.

Computing the adjusted Gini coefficient for Supplemental Figure 2.33A
The Gini coefficient is biased by sample size (215). Therefore, to adjust for total UMI
count differences between cells, we first downsampled the data from each cell to a total
of 500 UMIs (the minimum UMI count across all cells) using a multinomial distribution,
with probability equal to each gene’s UMI count divided by the total UMI count of the cell.
We then computed Gini coefficients for each cell using the downsampled data, and used
the z-score of the adjusted Gini coefficients to compare transcriptome inequality across
cells.
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Comparison of data from this study to public single cell dataset
Due to technical limitations, we have data from relatively few cells prior to the 28-cell
stage. Therefore, we compared single cell RNA-seq profiles of cells from the 16-cell
stage collected by Tintori et al. (19) to their corresponding lineages or immediate
descendants in our dataset (Supplemental Figure 2.19). We downloaded normalized
expression data (measured in reads per kilobase of transcript per million mapped reads,
RPKM) from Tintori et al. (19) and computed average log2 normalized expression levels
for each of their annotated lineages. We then applied the same log2 transformation on
our normalized gene expression data, and measured pairwise similarity between the
expression vectors for each lineage using Pearson correlation. To enrich for lineagespecific signals, we computed correlation using gene sets that had been selected by
Tintori et al. (19) using an iterative PCA approach. Gene sets 7, 9, and 10 in
supplemental document S1 of Tintori et al. (19) were used to discriminate 16-cell stage
lineages. Set 8 was excluded because most germline (P4) specific genes are also
differentially expressed over time throughout the whole embryo and thus confound time
with lineage. Intersecting genes from sets 7, 9, and 10 with genes detected in our data,
we obtained a list of 593 genes that we then used to generate the correlation matrix
shown in Supplemental Figure 2.19A. Hierarchical clustering was performed on the
correlation matrix using the pheatmap package with default parameters (216).
To demonstrate that our data are consistent with Tintori et al. (19) at the level of
single cells, we repeated their PCA analysis and projected 16- and 28-cell stage cells
from our dataset onto the PCA space derived from their dataset (Supplemental Figure
2.19B-E). The distribution and orientation of lineages in the PCA space was similar for
our and their data. For example, the PCA in the top sub-panel of Supplemental Figure
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2.19B was computed using all 16-stage cells from Tintori et al. (19) and 421 genes
(intersection of Set 7 and expressed genes in our data). In the bottom sub-panel of
Supplemental Figure 2.19B, we projected 292 cells from the 16- and 28-cell stages from
our dataset using the loading matrix derived from the PCA of the Tintori et al. data (19).
Germline (P4, Z2/Z3) and endoderm lineage (Ex, Exx) cells from our data are located at
the left and right-hand sections of the PCA projection respectively, consistent with the
pattern observed with cells from Tintori et al (19).
Spencer et al. (191) used microarrays to profile the transcriptomes of C. elegans
cell types obtained by fluorescent activated cell sorting. For each cell type they profiled,
they derived a set of genes that are enriched in that cell type compared to all other cells.
We used these “signature” gene sets to validate our cell type annotation and the
robustness of our data. First, we downloaded signature gene sets from cell types profiled
at the embryonic stage from
https://www.vanderbilt.edu/wormdoc/wormmap/Enriched_genes.html. We then used the
AUCell package (217) to check for enrichment of Spencer et al. (191) signature genes in
single cells from our dataset. For each cell, AUCell ranks genes by expression level and
computes a recovery curve for each gene set. It then uses “Area Under the Curve”
(AUC) as a measure of enrichment of the gene set.
We found most Spencer et al. (191) signature genes have strong enrichment in
the corresponding cell types in our data (Supplemental Figure 2.20). Due to the method
by which the Spencer et al. (191) signature genes were derived—comparing one cell
type to all other cells—most of the genes are tissue-specific, not cell-type specific, so
enrichment was in some cases also observed in a set of several related cell types in our
data.
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Spencer et al. (191) signature genes for pharyngeal muscle were unusual in that
they were enriched in intestine cells from our dataset. Examining the pharyngeal muscle
gene set, we noticed it contains elt-2 and elt-7, which are known to be endoderm specific
(218). Checking this gene set against expression patterns from Warner et al., 2019
(210), we found that 18 out of the top 20 genes are intestine specific/enriched.
Therefore, we concluded the pharyngeal muscle signature list is problematic and
dropped the comparison from Supplemental Figure 2.20.
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Figures

Figure 2.1 UMAP projection shows tissues and developmental trajectories in C.
elegans embryogenesis.
(A) UMAP projection of the 81,286 cells from our sc-RNA-seq dataset that passed our
initial QC. This UMAP does not include 4,738 additional cells that were initially filtered,
but were later whitelisted and included in downstream analyses. Color indicates the age
of the embryo that a cell came from, estimated from correlation to a whole-embryo RNA74

seq time series (186) and measured in minutes after an embryo’s first cell cleavage. (B)
Positions of cells from four samples of synchronized embryos on the UMAP plot. (C)
Histogram of estimated embryo time for all cells in the dataset. (D) Bar plot showing for
bins of embryo time, the percentage of cells in that embryo time bin that we were able to
assign to a terminal cell type or pre-terminal lineage. (E) Scatter plot showing correlation
of the number of cells of a given anatomical cell class in a single embryo (X axis, log
scale) with the number of cells recovered in our data (Y axis, log scale). Each point
corresponds to a cell class. Only cells with estimated embryo time >= 390 minutes are
included in the counts (many earlier cells are still dividing). Red line is a linear fit,
excluding points with y = 0.
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Figure 2.2 Annotation of the early lineage.
(A) Diagram showing the position of early mesoderm (MS lineage) cells marked by
expression of ceh-51. The lineage radiograph shows the average fluorescent intensity
(log10 scaled) of a CEH-51::GFP protein fusion measured by live imaging. The inner
rings show the generation of the founder cells, AB (which produces almost exclusively
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ectoderm and pharynx), MS (mesoderm and pharynx), C (muscle and ectoderm) and
P3, which gives rise to P4 (germline) and D (muscle). Daughter cells are named by their
relative positions at mitosis (e.g. ABa is the anterior daughter of AB, ABal is left daughter
of ABa). (B) UMAP projection of 926 early-stage cells (estimated embryo time <= 150
minutes), colored by embryo time. E lineage and germline cells are excluded and shown
separately in Supplemental Figure 2.7 and Supplemental Figure 2.12, as they
differentiate early compared to other lineages. (C) Same UMAP as (B), colored by ceh51 expression (red indicates cells with >0 UMIs for ceh-51). (D) Expression of hnd-1 and
pha-4 measured by sc-RNA-seq (UMAP) and live imaging of GFP protein fusions
(radiograph). (E) Cropped section of a UMAP of 8,083 neuron/glia/rectal progenitor cells
with embryo time <= 250 minutes (Supplemental Figure 2.15). This plot shows the
section of that UMAP that corresponds to the 3,233 cells from the ABpxp ectodermal
lineage (“ABpxp” is short-hand for two symmetric lineages, ABplp and ABprp). Colored
bold annotations highlight specific lineages that are discussed in the text. (F) Lineage
tree for the ABpxppp sub-lineage, highlighting cells that are present in the circled section
of (E). The (co-)expression pattern of marker genes identifies branches in the UMAP that
correspond to specific ABpxppp descendants. Additional ABpxppp descendants not
shown in this panel are annotated in (E), below the circled section.
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Figure 2.3 Developmental trajectories of ciliated neurons.
(A) UMAP of 10,740 ciliated neurons and precursors. Colors correspond to cell identity.
Text labels indicate terminal cell types. Numbers 1-16 indicate parents of 1 ADE-ADA, 2
CEP-URX 3 PHB-HSN 4 IL1 5 OLL 6 OLQ 7 ASJ-AUA 8 ASE 9 ASI 10 ASK 11 ADFAWB 12 ASG-AWA 13 ADL 14 ASH-RIB 15 AFD-RMD 16 AWC-SAA (purple) and BAGSMD (red). 4-6, 8-10, and 13 are listed as parents of only one cell type as the sister cells
78

die. Numbers 17-20 indicate grandparents of 17 IL1 (= IL2 parent) 18 OLQ-URY 19, 20
ASE-ASJ-AUA. Differentiated PHA was not conclusively identified but may co-cluster
with PHB. The parent of PHA is not present in this UMAP, but was located separately
within the area annotated as “rectal cells” in the UMAP in Supplemental Figure 2.3. The
tiny cluster labeled with an asterisk (*) is putatively AWC-ON on the basis of srt-28
expression. (B) UMAP plot colored by embryo time (colors matched to Figure 2.1A) and
gene expression (red indicates >0 reads for the listed gene). egl-21 codes for an
enzyme that is essential for processing neuropeptides (219). Its expression is used as a
proxy for the onset of neuron differentiation. mcm-7 codes for a DNA replication
licensing factor. Loss of mcm-7 expression in each UMAP trajectory approximately
marks the boundary between neuroblasts and terminal cells. unc-130 is known to be
expressed in the ASG-AWA neuroblast but neither terminal cell (220). (C) Cartoon
illustrating the lineage of the ASE, ASJ, and AUA neurons. (D) Heatmap showing
patterns of differential transcription factor expression associated with branches in the
ASE-ASJ-AUA lineage. Expression values are log-transformed, then centered and
scaled by standard deviation for each row (gene).
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Figure 2.4 Full vs. incomplete convergence of lineages producing common cell
types.
(A) UMAP of 854 IL1/2 neurons and progenitors colored by estimated embryo time (cells
selected on the basis of annotations in Figure 2.3A and Supplemental Figure 2.15). (B)
IL1/2 UMAP colored by ast-1 expression level (log2 size-factor normalized UMI counts).
(C) IL1/2 UMAP colored by expression of unc-39, a gene specific to branch 1. (D)
Heatmap showing the average expression level of lineage specific and terminal cell type
specific genes over time for each of the 3 branches. (E) Supplemental Figure 2.5A
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shows a UMAP of body wall muscle and mesoderm cells. This panel is a zoomed-in
view of that UMAP, including only 17,520 BWM cells, which are grouped into “bands”
based on marker gene expression patterns (here, a cell is considered to express a gene
if it or >= 2 of 5 of its nearest neighbors have >0 reads for the gene). (F) Physical
positions of cells in each BWM band (colors matched to panel E) in the embryo at 430
minutes. Adapted from Fig. 8B of (7). (G) Transcriptome Jensen-Shannon distance for
posterior (orange+green bands in panel E) BWM vs. row 2 (blue band) or row 1 (pink
band) head BWM over time. Heterogeneity between BWM subsets persists throughout
development and may reflect functional differences.
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Figure 2.5 Correlation between cell lineage and the transcriptome in the ectoderm.
(A) Jensen-Shannon (JS) distance between the transcriptomes of pairs of ectodermal
cells (AB lineage), faceted by cell generation and lineage distance. AB5 refers to the cell
generation produced by 5 divisions of the AB founder cell, and likewise for generations
AB6-9. The “transcriptome” of a given anatomical cell is defined as the average gene
expression profile of all sc-RNA-seq cells annotated as that anatomical cell. Pairs of
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bilaterally symmetric cells are excluded from the statistics. (B) Estimates of the extent to
which lineage predicts the transcriptome in AB5-9. (C) Distribution of the number of
“lineage signature transcription factors”—TFs that distinguish a cell from its sister—for all
cells in AB5-9. The outlier points in AB8 are instances where a terminal epidermal cell is
a sister of a neuroblast. (D) Proportion of lineage signature transcription factors for a cell
in a given generation that have expression maintained in 0, 1, or 2 of the cell’s daughters
in the subsequent generation. (E) Proportion of lineage signature TFs for which
expression in a given cell was maintained from the cell’s parent vs. newly activated after
the parent’s division.
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Tables
Table 2.1 Marker genes for terminal cell type annotations.
This table lists the marker genes that were used to annotate sc-RNA-seq cells with their
corresponding cell types. Expression patterns for marker genes were retrieved from
Wormbase (188) (https://wormbase.org) and EPiC (17)
(http://epic.gs.washington.edu/Epic2/). The UMAP column lists which UMAP the cell type
was located in. These UMAPs are shown in Supplemental Figures 2.4-S2.13 and can be
explored in the VisCello application (https://cello.shinyapps.io/celegans_explorer/). For
marker genes that have expression profiles in EPiC (17)
(http://epic.gs.washington.edu/Epic2/), we used protein fusion datasets when available,
and only used promoter fusion datasets when protein fusions were unavailable.
Cell type
BWM_far_posterior
BWM_posterior
BWM_anterior
BWM_head_row_2

UMAP
Muscle and mesoderm
Muscle and mesoderm
Muscle and mesoderm
Muscle and mesoderm

BWM_head_row_1

Muscle and mesoderm

Coelomocyte
GLR

Muscle and mesoderm
Muscle and mesoderm

hmc

Muscle and mesoderm

M_cell

Muscle and mesoderm

mu_int_mu_anal

Muscle and mesoderm

mu_sph
Z1_Z4
g1A
g1P

Muscle and mesoderm
Muscle and mesoderm
Pharynx
Pharynx

g2

Pharynx
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Marker genes
hlh-1, myo-3, egl-20
hlh-1, myo-3, cwn-1
hlh-1, myo-3, ceh-13
hlh-1, myo-3, ceh-34
hlh-1, myo-3, ceh-34, eya1
cup-4, lgc-26, let-381
unc-30, let-381, sfrp-1
hlh-8, sfrp-1, glb-26, dmd4
hlh-8, pal-1
hlh-8, mls-1, dsc-1, exp-1,
mig-1, unc-62
hlh-8, mls-1, dsc-1
ehn-3, unc-39
hlh-6, phat-2, phat-5, lys-8
hlh-6, phat-2, phat-1, lys-8
hlh-6, ceh-6, irx-1, dmd-4,
gly-15

mc1

Pharynx

mc2
mc3

Pharynx
Pharynx

Pharyngeal_intestinal_valve

Pharynx

pm1_pm2

Pharynx

pm3_pm4_pm5

Pharynx

pm6

Pharynx

pm7

Pharynx

pm8

Pharynx

Anterior_arcade_cell
Posterior_arcade_cell

Pharynx
Pharynx

hyp1_hyp2

Pharynx

MC

Pharynx

Intestine_anterior
Intestine_middle_and_posterio
r
Intestine_far_posterior

Intestine
Intestine
Intestine

hyp4_hyp5_hyp6

Hypodermis and seam
cells

hyp7_AB_lineage

Hypodermis and seam
cells

hyp7_C_lineage
Tail_hypodermis
P_cell
Seam_cell
G2_and_W_blasts

Hypodermis and seam
cells
Hypodermis and seam
cells
Hypodermis and seam
cells
Hypodermis and seam
cells
Hypodermis and seam
cells

AMsh

Glia and excretory cells

ADEsh

Glia and excretory cells
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ttx-1, pax-1, agr-1, ceh-45,
ceh-2
ttx-1, pax-1, agr-1
ttx-1, pax-1, agr-1, irx-1
ttx-1, lec-8, cwn-2, unc-62,
fos-1
tnc-2, tnt-4, tni-4, inx-20,
eyg-1
tnc-2, tnt-4, tni-4, ceh-22
tnc-2, ser-2, elt-4,
W05B10.4
tnc-2, tni-4, ceh-22, spp-7,
W05B10.4
ref-1, aff-1, pax-1, inx-20,
unc-129
inx-12
inx-12, let-23
mlt-11, mlt-8, slt-1, nhr-25,
nhr-67
ceh-19, nhr-239, glr-8
ZC204.12, cpr-1, ceh-37
irg-7, pal-1
cpr-1 and ceh-37 in subset
irg-7, faah-1, pbo-4, psa-3
elt-1, elt-3, slt-1, vab-3,
unc-130,
egl-17, ceh-32 in subset
elt-1, elt-3, unc-62, vab-3,
unc-130, tbx-2
ceh-13 in subset
elt-1, elt-3, tbx-8, tbx-9
lin-39 in subset
elt-1, elt-3, lin-44, vab-7
elt-1, elt-3, pax-3, plx-2,
lin-39, mab-5
bus-4, bus-8, bus-12, ceh16, rnt-1, elt-6
lin-12, ahr-1
aff-1, kcc-3, nas-31, pros1, F52E1.2, F16F9.3
aff-1, unc-62

CEPsh

Glia and excretory cells

ILsh_OLLsh_OLQsh
AMso
CEPso
ILso

Glia and excretory cells
Glia and excretory cells
Glia and excretory cells
Glia and excretory cells

hyp3

Glia and excretory cells

Excretory_cell

Glia and excretory cells

Excretory_gland

Glia and excretory cells

aff-1, kcc-3, aqp-7,
K09F5.6, mltn-13,
K08D12.4
aff-1, kcc-3
grd-15, grl-12
mls-2, inx-12, inx-13
grl-18, wrt-6
nhr-25, ceh-32, slt-1, sym1
pros-1, ceh-37, ceh-6, hlh11
lim-6, ser-2, aat-1

Excretory_duct_and_pore

Glia and excretory cells

irx-1, ceh-37, grl-2, let-23

XXX
Possibly_hyp1V
Possibly_ant_arc_V

eak-3, sdf-9, eak-6
mlt-8, qua-1, nhr-25
See note.

ADF
ADL

Glia and excretory cells
Glia and excretory cells
Glia and excretory cells
Early embryo,
germline, and rectum
Ciliated neurons
Ciliated neurons

AFD

Ciliated neurons

ASE

Ciliated neurons

ASG

Ciliated neurons

ASH

Ciliated neurons

ASI
ASJ
ASK
AWA

Ciliated neurons
Ciliated neurons
Ciliated neurons
Ciliated neurons

AWB

Ciliated neurons

AWC

Ciliated neurons

ADE

Ciliated neurons

CEP

Ciliated neurons

URX

Ciliated neurons

Germline
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glh-1, pgl-1, nos-1
ceh-19, cat-4, bas-1
K04D7.6, xbx-9, F15A4.5
gcy-8, gcy-18, gcy-23,
dac-1, ttx-1
che-1, ceh-36
ASEL: gcy-6, gcy-14, lim-6
ASER: gcy-5, gcy-22
gcy-11, capa-1
osm-10, R102.2, deg-1,
M04B2.6, unc-42
ins-6, cng-2
ssu-1, trx-1, nhr-6, sptf-1
F09E8.8, pax-2, C47D2.1
odr-7, nhr-216, ocr-1
srd-23, odr-1, daf-11, sox2
ceh-36, odr-1, daf-11, sox2
dat-1, cat-2, tba-9, pdf-1,
unc-62, cwn-2, ceh-13
dat-1, cat-2, tba-9, nhr-67,
nhr-67
gcy-32, gcy-35, gcy-36,
gcy-37

BAG
IL1

Ciliated neurons
Ciliated neurons

IL2

Ciliated neurons

OLL

Ciliated neurons

OLQ

Ciliated neurons

PHB_and_possibly_PHA

Ciliated neurons

AIA

Non-ciliated neurons
and
Ciliated neurons
Non-ciliated neurons

AIB

Non-ciliated neurons

AIM

Non-ciliated neurons

AIN

Non-ciliated neurons

AIY

Non-ciliated neurons

AIZ

Non-ciliated neurons

ALA

Non-ciliated neurons

ALN

Non-ciliated neurons

ALM_PLM

Non-ciliated neurons

ALM_BDU

Non-ciliated neurons

AVA

Non-ciliated neurons

AVB

Non-ciliated neurons

AVD

Non-ciliated neurons

AVE

Non-ciliated neurons

AVG

Non-ciliated neurons

AUA
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gcy-9, gcy-31, gcy-33
flp-3, agr-1, sox-2
tba-6, klp-6, cil-7, agr-1,
sox-2
sox-2, tbx-2
ocr-4, dyla-1, dhc-3, pcrg1
osm-10, R102.2, gpa-6,
cog-1
low expression of ceh-14,
srb-6, srh-74
ceh-6, dop-1, flr-4, che-7
ttx-3, mgl-1, flp-2, ins-1
snet-1, aptf-1, odr-2, glr-2
snet-1, flp-22, mbr-1, mls2, mod-5, unc-86, inx-19
ttx-3, mgl-1, K07C5.9, ast1
ttx-3, ceh-10, F17C11.2,
flp-9, glc-3,
bus-18, ser-2, nlp-15
ser-2, unc-86, eat-4, acc-2
flp-24, ceh-17, des-2, deg3, snf-11, flp-13
unc-86, lad-2, gcy-35
mec-17, mec-3, mec-7,
unc-86
mec-17, mec-3, mec-7,
unc-86, unc-62
acc-1, fax-1, unc-42, unc3,
flp-18, acr-16, acr-15
rig-3, gpa-14,
glr-1, glr-2, nmr-2, unc-3
fax-1, unc-42, unc-3, ceh31, pdf-1
unc-42, unc-3, unc-17, rig5, glr-1, glr-2, nmr-2
fax-1, unc-42, unc-3, glr-1,
glr-2, glr-5
lite-1, glr-1, glr-2, nmr-2,
lin-11,
ast-1, odr-2, F59E11.7,
unc-62

AVH

Non-ciliated neurons

AVJ

Non-ciliated neurons

AVK

Non-ciliated neurons

AVL

Non-ciliated neurons

CAN

Non-ciliated neurons

DA

Non-ciliated neurons

DB

Non-ciliated neurons

DD

Non-ciliated neurons

DVA

Non-ciliated neurons

DVC

Non-ciliated neurons

FLP

Non-ciliated neurons

I5

Non-ciliated neurons

PLM

Non-ciliated neurons

PVP

Non-ciliated neurons

PVQ_and_possibly_PVC

Non-ciliated neurons

PVR

Non-ciliated neurons

PVT

Non-ciliated neurons

RIA

Non-ciliated neurons

RIB

Non-ciliated neurons

RIC
RID

Non-ciliated neurons
Non-ciliated neurons

RIH

Non-ciliated neurons

RIM
RIS

Non-ciliated neurons
Non-ciliated neurons
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unc-42, lin-11, hlh-34, ceh6, flp-12, pdf-1
unc-42, lin-11, glr-1
flp-1, fax-1, unc-42, sox-2,
glr-5
unc-25, unc-46, unc-47,
lim-6, ceh-27, alr-1
pks-1, ceh-10, ace-3, acy2
gbb-1, gbb-2, unc-3, unc4, unc-17, unc-62, mab-9
gbb-1, gbb-2, unc-3, unc4, unc-17, unc-62, mab-9,
vab-7, ceh-6
unc-25, unc-30, unc-46,
unc-47, unc-62, snf-11
lin-44, nob-1, fax-1, nlp-12,
twk-16, lin-11
ceh-63, hlh-14, hlh-13, egl20
unc-86, mec-7, mec-3,
unc-62
unc-4, ceh-34, tbx-2, flp-4,
flp-13, unc-7
mec-17, mec-3, mec-7,
unc-86, egl-5
mbr-1, nlp-7, unc-30, lin11, pdf-1, glb-17
lin-11, vab-15, ceh-43, glr1
nlp-17, C35B1.7,
F26A10.1, Y43F8B.20,
acr-23, irx-1
hlh-14, unc-86, egl-20
gpa-2, mec-1, zig-5, vab15, dop-5, pdf-1, lim-6,
unc-6
glr-3, glr-6
aptf-1, glr-4, ser-4, sto-3,
unc-29
tbh-1, tdc-1, glr-5
unc-3, ceh-10, lim-4, pdf-1
unc-86, unc-130, nhr-67,
slt-1, rig-4
tdc-1, cex-1, glr-1, nmr-2
flp-11, unc-25, aptf-1, lim-6

RIV

Non-ciliated neurons

RMD

Non-ciliated neurons

RME

Non-ciliated neurons

SIA

Non-ciliated neurons

SIB

Non-ciliated neurons

SMB

Non-ciliated neurons

SMD

Non-ciliated neurons

URB_and_possibly_URA

Excretory_duct

Non-ciliated neurons
Time 350min
hypodermis + glia
Duct and pore

Excretory_pore_G1

Duct and pore

B

Rectal cells

F_U
K_Kprime

Rectal cells
Rectal cells

Y

Rectal cells

B_F_K_Kp_U_Y
rect_D

Rectal cells
Rectal cells

Rectal_gland

Rectal cells

T
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odr-2, lim-4, ceh-75, ast-1
lad-2, acc-1, unc-42, glr-1,
glr-4, glr-5,
ceh-6, mgl-1, unc-7, ast-1
ceh-32, unc-25, unc-46,
snf-11, sox-2, ser-2
ceh-17, ceh-24, unc-42,
vab-8, ser-6, lim-4
fax-1, ceh-24, unc-42, vab8, tmc-1, glr-5
sox-3, ceh-24, lim-4, vab8, unc-42
lad-2, acc-1, flp-22, odr-2,
unc-42, glr-1, glr-5
unc-86, sox-2, glr-8
psa-3, ceh-16, tlp-1, php3, elt-1
irx-1, ceh-37, grl-2, aff-1
irx-1, ceh-37, grl-2, lack of
aff-1
ceh-6, ref-2, mab-9, ceh27
egl-38, egl-20, mom-2
pha-4, pal-1, egl-38
ceh-6, ref-2, mom-2, nhr25, lack of cnd-1
ceh-6, ref-2, mab-9, daf-6
pha-4, pal-1, dve-1
pha-4, pal-1, dve-1, nac-2,
elt-3, tat-4

Supplemental Figures

Supplemental Figure 2.1 Method for estimating the age of the embryo that a scRNA-seq cell came from.
Embryo times are measured in minutes post first cleavage. (A) Embryo times are
estimated based on Pearson correlation of a single cell’s transcriptome to a bulk RNAseq time series (see Methods). Pointwise estimates of the correlation to each time point
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are smoothed using a Loess regression. (B) Distribution of estimated embryo times for
each biological sample. The average embryo time estimate in the Waterston lab sample
correlates with the real time duration that the embryos were incubated. Each sample
contains some outlier cells with abnormally low embryo times. Potential biological and
technical causes for the presence of these outlier cells are discussed in the Methods. (C)
Correlation of embryo time estimates based on Hashimshony et al. (186) to an alternate
set of embryo time estimates based on Boeck et al. (212). Estimates based on
Hashimshony et al. (186) were used for all downstream analyses. (D) Correlation
between cell birth times estimated based on our lineage annotations (x-axis) with cell
birth times computed based on automated analysis of imaging data (y-axis) (192).
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Supplemental Figure 2.2 UMIs recovered per cell decreases with embryo age.
All Y-axes are log scaled. (A) Distributions of number of UMIs recovered per cell, binned
by estimated embryo age. Median UMIs per cell decreases until ~400 minutes, after
which almost all cell division has stopped. Comparing each embryo time bin on the Xaxis to the subsequent bin, e.g. comparing 100-150 minutes to 150-200 minutes, the
decrease in median UMIs per cell is statistically significant for each step from 100-400
minutes (Wilcoxon rank sum tests, all p-values < 2.2e-16). Note that our quality control
procedures exclude cells with < 700 UMIs (or < 500 UMIs for neurons), causing the
decrease in UMIs/cell to be understated, as the proportion of cells falling below the cutoff
is greater for later stage embryos. (B) Number of cells included in each time bin from
panel A. (C and D) Number of UMIs and genes detected for cells with embryo time in the
range of 390-650 minutes, by tissue.
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Supplemental Figure 2.3 Cell type annotations for the global UMAP of 81,286 cells.
This plot shows more cell type annotations for the global UMAP from Figure 2.1A. This
UMAP does not include 4,738 additional cells that were initially filtered, but were later
whitelisted and included in downstream analyses (see Materials and Methods). For
fine-grained annotations of cell types in each major tissue, see Figure 2.3A and
Supplemental Figures 2.5-2.13. For fine-grained annotations of progenitor cell lineages,
see Supplemental Figures 2.14-2.17.
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Supplemental Figure 2.4 Cells included in each sub-UMAP.
Plots show which cells from the global UMAP (Supplemental Figure 2.3) are included in
each sub-UMAP (Supplemental Figures 2.5-2.17), including UMAPs aimed at visualizing
terminal cell types (A, B) and UMAPs focused aimed at visualizing progenitor lineages
(C, D). Note that the actual assignment of cells to sub-UMAPs was performed based on
a 3D version of the global UMAP (not shown). In (C), all cells included in the Time 150
min. sub-UMAP are also included in the Time 300 min. sub-UMAP.
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Note: The figures below show UMAPs of muscle and the non-pharyngeal mesoderm
(Supplemental Figure 2.5), pharynx (Supplemental Figure 2.6), intestine (Supplemental
Figure 2.7), hypodermis and seam cells (Supplemental Figure 2.8), glia and excretory
cells (Supplemental Figure 2.9), non-ciliated neurons (Supplemental Figure 2.10), touch
receptor neurons (Supplemental Figure 2.11), germline (Supplemental Figure 2.12), and
rectum (Supplemental Figure 2.13). A UMAP of ciliated neurons is shown in the main
text (Figure 2.3A). UMAPs focused on annotating progenitor lineages are shown in
Supplemental Figures 2.14-2.17.
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Supplemental Figure 2.5 UMAP of 22,371 body wall muscle and non-pharyngeal
mesoderm cells.
(A) Labels indicate cell types. See Table 2.1 for marker genes used to annotate cell
types. MS, C, and D indicate cell lineages. Abbreviations: BWM = body wall muscle,
mu_int = intestinal muscle, mu_anal = anal depressor muscle, mu_sph = anal sphincter
muscle, hmc = head mesodermal cell. (B) Colors show estimated embryo times (minutes
post first cleavage) for each cell.
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Supplemental Figure 2.6 UMAP of 10,784 pharyngeal cells.
(A) Labels indicate cell types. Abbreviations: pm = pharyngeal muscle, mc = pharyngeal
marginal cell, g1A/g1P/g2 = pharyngeal gland, vpi = pharyngeal-intestinal valve, hyp =
hypodermis, ant. arc. = anterior arcade cells, post. arc. = posterior arcade cells. Anterior
and posterior arcades from late embryos converge in the UMAP to a common
transcriptomic profile (pink cells at the bottom of the plot). Numeric labels indicate: 1
parent of NSM 2 MC 3 parent of MI and pm1DR 4 grandparent of I2 5 parent of M1 6
parent of M2 and M3 7 parent of M5 and I6 8 parent of I1 9 parent of M4 10 parent of g2
11 parent of g1P and I3 12 parent of g1A. (B) Colors show estimated embryo times
(minutes post first cleavage) for each cell.
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Supplemental Figure 2.7 UMAP of 1,734 intestine cells.
(A) Labels indicate subsets of intestine cells and their relative position on the anteriorposterior axis. See Table 2.1 for marker genes used to annotate cell types. (B) Colors
show estimated embryo times (minutes post first cleavage) for each cell.
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Supplemental Figure 2.8 UMAP of 12,254 hypodermis and seam cells.
(A) Labels indicate cell types. See Table 2.1 for marker genes used to annotate cell
types. hyp1-3 are not included here. hyp1-2 appear in the pharynx UMAP (Supplemental
Figure 2.6), and hyp3 appears in the glia UMAP (Supplemental Figure 2.9), consistent
with their cell lineage (hyp1-2 are sisters/cousins of arcade cells, and hyp3 are sisters of
ILsoDx). (B) Colors show estimated embryo times (minutes post first cleavage) for each
cell.
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Supplemental Figure 2.9 UMAP of 7,512 glia, excretory cells, and progenitors.
(A) Labels indicate cell types. Some non-glial/excretory cells are also included in the
UMAP, such as neuron/glia/rectal progenitors. (B) Colors show estimated embryo times
(minutes post first cleavage) for each cell.
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Supplemental Figure 2.10 UMAP of 14,728 non-ciliated neurons and progenitors.
For a UMAP of ciliated neurons, see Figure 2.3A. (A) Text labels indicate terminal cell
types. Numeric labels indicate: 1 PVC-LUA neuroblast 2 parent of PVQ 3 parent of DVC
4 FLP-AIZ neuroblast 5 FLP-AIZ-RMG neuroblast 6 parent of URADx 7 progenitors of
ALM, BDU, PLM, and ALN (see Supplemental Figure 2.11 for a UMAP of the touch
receptor lineages) 8 parent of RIM 9 AVG-RIR neuroblast 10 parent of RIC 11 parent of
AVH 12 parent of RIA 13 ALA-RMED neuroblast 14 RMED, early after parent’s division
15 parent of RID. (B) Colors show estimated embryo times (minutes post first cleavage)
for each cell.
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Supplemental Figure 2.11 UMAP of 1,300 touch receptor neurons, URB neurons,
and progenitors.
URB neurons are included because they cluster near the touch receptors in the UMAP
of all non-ciliated neurons (Supplemental Figure 2.10). This is in part due to high unc-86
expression. (A) Labels indicate cell type (for terminal cells) or lineage (for progenitors).
(B) Colors show estimated embryo times (minutes post first cleavage) for each cell. (C)
Location of cells shown in panel A on the UMAP of all non-ciliated neurons from
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Supplemental Figure 2.10. (D) Expression pattern of unc-86 on the UMAP of all nonciliated neurons. Both touch receptor lineages and URB express high levels of unc-86.
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Supplemental Figure 2.12 UMAP of 3,476 early embryo, germline, and rectal cells.
This UMAP was used only for its trajectory of germline development (500 cells). Other
lineages that are included in this UMAP were better resolved in other UMAPs, shown
below. (A) Germline cells highlighted in red. (B) Colors show estimated embryo times
(minutes post first cleavage) for each cell. These estimates, which are based on
correlation to a whole-embryo bulk RNA-seq time series, are inaccurate for germline
cells, as genes that follow the same temporal dynamics for all somatic cells often have
different expression dynamics in the germline.
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Supplemental Figure 2.13 UMAP of 1,598 rectal cells and progenitors.
(A) Text labels indicate terminal cell types. Numeric labels indicate: 1 parents of (Y and
DA7) and (DA6 and DA9). 2 parent of PVP and rect_V 3 parent of PVT and rect_D 4
parent of K and K’ 5 parents of (B and DVA) and (F and U) 6 Parent of the tail spike cells
and hyp10 7 Parent of PHsh and hyp8/9. (B) colors show estimated embryo times
(minutes post first cleavage) for each cell. The cluster of cells from late embryos (>580
minutes) in the center of the UMAP are AMsh (glia, not rectal cells) that were included in
this UMAP by mistake.
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Note: Supplemental Figures 2.14-2.17 show a representative subset of the UMAPs
that were used to annotate progenitor lineages. Several additional UMAPs can be
visualized in VisCello (https://cello.shinyapps.io/celegans_explorer/).

Supplemental Figure 2.14 UMAP and detailed annotation of 926 cells from
embryos < 150 minutes post first cleavage.
E lineage and germline cells are excluded from the UMAP and were analyzed separately
(Supplemental Figure 2.7 and Supplemental Figure 2.12). (A) Detailed labeling of
lineages, co-visualized with the lineage tree. (B) Colors show estimated embryo times
(minutes post first cleavage) for each cell. (C) Screenshot of an interactive covisualization implemented in VisCello (https://cello.shinyapps.io/celegans_explorer/),
highlighting the connection between MS lineage clusters and corresponding leaves in
the lineage tree.
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Supplemental Figure 2.15 UMAP and detailed annotation of 8,083 AB lineage
neuron/glia/rectal progenitor cells from embryos < 250 minutes post first
cleavage.
This UMAP includes only AB lineage cells that give rise to neurons, glia, and rectal cells.
(A) Detailed labeling of lineages, co-visualized with the AB lineage tree. (B) Colors show
estimated embryo times (minutes post first cleavage) for each cell. (C) Screenshot of an
interactive co-visualization implemented in VisCello
(https://cello.shinyapps.io/celegans_explorer/), highlighting the connection between
ABpxppp lineage clusters and corresponding leaves in the lineage tree.
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Supplemental Figure 2.16 UMAP and detailed annotation of 31,683 cells from
embryos < 300 minutes post first cleavage.
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E lineage and germline cells are excluded from the UMAPs and were analyzed
separately (Supplemental Figure 2.7 and Supplemental Figure 2.12). (A) Detailed
labeling of lineages, co-visualized with the lineage tree. (B) Colors show estimated
embryo times (minutes post first cleavage) for each cell. (C) Screenshot of an interactive
co-visualization implemented in VisCello (https://cello.shinyapps.io/celegans_explorer/),
highlighting the connection between the pharynx cluster in the UMAP and the
corresponding leaves in the lineage tree. All cells in the pharynx cluster are annotated as
descendants of the ABalp, ABara and MS lineages, consistent with previous
observations that pharyngeal cells only arise from these lineages.
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Supplemental Figure 2.17 UMAP of 8,233 non-pharyngeal mesoderm cells,
focused on the early lineage.
This UMAP includes the same cells as the muscle and mesoderm UMAP (Supplemental
Figure 2.5), but excludes putative C and D lineage body wall muscle, MS lineage body
wall muscle with estimated embryo time >400 minutes (post first cleavage), and
coelomocytes with embryo time >400 minutes. This UMAP serves as a representative
example of a set of several UMAPs used to connect terminal cells to their immediate
progenitors. Additional UMAPs can be viewed in VisCello. (A) Text labels indicate MS
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lineages (i.e. “xppa” = MSxppa). Bold text labels indicate cell types. MSxppapx was not
conclusively identified, but is presumed to be included in the head BWM cluster. (B)
Estimated embryo time for each cell. (C) diagram of the MS lineage. Colored sublineages match the colors of cell groups in panel (A).
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Supplemental Figure 2.18 Summary of lineage annotations.
Each row corresponds to a subset of cells in the C. elegans embryonic cell lineage. Row
labels consist of one or two letters, which identify a broad lineage (AB, MS, C, D, or E),
and a number, which specifies the number of cell divisions since the founding cell of the
broad lineage. For example, “AB5” refers to the 32 cells produced by 5 divisions of the
AB founder cell, and “C2” refers to the 4 cells produced by 2 divisions of the C founder
cell. The founder cells themselves are not included in the plot. The label “Z2/Z3” is an
exception to the nomenclature and refers to the two germline lineages, Z2 and Z3.
Bar lengths indicate the percent of cells within the specific lineage and cell
generation specified by the row label that are included in our annotations of our single
cell RNA-seq dataset. Lineages that undergo programmed cell death are excluded from
the statistics. Numbers to the right of the bars indicate the absolute number of lineages
annotated and the total number of lineages present within a particular cell generation.
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Supplemental Figure 2.19 Comparison of data from this study to data from Tintori
et al., 2016 (19).
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Tintori et al. (19) profiled the transcriptomes of single cells from the C. elegans 1- to 16cell stages. (A) Heatmap showing Pearson correlations between the log2-scaled gene
expression profiles of 16-cell stage cells from Tintori et al. (19) vs. 16- and 28-cell stage
cells from this study. Correlation was computed using informative genes selected by an
iterative PCA approach used by Tintori et al. (19) (see Materials and Methods). (B-E)
First sub-panel shows a PCA projection computed using 16-cell stage cells from Tintori
et al. (19), reproducing their original analysis. Second sub-panel shows a projection of
16- and 28-cell stage cells from this study into the same PCA space. Each PCA uses a
different set of informative genes, as originally defined by Tintori et al. (19), to
discriminate particular lineages (see Materials and Methods). For each PCA, the gene
expression level of a selected lineage-specific marker gene was plotted. Gene
expression is measured in log2 RPKM for data from Tintori et al. (19), and log2 sizefactor normalized UMI counts for data from this study.
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Supplemental Figure 2.20 Comparison of data from this study to microarray data
from Spencer et al., 2011 (191).
Each panel shows a global UMAP of cells from this study, colored by a score that
measures the extent to which each single-cell transcriptome is enriched for genes from a
particular gene set reported by Spencer et al. (191). Signature gene sets from Spencer
et al. (191) were downloaded from
https://www.vanderbilt.edu/wormdoc/wormmap/Enriched_genes.html. Each signature
gene set corresponds to genes that are enriched in a particular embryonic cell type
compared to all other cells in the Spencer et al. microarray data (191). Signature genes
are therefore mostly tissue-specific, rather than cell-type specific. Gene set enrichment
scores were computed using the AUCell package (157). Comparison with pharyngeal
muscle was dropped because most of the signature genes reported in Spencer et al.
(191) for this cell type are intestine specific, as confirmed by a third dataset (191). See
Materials and Methods for more details.
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Supplemental Figure 2.21 Ciliated neuron developmental trajectories are more
continuous in a 3D UMAP.
This plot is a 2D screenshot of part of a 3D UMAP of ciliated neuron cells, oriented to
show specific lineage relationships. The cells are the same as in Figure 2.3A; the only
difference is projecting into 3D instead of 2D. Developmental trajectories connecting the
ASG-AWA and ADF-AWB neuroblasts to their respective daughter cells are continuous
in this UMAP space, as is the branching trajectory of the left and right ASE neurons
(ASEL and ASER). In the ASG-AWA and ADF-AWB trajectories, there are sections that
appear before the branch points in the UMAP, but based on our embryo time estimates
are likely to be terminal cells and not the parent neuroblasts. These sections may
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contain both daughter cells of each trajectory after their birth but before they
differentiate. Cells in the “ADF and AWB” section co-express in the same cells the
marker genes lag-1, which persists only in ADF, and lim-4, which persists only in AWB;
however, their estimated embryo times span ~100 minutes after the parent cells’ division
time. Note that the grey, unannotated cells below the ADF trajectory are behind the ADF
cells in 3D space, as are the grey cells overlapping the AWB trajectory.
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Supplemental Figure 2.22 Differentially expressed transcription factors associated
with ciliated neuron lineage branches.
Heatmaps showing patterns of differential transcription factor expression associated with
branches in (A) the ASG-AWA lineage, (B) the ADF-AWB lineage, (C) the IL1-IL2
lineage, and (D) the URX-CEPDx lineage. A heatmap for the ASE-ASJ-AUA lineage is
shown in Figure 2.3D. Expression values are log-transformed, then centered and scaled
by standard deviation for each row (gene). In each of the ASG-AWA and ADF-AWB
lineages, there is a set of cells that are before the branch point of the trajectory in UMAP
space (see Supplemental Figure 2.21), but based on embryo time estimates and marker
gene expression patterns, are likely to be terminal cells. In the ADF-AWB lineage, these
121

cells co-express lag-1, which is selectively retained in ADF, and lim-4, which is
selectively retained in AWB, suggesting that this cell set may include undifferentiated,
terminal ADF and AWB cells.
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Supplemental Figure 2.23 Multilineage priming in the ASE-ASJ-AUA lineage.
(A) Section of the ciliated neuron UMAP from Figure 2.3A that is shown in panels B and
C. This section includes the trajectory of the lineage that produces the ASE, ASJ, and
AUA neurons (ABalpppppp/ABpraaappp). (B) Expression patterns for transcription
factors that are expressed in the ASE-ASJ-AUA neuroblast and selectively maintained in
only one of its daughters. Red and blue points indicate cells that express >= 1 TF for
which expression is maintained only in the ASE lineage (red) or only the ASJ lineage
(blue). Purple points indicate cells that express >= 1 TF from both sets. (C) Expression
pattern of hlh-3, which is expressed in the ASE-ASJ-AUA neuroblast and maintained in
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the ASE parent but not the ASJ-AUA parent. (D) Fluorescent signal from a HLH-3::GFP
protein fusion from EPiC (17) (series 20160301_hlh-3_OP650_L2). Red indicates high
signal, yellow/green indicate medium signal, blue indicates low signal, and purple
indicates no signal. Due to translation and the folding time of GFP, the fluorescent signal
has a time lag compared to the RNA expression in panel C. The presence of signal in
the ASJ-AUA parent indicates that HLH-3 protein does not undergo asymmetric
localization during cell division; instead, it is simply maintained in the ASE lineage and
allowed to degrade in the ASJ-AUA lineage.
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Supplemental Figure 2.24 Prevalence of multilineage priming in C. elegans.
X-axis shows different cell generations of the ectoderm (AB lineage) and mesoderm (MS
lineage). “AB5” refers to the generation produced by 5 divisions of the AB founder cell,
and likewise for AB6-8 and MS3-5. Y-axis shows the proportion of lineages in a given
generation that co-express at least one transcription factor (TF) that has expression
selectively maintained in one daughter, and at least one TF that has expression
selectively maintained in the other daughter (e.g. TF A expressed in parent and daughter
1, TF B expressed in parent and daughter 2). Lineages that satisfy these criteria are
considered to exhibit “multilineage priming.” Text labels above each bar indicate the
absolute number of lineages in each generation that exhibit multilineage priming
(numerator) and the total number of lineages included in the analysis (denominator).
Lineages that do not have exactly two, transcriptomically distinct daughters annotated in
our dataset are excluded from the statistics. Cell generations that are not shown in this
plot were excluded due to having a sample size of <= 3 lineages.
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Supplemental Figure 2.25 Examples of lineages that form discontinuous
trajectories in UMAP space.
(A) UMAP of 7,512 glia, excretory cells, and progenitors (same as Supplemental Figure
2.9). ILso glia are formed by three input lineages. Two input lineages, the ILso-AVD
parent and the ILso(D)-hyp3 parent, form discontinuous trajectories with terminal ILso.
Some early terminal ILso cells are likely to be unannotated, so it is not clear if there is a
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continuous or discontinuous trajectory with the third input lineage, the ILso(V)-SAA(D)
parent. (B) Global UMAP of 81,286 cells (same as Figure 2.1A). Annotated cell
populations are the same as in panel A, plus additional neuron types. The AVD, AVK,
and URB neurons are sisters of glia/excretory cells, but form discontinuous trajectories
with their parents. (C) UMAP of 8,233 non-pharyngeal mesoderm cells (same as
Supplemental Figure 2.17). Coelomocytes and Z1/Z4 (the somatic gonad precursors)
form discontinuous trajectories with their parents. (D) Global UMAP, same as panel B.
Annotated cell populations are the same as in panel C.
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Supplemental Figure 2.26 Counts of differentially expressed genes for lineages
that form continuous vs. discontinuous trajectories in UMAP space.
Each row (y-axis) corresponds to a pair of terminal sister cells in the ectoderm (AB
lineage, generations 9 and 10) or mesoderm (MS lineage, generation 6). Bar length (x128

axis) indicates the number of genes that are both differentially expressed (fold difference
> 3, q-value < 0.1) between the sister cells and also differentially expressed (same
thresholds) between at least one of the sisters and their parent. Genes that satisfy these
criteria are genes that are changing over time in a lineage-specific manner (and
therefore exclude broadly expressed genes). Before performing differential expression
analysis, the sc-RNA-seq cells that correspond to each of the listed anatomical cells and
their parent were downsampled to ensure that each comparison had approximately the
same statistical power. Rows are grouped based on whether or not the developmental
trajectories formed by the sister cells and their parent in UMAP space were
discontinuous for at least one sister. Trajectories were considered discontinuous only if
the discontinuity was present in both the global UMAP (Figure 2.1A, Supplemental
Figure 2.3) and the relevant tissue UMAP (Figure 2.3A, Supplemental Figures 2.9-2.10,
2.17). Rows are colored to indicate whether or not the sister cells share the same
broadly-defined cell type. For example, ASG and AWA, two ciliated neurons, are
considered to have the same broadly-defined cell type, while AFD and RMD, a ciliated
and non-ciliated neuron respectively, are considered to have different broadly-defined
cell types.
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Supplemental Figure 2.27 Embryo time distributions for trajectories included in
Supplemental Figure 2.26.
Ridge plot shows the distribution of estimated embryo times (minutes post first cleavage)
for all of the sc-RNA-seq cells annotated as one of the terminal cells listed in
Supplemental Figure 2.26, or its parent. For example, the ridge line for the row labeled
AFD has the distribution of embryo times for all sc-RNA-seq cells annotated as either
AFD (lineage = ABalpppapav/ABpraaaapav) or the AFD-RMD parent (lineage =
ABalpppapa/ABpraaaapa). Rows are grouped based on whether or not the listed
terminal cell forms a discontinuous trajectory with its parent in UMAP space. Trajectories
were considered discontinuous only if the discontinuity was present in both the global
UMAP (Figure 2.1A, Supplemental Figure 2.3) and the relevant tissue UMAP (Figure
2.3A, Supplemental Figures 2.9-2.10, 2.17).
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Supplemental Figure 2.28 Lineage distance vs. transcriptome distance in AB
generation 8.
Jensen-Shannon (JS) distance between the transcriptomes of pairs of cells in AB8, the
generation produced by 8 cell divisions since the AB founder cell. Data is faceted by
lineage distance and by whether the pair consists of two pre-terminal cells, one preterminal and one terminal cell, or two terminal cells. Most terminal epidermal cells in the
AB lineage are produced in AB8, while most terminal neurons, glia, and pharyngeal cells
are produced in the subsequent generation, AB9. The terminal epidermal cells in AB8
exit the cell cycle and begin to differentiate, resulting in a large transcriptome distance
between them and neuron/glia/pharynx progenitor cells that remain in the cell cycle.
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Supplemental Figure 2.29 Correlation between cell lineage and the transcriptome
in the mesoderm.
(A) Jensen-Shannon (JS) distance between the transcriptomes of pairs of mesoderm
cells (MS lineage), faceted by cell generation and lineage distance. MS4 refers to the
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cell generation produced by 4 divisions of the mesoderm founder cell (MS), and likewise
for generations MS5-6. The “transcriptome” of a given anatomical cell is defined as the
average gene expression profile of all sc-RNA-seq cells annotated as that anatomical
cell. Pairs of bilaterally symmetric cells are excluded from the statistics. The MS6
generation contains both terminal cells and pre-terminal cells that are still dividing. The
data for MS6 in the plot is faceted to separate these, comparing only pairs of preterminal cells (left panel) or only pairs of terminal cells (right panel). (B) Estimates of the
extent to which lineage explains the transcriptome in MS4-6, using a pseudo-R^2
statistic (see Materials and Methods). (C) Distribution of the number of “lineage
signature transcription factors”—TFs that distinguish a cell from its sister—for cells in
MS4-6. (D) Proportion of lineage signature transcription factors for a cell in a given
generation that have expression maintained in 0, 1, or 2 of the cell’s daughters in the
subsequent generation. (E) Proportion of lineage signature TFs for which expression in a
given cell was maintained from the cell’s parent vs. newly activated after the parent’s
division.
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Supplemental Figure 2.30 Both recent and distant ancestry contribute to the
ability of the lineage to predict a cell’s transcriptome.
In Figure 2.5B, we used a pseudo-R2 statistic to estimate the extent to which lineage
predicts the transcriptomes of cells within a given generation. Specifically, our pseudo-R2
statistic computes how much more similar are the transcriptomes of sister cells than
those of random pairs of cells (see methods section titled “Pseudo-R2 statistic”).
Here, we estimate how much of the similarity of sisters is specifically due to gene
expression signatures associated with their parent, and how much is due to gene
expression signatures associated with more distant ancestors. We describe how these
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estimates are computed in the methods section titled “Methods used in Supplemental
Figure 2.30”.
Each panel in the figure corresponds to a generation of the AB lineage. Each bar
on the x-axis corresponds to one of the generations that precede it. For example, AB5 is
preceded by the generations AB4, AB3, AB2, and AB1. The height of each bar
represents the contribution of gene expression signatures associated with that specific
ancestor generation to the ability of the lineage to predict the transcriptome in the
descendant generation. The sum of the heights of all bars in a panel is equal to the total
pseudo-R2 for the descendant generation (Figure 2.5B).
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Supplemental Figure 2.31 Hierarchical clustering of progenitor lineage
transcriptomes.
This heatmap shows the log2 expression (log2 transcripts per million) of all genes (rows)
that are expressed in at least one pre-terminal lineage (columns). Genes and lineages
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are ordered by hierarchical clustering. The right panel shows the expression values in
terminal cell bins, with genes (rows) ordered by the clustering as generated from the preterminal lineages and terminal cell bins (columns) ordered as in Supplemental Figure
2.32.
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Supplemental Figure 2.32 Hierarchical clustering identifies signatures of tissue
and cell type differentiation.
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This heatmap shows the log2 expression (log2 transcripts per million) of all genes (rows)
that are expressed in at least one terminal cell bin (columns). Genes are ordered by
hierarchical clustering, and cell bins are ordered by tissues (colored as in the legend),
and within tissues by the beginning of the time bin in minutes (early to late). Gene
clusters are labeled by sites of predominant expression. Numbers in parentheses are the
number of genes in that cluster.
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Supplemental Figure 2.33 Transcriptome specialization and transcription factor
usage across cell types and time.
(A) A global UMAP with 81,286 cells colored by the Gini coefficient of their gene
expression vector, adjusted to correct for sample size bias and scaled by converting to
z-scores. High Gini coefficients indicate that a small set of genes produces a large
fraction of cell mRNA content. (B) Number of TF expressed in g1 gland over time.
Equation shows linear regression result. Points are colored by estimated embryo time.
(C) Box plot showing TF activation times—the embryo time when a TF first becomes
expressed—grouped by TF family. For each TF, its activation time is defined as the 5th
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percentile of the estimated embryo time values for cells that express that TF. TF family
annotations are taken from the CIS-BP database (221). Families that have fewer than 10
members detected in the current dataset were excluded from this plot. (D) Number of
differentially expressed TFs and TF family composition across broad cell types.
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Supplemental Figure 2.34 Distribution of estimates for the proportion of UMIs in a
cell that come from background RNA.
(A) The process for making the estimates is described in the methods section “Per-cell
background correction and filtering”. Due to the sparsity of the single cell data, the
estimates are noisy. Numbers to the left and right of the vertical line indicate the
proportion of cells with estimated background fraction < or >= 75%. Cells with
background fraction >= 75% are filtered from all downstream analyses. (B) After per-cell
background correction, cells with low and high background fractions have near-identical
average gene expression profiles. Plot shows average gene expression profiles
(measured in transcripts per million) computed from non-head body wall muscle cells
divided into two groups: cells with estimated background fraction < 30% (x axis) and
cells with background fraction in the range [30%, 75%].
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CHAPTER 3 DEVELOPMENTAL TRAJECTORY OF PRE-HEMATOPOIETIC STEM
CELL FORMATION FROM ENDOTHELIUM

The contents of this chapter have been previously published as:
Zhu Q*, Gao P*, Tober J*, Bennett L, Chen C, Uzun Y, Li Y, Howell ED, Mumau M, Yu
W, He B. Developmental trajectory of pre-hematopoietic stem cell formation from
endothelium. Blood. 2020 May 11.
* These authors contributed equally.
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Introduction
Hematopoietic ontogeny involves multiple “waves” in which HSPCs with different
potentials differentiate from HE cells. HE cells in the yolk sac (YS) differentiate into
committed erythro-myeloid (EMP) and lymphoid progenitors, and the caudal arteries
produce lymphoid progenitors and pre-HSCs (222, 223). YS hematopoiesis can be
recapitulated in embryonic stem (ES) cell cultures, where the molecular events are welldescribed (224, 225). Groundbreaking studies described the transcriptomes of HE and
pre-HSCs in the major caudal artery, the dorsal aorta, at single cell resolution (39, 226228). However, these analyses did not examine the distribution or chromatin landscapes
of cells along the trajectory, or the heterogeneity of cells in the intra-arterial clusters
(IACs), due to the limited number of cells sequenced. To gain insights into the molecular
mechanisms mediating the differentiation of arterial E cells into IACs we performed
single-cell RNA sequencing (scRNA-Seq) and single-cell assay for transposaseaccessible chromatin sequencing (scATAC-Seq). Our data reveal a continuous trajectory
from E to IAC cells, previously undefined transitional cell populations along the
trajectory, the pathways and transcription factors active in these cells, and describe the
molecular heterogeneity of IAC cells.

Results
scRNA-Seq reveals a continuous trajectory from endothelial cells to IAC cells
Our strategy was to analyze all cells along the trajectory in a single sample to determine
their distribution between different transcriptional states, and combine that with analyses
of purified sub-populations to make accurate cell assignments and obtain additional
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coverage of rare cells (Figure 3.1A). We captured the entire trajectory by purifying a
population containing all E, HE, and IAC cells (E+HE+IAC) from E9.5 and E10.5
embryos using a combination of endothelial markers (Supplemental Figure 3.1A). We
also purified subpopulations of HE and E cells from E9.5 and E10.5 embryos based on
expression of green fluorescent protein (GFP) from the Runx1 locus(229) (Supplemental
Figure 3.1B). We confirmed that only HE cells were capable of producing hematopoietic
cells ex vivo (Supplemental Figure 3.1C). Kithi IAC cells were excluded in the sorts,
therefore HE and E cells were negligibly contaminated with HSPCs (Supplemental
Figure 3.1D). We purified IAC cells from E10.5 and E11.5 embryos using antibodies
recognizing endothelial markers and Kit, E9.5 yolk sac EMPs (E9.5 YS-EMP), and E14.5
fetal liver HSCs (FL-HSCs) (Supplemental Figure 3.2).
Summary statistics for collected cell populations are shown in Figure 3.1B and
Table 3.1. We used uniform manifold approximation and projection (UMAP) to reduce
the data dimension (117). After filtering out non-endothelial and non-hematopoietic cells
(Supplemental Figure 3.3A) and reducing batch effect using an “informative feature
selection” method (Supplemental Figure 3.4, Materials and Methods), UMAP of the
combined datasets shows a continuous trajectory from E to IAC cells (Figure 3.1C,D,
Supplemental Figure 3.3). E14.5 FL-HSCs are disconnected from this trajectory,
therefore, are more distantly related (Figure 3.1C).
Two streams of Efbn2+ E cells in the UMAP converge to form a stem leading to
HE and IACs (Figure 3.1E). Analyses of E10.5 E+HE+IAC cells manually separated into
VU arteries and DA demonstrated that VU cells contribute to one of these streams and
DA to both streams (Figure 3.1F). The E+HE+IAC samples, which demonstrate the
distribution of cells at various stages, show that at E9.5, IAC cells constitute only 0.5% of
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the E+HE+IAC population, but at E10.5 the fraction of IAC cells expands 7 fold,
representing 3.5% of the population, consistent with histological analyses showing
increased numbers of IACs between these two embryonic stages (230, 231) (Figure
3.1D,G).
Unsupervised clustering identified 7 distinct populations in the combined dataset,
and separated the two streams of E cells into distinct clusters (Supplemental Figure
3.5A-C). One cluster, containing only DA E cells, expresses high levels of Wnt target
genes (Wnthi E) (Supplemental Figure 3.5D). The second cluster, Wntlo E containing
both DA and UV cells, expresses lower levels of Wnt target genes. Wnthi E and Wntlo E
could be further subdivided into arterial E (AE) and venous E (VE) by computing an
arterial/venous score based on sets of AE and VE specific genes (232) (Figure 3.2A-D).
Pseudo-time-ordered Wnthi and Wntlo E cells prior to the point where the AE score
exceeded the VE score were defined as VE, and after that point were defined as AE.
Wnthi AE and Wntlo AE then converge to form a distinct cluster determined by both
UMAP and another method PHATE (233), that we termed conflux AE (Figure 3.2A,
Supplemental Figure 3.5E). The confluence of transcriptomes in conflux AE is driven by
the loss of Wnthi/lo AE-specific gene expression and increased levels of transcripts from
later stage-specific genes (Figure 3.2D,E). For example, expression of Wnt target genes
Foxq1 and Nkd1 in Wnthi AE cells, and Tmem255a in Wntlo AE cells are down-regulated
in conflux AE (Figure 3.2D). Cell cycle is also significantly inhibited in conflux AE
(Supplemental Figure 3.5F,G), while Notch signaling is elevated, seen by increased
expression of the Notch ligand Dll4 and transcription factor Hey2 (Figure 3.2D;
Supplemental Figure 3.3C). Additional pathways activated in conflux AE include those
regulating cell shape and motility (“elastin fiber formation””, “platelet adhesion to
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exposed collagen”, “gap junction assembly”) and processes important in hematopoietic
cells (“MAPK signaling for integrins”) (Figure 3.2F).

Runx1 regulates progression through a developmental bottleneck between preHE and HE
Conflux AE gives rise to HE and IAC cells, which are characterized by high levels of
Runx1 and Gfi1, and IAC by expression of the pan-hematopoietic marker gene Ptprc
(encoding CD45) (Figure 3.3B; Supplemental Figure 3.3C). Between conflux AE and HE
is a distinct cluster of endothelial cells that we named pre-HE. UMAP and pseudotime
trajectories of E10.5 E+HE+IAC reveal an accumulation of pre-HE cells, suggesting a
bottleneck between pre-HE and HE (Figure 3.3C) that is prominent at E10.5 although
not at E9.5 (Figure 3.1D). Gfi1, a direct RUNX1 target that participates in extinguishing
endothelial fate (234), shows elevated expression immediately after cells pass through
the bottleneck and become HE, while high levels of Sox17, the Notch target Hey2, and
the arterial marker Cd44 are found in pre-bottleneck populations including conflux E and
pre-HE (Figure 3.3B). To provide further evidence for the bottleneck, we utilized
Velocyto and scVelo, which infer directionality of differentiation by modeling dynamics of
unspliced versus spliced RNAs when a gene is up or down-regulated (141, 235).
Velocyto and scVelo showed a marked decrease in RNA velocity in pre-HE cells,
suggesting a differentiation barrier restricting their progression towards HE (Figure 3.3C,
Supplemental Figure 3.6). Once pre-HE cells transit to HE, however, they smoothly
differentiate to IAC cells. Several pathways known to promote Runx1 expression and
HSPC formation are upregulated in pre-HE, including Notch, tumor necrosis factor, fluid
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shear stress, cytokine signaling, and synthesis of eicosanoids, vitamins, and sterols (52,
53, 236-241), suggesting these pathways are important in pre-HE (Figure 3.3D,
Supplemental Figure 3.7). Once cells transition to HE, RUNX1 plays a predominant role.
Runx1 expression is upregulated in approximately 7% of pre-HE cells suggesting
that RUNX1 levels regulate passage through the bottleneck (Figure 3.3B, Supplemental
Figure 3.6B). We tested this hypothesis using several approaches. First, we compared
the distribution of cells between conflux AE, pre-HE, HE, and IAC in Runx1+/- and
Runx1+/+ littermates by scRNA-Seq. We observed a 68% reduction in the proportion of
HE and IAC cells in E10.5 Runx1+/- compared to Runx1+/+ embryos, and a
commensurate 56% increase in pre-HE, consistent with the hypothesis that RUNX1
levels regulate transit through the bottleneck (Figure 3.3E). We also performed the
reciprocal experiment; ectopically expressing RUNX1 in all endothelial cells by activating
a conditional Runx1 cDNA in the Rosa26 locus (cR1) using an endothelial-specific
tamoxifen-inducible Cre driven from the vascular endothelial cadherin (Cdh5) regulatory
sequences (Cre) (242). We previously showed that ectopic expression of RUNX1 in all
endothelial cells in Cre;cR1/+ embryos increased the frequency of functional HE cells
compared to control embryos (cR1/+) (242). scRNA-Seq analysis demonstrates these
results from an increase in the proportion of HE cells and a proportionate decrease in
pre-HE cells (Figure 3.3F), confirming that RUNX1 levels regulate the number of pre-HE
cells that transit through the bottleneck to become HE. Second, we determined whether
RUNX1 haploinsufficiency reduced the number of phenotypic HE cells by confocal
microscopy. SOX17 is expressed in AE cells and promotes HE specification, whereas
HE cells are RUNX1+SOX17low/- (243, 244). The ratio of RUNX1+SOX17low/- HE cells
versus RUNX1-SOX17+ AE cells in the dorsal aorta was significantly lower in E9.5
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Runx1+/- embryos compared to Runx1+/+ embryos (Supplemental Figure 3.8). Finally, we
measured the frequency of functional HE cells within a purified population of CD44+
E+HE+IAC cells (Supplemental Figure 3.2G), which are enriched for conflux AE, pre-HE,
HE, and IAC (245) (Figure 3.3B). RUNX1 haploinsufficiency reduced the frequency of
functional HE cells by 77% (Figure 3.3G), consistent with the observed reduction in the
scRNA-Seq experiment (Figure 3.3E). Together these data confirm that RUNX1 level
regulates the number of pre-HE cells that transit through the bottleneck to become HE
cells.

scATAC-Seq identifies putative Runx1 enhancers and transcription factor motifs
that gain accessibility in pre-HE
To identify signals that may activate Runx1 expression in pre-HE, we performed paired
scRNA-Seq and scATAC-Seq on E10.5 CD44+ E+HE+IAC cells to identify Runx1
enhancers and the stages they are accessible. High quality open chromatin profiles were
obtained for 1670 cells, covering various cell types from E to IAC (Supplemental Figure
3.9). The joint embedding of scRNA-Seq and scATAC introduced a gap between pre-HE
and IAC cells on the UMAP. This results from the developmental bottleneck around
E10.5 that causes an underrepresentation of HE cells connecting pre-HE and IAC in
some samples. (Figure 3.4A). We devised a computational approach that matches
scATAC-Seq clusters with scRNA-Seq clusters (Figure 3.4A, Supplemental Figure 3.10),
and subsequently linked enhancers with their target promoters (Figure 3.4B). Accuracy
of our method was benchmarked using known hematopoietic and endothelial enhancers
(Figure 3.4C, D). We applied chromVar (246) to assess differential transcription factor
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(TF) binding patterns along the EHT trajectory (Figure 3.4E). Results show strong
correlation with the TF expression patterns and are consistent with pathway analyses
from scRNA-Seq data. For example, strong TCF/LEF binding activity was detected in
Wnthi E that abruptly decreased in conflux AE (Figure 3.4E, F). SOX and FOX binding
sites are mostly open in conflux AE and pre-HE. Binding sites for a large group of TFs
had increased accessibility beginning at the pre-HE stage, including HES1, GATA,
SMAD, and TFs such as MECOM, EGR1, and YY1 that regulate HSC homeostasis
(247-249), the latter group suggesting that an HSC-specific transcriptional program may
initiate at the pre-HE stage.
Runx1 contains two promoters, an upstream P1 promoter that is first utilized in
committed HSPCs, and a more proximal P2 promoter that is active in HE and HSPCs
(250). Consistent with this, P1 first becomes accessible in IAC cells, whereas P2 is
accessible in all endothelial cells including pre-HE (Figure 3.5A), which may permit or
contribute to the stochastic Runx1 expression observed in a subset of endothelial cells
(Figure 3.3B). Using our computational approach, we predicted 27 enhancer-promoter
(E-P) interactions, which recapitulate 11 out of 22 previously identified E-Ps based on
chromosome conformation capture assays (251, 252) (Figure 3.5A, also see Materials
and Methods). All of the predicted enhancers exhibit higher co-accessibility with P1
compared to P2, therefore only E-Ps to P1 are indicated. A significance plot of the
predicted E-Ps reveals several enhancers whose chromatin openness is significantly
correlated with Runx1 expression, including the Runx1 +23 enhancer (Figure 3.5B).
Several of the predicted enhancers exhibit stage-specific co-accessibility with the P1
promoter (Figure 3.5C). Interestingly, one candidate enhancer located 371 kb upstream
of Runx1 P1 was accessible only in pre-HE and IACs, and not in other endothelial cell
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populations (Figure 3.5A, C). This candidate enhancer was previously shown by circular
chromosome conformation capture sequencing to interact with the +23 enhancer and P1
in a hematopoietic progenitor cell line (251). The -371 enhancer drove expression of a
reporter gene in the intermediate cell mass and posterior blood island of zebrafish
embryos, both of which are sites of hematopoietic ontogeny (251). The scATAC-Seq
signal encompassing the -371 enhancer begins to increase in conflux AE cells and
reaches a maximum in pre-HE cells (Figure 3.5A, D). This change in accessibility in preHE coincides with the activation of Runx1 expression in a subset of pre-HE cells (Figure
3.5D). However, unlike the +23 enhancer, the chromatin accessibility of the -371
enhancer subsequently decreases in IAC cells and is no longer open in FL-HSCs
(Figure 3.5A). The candidate -371 enhancer contains GATA, STAT, and JUN motifs,
indicating that GATA2 and cytokine and/or inflammatory signaling may contribute to the
opening of this enhancer in pre-HE (Figure 3.5A). An independent co-expression
analysis based on the scRNA-Seq data reveals that these factors form a co-expression
gene module that precedes and correlates with Runx1 expression (Figure 3.5E),
suggesting they may cooperatively regulate Runx1 expression. Notably, neither the -371
nor the +23 enhancers contain SOX motifs, which are recognized by a repressor of
Runx1 expression, Sox17 (244). Other TF motifs enriched in the 27 called Runx1
enhancers include ETS, FOX, SOX, KLF/SP, RUNX, and SMAD, which are recognized
by TFs with well-documented roles in HSPC formation (253-255).

Two waves of HSPCs form in the IACs
We also examined the transition of HE to IAC cells and the composition of IAC cells.
Principal component analysis (PCA) depicts a sharp U-turn as HE differentiates into IAC
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cells, reflective of a marked decrease in AE gene expression and activation of
hematopoietic genes (Figure 3.6A). For example, the AE-specific gene Gja5 is primarily
expressed on the HE side of the trajectory, while expression of Spn (encoding CD43),
Ptprc (encoding CD45) and the Rho GTPase Rac2 rapidly increases in IAC cells (Figure
3.6B, Supplemental Figure 3.11A, B). Transient expression of the chromatin remodeling
protein Nupr1 occurs at the U-turn, while Hey1 and Sox17 transcripts significantly
diminish as IAC cells mature (Figure 3.6B, Supplemental Figure 3.11B).
IACs contain pre-HSCs that cannot engraft adult mice directly, but can mature in
vivo or ex vivo into adult-repopulating HSCs(36, 38, 256). Pre-HSCs are classified as
type I or II based on CD45 expression; type I are CD45-, and the more mature type II are
CD45+ (38). E10.5 IACs contain only type I pre-HSCs, whereas E11.5 IACs contain both
type I and II pre-HSCs(38). Additionally, multiple progenitors with lymphoid, myeloid,
lympho-myeloid, or multi-lineage potential emerge prior to or contemporaneously with
pre-HSCs (222), at least a subset of which are CD45+ (226, 257, 258). We compared
E10.5 CD45+IAC cells that contain HSC-independent progenitors and lack pre-HSCs to
E11.5 CD45+CD27+CD144+ IAC cells enriched for type II pre-HSCs (E11.5 pre-HSCs)
(38, 259) to determine their developmental relationship (Supplemental Figure 3.2C,D).
The two populations bifurcate in the third principal component of PCA plots; specifically,
the majority of E10.5 CD45+ IAC cells occupy one end of the PC3 axis, and E11.5 preHSCs reside on the other end (Figure 3.6C, D). E11.5 pre-HSCs demonstrated a high
correspondence with previously published data (39) (Supplemental Figure 3.12A). We
determined the fraction of pre-HSCs in E10.5 and E11.5 IAC cells using a K-nearestneighbor classifier. About 2% of E10.5 IAC cells were found to be molecularly similar to
E11.5 type II pre-HSCs; this fraction of pre-HSCs increases to 67% in E11.5 IAC cells
153

(Figure 3.6D), consistent with previous limiting dilution assay results demonstrating an
increase in functional pre-HSCs between E10.5 and E11.5 (36). To determine the fate
bias of cells from earlier stages, we used Palantir and FateID (144, 260). T-SNE plot
generated by Palantir analysis shows a bifurcation pattern similar to the PCA result
(Supplemental Figure 3.11C). Distribution of the fate probabilities suggests that
compared to E9.5 HE, E10.5 HE has higher probability of choosing pre-HSC fate, and
E11.5 IACs contain more pre-HSC-like cells than E10.5 IACs (one-sided KolmogorovSmirnov test, Supplemental Figure 3.11D, E).
The 974 genes more highly expressed in E11.5 pre-HSCs compared to E10.5
CD45+ IAC cells include known markers of pre-HSCs and/or HSCs (Eya2, Procr, Cd27,
and Mecom) (39, 247, 259, 261, 262), while the 877 genes up-regulated in E10.5 CD45+
IAC cells include proliferation related genes (Myc) and lympho-myeloid associated
genes (Il7r, Fcer1g) (Figure 3.6E, F). Among the differentially expressed genes, some
transcription factors, such as Myc, Klf2, Smad7, Mecom, Meis2 and Nfix, are expressed
in HE cells, and show strong bifurcation in expression as cells become IAC cells
(Supplemental Figure 3.11F). Pathway analysis suggests E11.5 pre-HSCs gain stemcell specific features such as “OCT4, SOX2, NANOG represses genes related to
differentiation”, while pathways associated with E10.5 CD45+ IAC cells are associated
with cell cycle and/or related to a specific hematopoietic lineage, such as “TCF
dependent signaling in response to WNT” (Figure 3.6G). Interestingly, E11.5 pre-HSCs,
although sampled 1 day later in development compared to E10.5 CD45+ IAC cells, retain
many pathways from E/HE stages, such as “Signaling by BMP” and “eNOS activation”,
suggesting a relatively slow shutdown of the E/HE program in pre-HSCs. In contrast,
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subsets of E10.5 CD45+ IAC cells show lineage-specific differentiation bias; Il7r is upregulated in 26%, and Gata1 in 3% of E10.5 CD45+ IAC cells (Figure 3.6F).
Previous scRNA-Seq studies identified committed progenitors in E10.5 and
E11.5 IACs but concluded they were contaminating erythro-myeloid progenitors (EMPs),
likely originating from the yolk sac, that had been circulating in the blood and became
attached to the IACs (39, 226). We addressed the possibility that the E10.5 CD45+ IAC
cells we profiled are contaminating YS EMPs. Direct comparison shows E10.5 CD45+
IAC cells and E9.5 YS-EMP are molecularly and functionally distinct (Figure 3.6H,
Supplemental Figure 3.12C). E10.5 CD45+ IAC cells contained progenitors of
macrophages and granulocytes/monocytes, but very few erythroid or megakaryocytic
progenitors compared to E9.5 YS-EMPs (Figure 3.6H). E10.5 CD45+ IACs have potent
lymphoid potential; limiting dilution assays revealed a high frequency of cells (1:6)
capable of producing B cells following culture on OP9 stromal cells or T cells on OP9
expressing the Notch ligand delta-like 1 (Figure 3.6I, J). E10.5 CD45- IAC cells also
contained progenitors with lymphoid and myeloid potential, although their frequency was
lower than in the E10.5 CD45+ IAC population. In summary, E10.5 CD45+ IAC cells
represent a distinct wave of lympho-myeloid-biased progenitors in IACs that appear prior
to E11.5 type II pre-HSCs.

Discussion
Our single cell analyses provide new insights into the process by which endothelial cells
differentiate into pre-HSCs. First, we define a precursor of HE we have named pre-HE,
in which multiple pathways known to regulate HSPC formation appear to act. Also,
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through trajectory analyses and genetic perturbation experiments we identified a
bottleneck separating pre-HE from HE, indicative of a developmental barrier that must
be overcome at that transition. It is long known that embryonic hematopoiesis is
exquisitely sensitive to Runx1 dosage, as reduced Runx1 dosage decreases the number
of HE cells, IACs and committed hematopoietic progenitors in the embryo (263-265).
Our scRNA-Seq analyses show that the deficits caused by reduced Runx1 dosage are
caused, at least in part, by the inefficient transition of pre-HE to HE cells. The molecular
underpinnings of the bottleneck at the pre-HE to HE transition are not known. One
possibility is that Runx1 expression may be actively repressed in the majority of pre-HE
cells by TFs such as Sox17 (244, 266), which is highly expressed in pre-HE, and binding
sites for which are accessible in pre-HE. A requirement for chromatin remodeling may
also be a limiting factor in pre-HE, as multiple epigenetic regulatory proteins have been
shown to affect Runx1 expression in HE, some of which may act at the pre-HE to HE
transition (267).
Prior to HE, Runx1 is expressed at low levels in a subset of endothelial cells,
consistent with the chromatin accessibility of the P2 promoter and of several Runx1
enhancers in endothelial cells. Runx1 expression in endothelial cells appears to be
stochastic; it then becomes elevated in a subset of pre-HE cells, and is uniformly high in
HE and IACs. The mechanism by which Runx1 expression is activated in a subset of
pre-HE cells is not known, but our experiments provide some clues. scATAC-Seq
revealed that a distal enhancer in Runx1 (-371), previously validated in zebrafish
transgenic embryos and conserved in mammals (251), first becomes accessible in preHE. Highly conserved TF motifs in the -371 enhancer include GATA, STAT, and JUN,
implying that TFs that bind these motifs may play a role in opening the enhancer in pre156

HE. Gata2 expression is activated in a pulsatile manner in endothelial cells in the DA
(268), which may contribute to the stochastic expression of Runx1 in arterial endothelial
cells. STAT and JUN motifs are recognized by TFs that are effectors of inflammatory
signaling pathways, including type I and II interferons, and tumor necrosis factor, all of
which promote HSPC formation from arterial endothelium (52, 269, 270). Hence
signaling pathways known to promote later Runx1 expression in HE could potentially
initiate Runx1 expression in a subset of pre-HE cells by activating the candidate -371
pre-HE enhancer. At later stages, in IACs and FL-HSCs, multiple additional enhancers,
including the +23 enhancer gain accessibility and interact with the P1 promoter to further
elevate Runx1 expression.
A second important concept gleaned from our data is that the IACs contain at
least two distinct HSPC subtypes, committed lympho-myeloid-biased progenitors and
pre-HSCs, that can be distinguished molecularly. These appear sequentially, with CD45+
lympho-myeloid-biased progenitors preceding the formation of type II pre-HSCs. The
mechanisms underlying the generation of these two types of HSPCs is of great interest.
It is not known, for example, if they independently differentiate from an equivalent
population of immature IAC cells. Alternatively, they may be derived from distinct
populations of HE cells. Our cell fate analysis suggests that E10.5 HE is more likely to
assume pre-HSC fate than E9.5 HE, which is consistent with the observation that E11.5
IACs contain more pre-HSCs than E10.5 IACs. The bifurcation of fate may be partially
driven by early differential expression of transcription factors specific to pre-HSCs or
lympho-myeloid-biased progenitors. The lympho-myeloid-biased progenitors are more
developmentally “mature” compared to the type II pre-HSCs, suggesting that they are
more driven towards terminal differentiation. A similar population of lympho-myeloid
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restricted progenitors that originates in the yolk sac colonizes the FL and thymus prior to
HSCs (271, 272). Lympho-myeloid-biased progenitors in the arterial IACs may serve a
similar function.
The earlier emergence of lympho-myeloid-biased progenitors in the arteries may
have implications for ongoing efforts to generate pre-HSCs from ES cells. The
acquisition of lymphoid potential is often used as a surrogate for pre-HSC formation.
However, it is possible that conditions favoring the production of this earlier population of
committed lympho-myeloid progenitors may be suboptimal for the later formation of preHSCs. If this is the case, then inhibiting the differentiation of lympho-myeloid progenitors
in ES cell cultures may improve pre-HSC production ex vivo.

Materials and Methods
Animal husbandry
B6C3F1/J 3-week old female mice were purchased from Jackson Laboratories (Stock
no: 100010). Females were injected with 5 IU pregnant mare serum gonadotropin and
48 hours later with 5 IU human chorionic gonadotropin (Sigma), then immediately paired
overnight with C57BL6/J male mice. Runx1:GFP (Runx1tm4Dow) (229) homozygous male
mice were mated to super-ovulated B6C3F1/J 3-week old female mice to generate
embryos for purification of E and HE cells. Female B6C3F1/J mice were mated with
male B6129SF1/J mice for isolating fetal liver HSCs. Ectopic RUNX1 expression in
endothelial cells in Tg(Cdh5-cre/ERT2)1Rha embryos (273) that contained an
activatable Runx1 cDNA in the Rosa26 locus was described previously (242). Runx1+/mice (Runx1tm1Spe) were described previously (264). The morning post mating is
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considered embryonic day (E) 0.5. E9.5-E11.5 embryos were accurately staged at the
time of harvest by counting somites. Embryos that showed abnormal development were
discarded. Mice were handled according to protocols approved by the University of
Pennsylvania’s Institutional Animal Care and Use Committee and housed in a specificpathogen-free facility.

Embryo dissection and FACS
Yolk sacs were removed from embryos, and vitelline vessels were retained with the
embryonic portion. The head, cardiac and pulmonary regions, liver, digestive tube, tail
and limb buds were removed. The remaining portion containing the aorta-gonadmesonephros (AGM) region, portions of somite, umbilical and vitelline vessels were
collected. E9.5 and E10.5 yolk sacs were collected for isolation of EMPs. Tissues were
dissected in phosphate buffered saline (PBS)/10% Fetal Bovine Serum (FBS) and
Penicillin/Streptomycin (Sigma), followed by dissociation in 0.125 Collagenase (Sigma)
for 1 hour. Tissues were washed and filtered through a 40-micron filter and resuspended
in antibody solution. Cells were sorted on either BD Influx, MoFlow Astrios EQ
(Beckman), BD Jazz, or BD Aria, all equipped with a 100-micron nozzle, and run at a
pressure of 17 psi with flow rates less than 4000 events/second. Sorted cells for
functional assays were collected in PBS/20% FBS/25mM HEPES. For scRNA-Seq and
scATAC-Seq, cells were collected in IMDM/20% FBS in low-retention microcentrifuge
tubes (Denville).
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scRNA-Seq
Sorted cells were immediately processed for library preparation using the 10x Genomics
Chromium Single Cell 3′ Reagent Kit v2. Libraries were quantified using the dsDNA
High-Sensitivity (HS) Assay Kit (Invitrogen) on a Qubit ﬂuorometer and the qPCR-based
KAPA assay (Kapa Biosystems). Library quality assessment was performed on the
Agilent 2100 Bioanalyzer in combination with the Agilent High Sensitivity DNA kit.
Indexed libraries were pooled and sequenced on an Illumina HiSeq 4000 or NextSeq
550 using paired-end 26 × 98 bp read length.

scATAC-Seq
Sorted cells were centrifuged at 300x g for 5 min at 4 °C and resuspended in 50 µL of 1x
PBS + 0.04% BSA. 45 µL of supernatant was carefully discarded, and 45 µL of chilled
lysis buffer was added and mixed by pipetting gently. After incubation for 5 min on ice,
50 µL of chilled wash buffer was added without mixing. The mix was centrifuged at 500x
g for 5 min at 4 °C, and 95 µL of supernatant was discarded. 45 µL of chilled diluted
nuclei buffer was added without mixing, and the mix was centrifuged at 500x g for 5 min
at 4 °C. The nuclei pellet was resuspended in 7 µL of chilled diluted nuclei buffer. 2 µL of
nuclei suspension was used to determine the cell concentration by a Countess II cell
counter (Invitrogen), and the remaining 5 µL of nuclei suspension was processed for
library preparation using the Chromium Single Cell ATAC Reagent Kits protocol.
Libraries were quantified using the dsDNA HS Assay Kit on a Qubit fluorometer and the
qPCR-based KAPA assay. Library quality assessment was performed using the Agilent
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2100 Bioanalyzer with the Agilent High Sensitivity DNA kit. Indexed libraries were pooled
and sequenced on an Illumina NextSeq 550 using paired-end 50 × 50 bp read length.

OP9 co-culture assays
FACS sorted cells were plated in limiting dilutions on OP9 (ATCC) or OP9-delta-like 1
stromal cells in 96-well plates containing Minimum Essential Medium Eagle - alpha
modification (alpha MEM), 20% FBS (Hyclone, Gibco) and Pen/Strep. 5 ng/mL Flt3L and
10 ng/mL IL-7 were added to the medium for OP9 co-cultures. The medium for the OP9DL1 co-cultures was supplemented with 5 ng/mL Flt3L and 1 ng/mL IL-7. Co-cultures
were conducted for 10-13 days and subsequently, flow cytometry was performed on a
LSR-II (BD). The flow cytometry antibody panel for OP9 co-cultures included the
hematopoietic markers Mac1, Gr1, CD19, B220, and CD45, while the OP9-DL1 cocultures were analyzed for CD45, CD90, and CD25. Limiting range was determined
using the extreme limiting dilution analysis (ELDA) software analysis tool (274).

Methylcellulose assays
To enumerate erythroid, myeloid, and megakaryocyte progenitors, sorted cells were
cultured in M3434 (StemCell Technologies) for 7 days. Colonies were scored based on
morphological criteria.
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Hemogenic endothelial (HE) cell assay
Sorted cells were plated in limiting dilutions with OP9 stromal cells for 8-10 days in alpha
MEM containing 10ng/mL of IL-3, IL-7, Flt3, and SCF. Cells were analyzed by flow
cytometry for hematopoietic markers (B220, CD19, Mac1, Gr1, and CD45), and ELDA
software analysis tool (274) was used to determine the frequency of HE.

Whole-mount immunofluorescence and confocal microscopy
Embryos were prepared as previously described (37). Embryos were stained with rabbit
anti-mouse/human RUNX1/AML1+RUNX2+RUNX3 and rabbit anti-mouse/human Sox17
at a working concentration of 1:500. Secondary antibodies used were goat anti-rabbit
Alexa Fluor 488 (1:1000, Abcam ab150077, against Runx1) and goat anti-rabbit Alexa
Fluor 647 (1:500, Abcam ab 150083, against Sox17). Images were acquired on a Zeiss
LSM 880 AxioObserver inverted microscope equipped to detect 488, 561, and 633nm
wavelengths. Images were analyzed using Fiji software (275).

scRNA-Seq data analysis
Data pre-processing and filtering of non-endothelial and non-hematopoietic cells
Raw sequencing reads were first pre-processed with 10x Genomics Cell Ranger pipeline
and aligned to the mouse mm10 reference genome. An initial filtering was performed on
the raw gene-barcode matrix output by the Cell Ranger cellranger count function,
removing barcodes that have less than 1000 transcripts (quantified by unique molecular
identifier (UMI)) and 1000 expressed genes (“expressed” means that there is at least 1
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transcript from the gene in the cell). Barcodes that pass this filter were considered as
cells and were fed into downstream dimensionality reduction and clustering analysis. In
the global UMAP with 37,766 cells combined from all datasets, we noticed several
contaminant cell types, including mesenchymal-like cells that express high levels of
collagen, erythroid progenitors, and Lyve1+ endothelial cells that likely have a lymphatic
or YS origin (Supplemental Figure 3.3A). Since these contaminant cell types are not
directly associated with EHT, we removed them from our downstream analyses, thereby
obtaining a UMAP exclusively with endothelial cells and hematopoietic cells
(Supplemental Figure 3.3B).
Unsupervised clustering on the cleaned global UMAP reveals a clear separation
between IACs and other hematopoietic progenitors. For example, Haptoglobin (Hp) is
highly expressed in most YS EMPs, but has almost zero expression in IAC cells
(Supplemental Figure 3.3B). Genes such as Gata1 were found to be expressed in
subset of EMP and a few IAC cells (Supplemental Figure 3.3B). We found a Bnip3hi
population in the E10.5 CD44+ E+HE+IAC samples, and a group of low-quality
endothelial cells marked by low UMI counts per cell (Supplemental Figure 3.3B). After
filtering out these cells, we obtained a final UMAP with 23,081 cells representing the
EHT trajectory (Supplemental Figure 3.3C). We ran Louvain clustering on this global
UMAP and assigned cell types based on differentially expressed genes (Supplemental
Figure 3.3C). The cell distributions of each dataset post cleaning are shown in Figure
2C.
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Feature selection, dimensionality reduction, and unsupervised clustering
Gene-barcode UMI count matrix combined from all datasets was first processed with a
standard pipeline utilizing the Monocle 3 package (276). An initial variable expressed
gene (VEG) selection was performed on the size-factor corrected, log2 transformed
expression matrix using the feature dispersion table output by Monocle
estimateDispersions and dispersionTable functions. The estimateDispersions function
models how a gene’s variance is related to its average expression. We tested various
cutoffs for dispersion, and found a relatively consistent pattern in the resulting UMAP.
We found relaxing the cutoff to dispersion_empirical/dispersion_fit > 0.5 improves the
clustering result, especially in detecting rare cell types/states. This procedure is similar
to choosing x number of top variable genes in the Seurat pipeline, where x is an arbitrary
number selected by the user. Furthermore, we require a gene to be expressed in at least
more than 1 transcript in a minimum of 10 cells in order to be used as a VEG for
dimensionality reduction. To produce a low dimensional embedding of the data, principal
component analysis (PCA) was performed on the VEG-cell matrix, and the top PCs were
used as features for the UMAP algorithm. UMAP was computed using the umap function
in the uwot R package, with “cosine” distance metric, 20 nearest neighbors, and the rest
of the parameters utilized were default. Louvain clustering was run on the K-nearest
neighbor graph (K = 20) constructed from cell embeddings on the UMAP. Additionally,
we ran PHATE (233) on the same set of EHT cells with the default parameter setting,
and obtained a similar trajectory as in the UMAP (Supplemental Figure 3.5E).
We noticed that VEGs selected using Monocle 3 or Seurat contained genes that
are cell-type specific, as well as genes associated with cell cycle and batch differences.
Some highly expressed house-keeping genes are also called as VEGs, likely due to
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variation in sequencing depth across batches. The UMAP produced by the Monocle 3 or
Seurat pipeline is globally reflective of cell type, but locally affected by batch and cell
cycle, causing some clusters to be less representative of underlying cell states
(Supplemental Figure 3.4D).
To select features that are most reflective of cell type transitions during EHT and
less affected by batch or cell cycle difference, we devised a feature selection procedure
called informative feature (IFF) selection. IFF takes an initial clustering generated by
other single-cell clustering methods such as Monocle 3, Seurat and SC3 (277-279) and
then computes the expressed (non-zero) fraction of each gene for each cluster. Genes
that are detected in too few cells (e.g., less than 10% in every cluster) are filtered out. To
determine the “inequality” of the gene’s expression across clusters, we calculated Gini
coefficient on the per-cluster-expressed-fraction vector. The distribution of Gini
coefficients shows a clear peak on the left (Supplemental Figure 3.4A). Genes in the
peak are highly enriched for housekeeping and cell cycle functions, while genes in the
right long tail are strongly enriched for cell type specific ontologies (Supplemental Figure
3.4B, C). This allows us to separate the majority of “cell-type-informative-features” from
“ubiquitous features”. We found that IFF significantly improves the clustering result by
mitigating the batch effect (Supplemental Figure 3.4D) and identifies underlying cell
subtypes and states (Supplemental Figure 3.4F-H). The method is also robust to initial
clustering parameter choice (Supplemental Figure 3.4E).
The IFF selection procedure is conceptually similar to the dpFeature selection
introduced in the Monocle 2 package, which requires an initial clustering that is most
reflective of cell type and selects cell-type-specific features by differential gene
expression test. However, unlike the dpFeature, IFF selection is more permissive, as it
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does not require a gene to be significantly differentially expressed in one cell type to be
selected. Additionally, genes expressed in a subset of clusters with a relatively weak but
specific pattern are informative of cell type segregation, and a high Gini coefficient
enables them to be selected as IFFs. Since Gini coefficient computation is based on the
per-cluster-expressed-fraction rather than normalized expression, this procedure is also
insensitive to various modeling assumptions underlying different single cell data
normalization methods.

Differential expression analysis
We ran differential expression analysis using the “sSeq” algorithm implemented in the
cellrangerRkit package and used FDR < 0.05 and log2 fold change >1 to call
differentially expressed genes (DEGs).

Pathway enrichment analysis
To directly compute a per-cell enrichment score for each pathway in the Reactome
database (280), we used an approach based on the AUCell package (157). We slightly
modified the standard AUCell pipeline; instead of using all genes for ranking, we initially
removed the majority of housekeeping genes using the IFF selection method described
above, thereby retaining genes that are mostly cell-type specific (top 25% of genes
ranked by Gini coefficient). To derive pathways that are differentially active along the
EHT trajectory and between pre-HSC and lympho-myeloid-biased progenitors, we
subsequently performed stage-wise Student’s t test on the enrichment score (q-value <=
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0.01). For Figure 3.2F, 3.6G, Supplemental Figure 3.5D, and Supplemental Figure 3.7,
we removed pathways with fewer than 5 genes. Redundant pathways were removed if
the Jaccard index (number of shared genes/number of all genes) for the pair of
pathways was greater than 0.1 and the pathway had a higher q-value. For Supplemental
Figure 3.4B, C, we computed gene ontology (GO) enrichment using the ClusterProfiler
package (281), q-value cutoff of 0.05 and ontology type “Biological Process” (BP).

Pseudotime assignment
We applied Slingshot, one of the best performing trajectory inference methods based on
a benchmark study of 45 methods (135), to the cleaned data, as described above.
Slingshot infers trajectory by fitting a principal curve along a user-selected low
dimensional embedding of the data and assigns each cell a pseudotime based on its
projection onto the curve. We used the UMAP in Figure 1C, excluding FL-HSC, as the
input to the Slingshot algorithm. The starting cluster was set to the “E9.5 E” population,
and the terminal cluster was set to the “IAC” population. Computed pseudotime was
used for ordering cells along heatmaps in Figure 1G, 2F, and Supplemental Figure 3.7.
For Figure 3.2B, C and F, Slingshot was re-run with cells in the Figure 3.2B UMAP,
which is a subset of the Figure 3.2A UMAP containing only Wnthi E, Wntlo E, Conflux AE
and pre-HE. Cells in heatmaps of Figure 3.6E, G and Supplemental Figure 3.11B were
ordered based on the PC score, rather than Slingshot-assigned pseudotime.
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Single cell RNA velocity analysis
We applied two methods, Velocyto and scVelo to estimate cell velocity in EHT. We used
the “velocyto run10x” command with mm10 reference genome to quantify spliced and
unspliced mRNAs. The output loom file was analyzed using the “velocyto.R” package
and the scVelo python package. For the E10.5 E+HE+IAC dataset shown in Figure 3.3,
we sequenced ~56k reads/cell, and 13.3% UMIs contained unspliced intronic
sequences. Velocyto analysis allows estimation of RNA velocity of single cells by
distinguishing between unspliced and spliced mRNAs, which is predictive of the rate of
transcriptome change along the EHT trajectory. We used the
“gene.relative.velocity.estimates” function with fit.quantile = 0.05, deltaT = 1, kCells = 20
to calculate RNA velocity and subsequently, visualized the velocity vector field in the
UMAP using the “show.velocity.on.embedding.cor” function with 20-cell neighborhood
and 80 grid points along each UMAP axis. Compared with the steady-state model used
in Velocyto, scVelo implements a more sophisticated dynamic model that models the full
splicing kinetics. We ran scVelo with its default parameter setting and plotted its
predicted velocity on the same UMAP as Velocyto.

Fate probability analysis
We applied Palantir and FateID to determine the probabilities of HE cells becoming preHSCs and lympho-myeloid-biased progenitors (144, 260). Input to both methods are
log2 transformed normalized UMI count matrix, filtered with genes selected by the IFF
method. Results with default parameter settings are plotted on the T-SNE embedding by
Palantir as shown in Supplemental Figure 3.11D.
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Comparison with published scRNA-Seq data
We compared our data to three published scRNA-Seq datasets. Zhou et al. (39)
sequenced 181 cells including E, pre-HSC and HSC cells. Baron et al. (226) sequenced
1121 E, HE, EHT and IAC cells from E10 and E11 AGM using CEL-Seq. Mass et al.
(282) sequenced ~90 E10.25 EMP cells. First, we performed PCA on our data using
shared genes with the public data, then used the top 10 PCs to compute a UMAP using
the umap function from the uwot package. Using the PCA loading matrix, we projected
public data onto the same PCA space, then predicted UMAP embedding using
umap_transform function with the previously computed UMAP model. For each
projected cell, we mapped it to cell types annotated in this study by 3-nearest-neighbor
classification. The final co-embedding for public data with our data are shown in
Supplemental Figure 3.12.

scATAC-Seq data analysis
Data pre-processing and peak calling
scATAC-Seq reads were aligned to the mouse mm10 reference genome using the
“cellranger-atac mkfastq” command. Peaks were called using MACS2 with the FDR
cutoff of 0.10 and the following parameters: -q 0.10 --broad --broad-cutoff 0.10) (283).
Quality control statistics of the data were generated using the scATAC-pro package
(284) and are shown in Supplemental Figure 3.9. We implemented a custom PERL
script to quantify the reads overlapping with peaks individually for each cell. The read is
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considered to overlap with the peak if at least half of the read overlaps. By quantifying
the reads for each individual cell, we obtained a peak-barcode matrix. The peak-barcode
matrix underwent an initial filtering, requiring a barcode to have at least 2,000 fragments,
1,000 detected peaks and at least 20 percent fragments in peak to be considered as a
“cell”. Additionally, for each peak, we computed the fraction of cells with non-zero value,
and removed peaks that were detected in fewer than 1% of all cells. The final cleaned
matrix contains 1670 cells and 150,427 peaks. We also computed a normalized data
matrix by first log2 transforming the data (with 1 pseudocount added) and regressing out
variance explained by total detected peaks per cell estimated with the “lmFit” function in
the limma package (285). This normalized matrix was used for differential accessibility
test and preliminary matching of scRNA-Seq and scATAC-Seq clusters.

scATAC-Seq clustering and differential accessibility analysis
Traditional feature selection methods designed for scRNA-Seq data do not work well on
scATAC-Seq data, due to much greater sparsity and a binary data distribution (per
genomic locus per cell, the expected read count is 0, 1 or 2). This makes it difficult to
select the most informative features for clustering and cell identity mapping.
Using the IFF selection method described above, we were able to obtain a
UMAP with cells separated into several distinct neighborhoods, which significantly
improved the Louvain clustering quality (Supplemental Figure 3.4F-H). To identify
differentially accessible peaks (DAPs), we first binarized data as either open (>1) or
closed (0), then calculated the fraction of cells that have open states for each peak in
each cluster. We ran one-vs-rest Chi-square test on the fractions and called cluster170

specific peaks (DAPs) using FDR < 0.05 and absolute log2 fold change >1. Fold change
is defined as the ratio of open fractions between the two groups.
We observed that DAPs and DEGs show strong co-enrichment patterns at
genomic loci for certain pairs of scATAC-Seq and scRNA-Seq clusters (Supplemental
Figure 3.10A). Many of the DAPs are located near promoters of the matched DEG, but
some are much more distant. By computing a co-enrichment value, we established an
initial mapping between DAPs and DEGs (Supplemental Figure 3.10A).

Seurat alignment and co-embedding of scATAC-Seq and scRNA-Seq cells
We used the Seurat alignment algorithm (279) to co-embed scATAC-Seq and scRNASeq cells onto a single UMAP shown in Figure 3.4A. We first matched each cell-typespecific DEGs with corresponding DAPs 200 kb up and downstream of the TSS, using
the method described above, obtaining 12,768 links between 2,379 DEGs and 10,126
DAPs. We then summed up DAP fragments for each DEG, obtaining a gene-by-cell
activity score matrix as the “gene activity matrix” for Seurat alignment. Transfer anchors
were computed using the “FindTransferAnchors” function in Seurat, with dimensionality
reduction method set to “cca” (canonical correlation analysis). scATAC-Seq cells were
then transferred to scRNA-Seq reference using the “TransferData” function, using 15
nearest neighbors and PCA for computing the weighted correction vectors. Finally,
scATAC-Seq and scRNA-Seq Seurat objects were merged using the “merge.Seurat”
function, and joint UMAP was computed with top 20 PCs and 15 nearest neighbors. Cell
type labels were transferred from scRNA to scATAC using Seurat. Contaminant cell
types, including mesenchymal, Lyve1+ E and Bnip3hi E were removed from both scRNA171

Seq and scATAC-Seq data, and only cells involved in EHT were used to generate the
UMAP shown in Figure 3.4A.

Inference of enhancer-promoter (E-P) links
The DAP-DEG matching procedure could link cell-type-specific peaks to nearby celltype-specific genes. However, this association required both differential expression and
differential chromatin accessibility to be significant, potentially missing E-P links with
weaker signal. Inspired by the Seurat alignment algorithm and eQTL inference method,
we used linear regression on matched scATAC-Seq and scRNA-Seq meta cells to find
gene-distal peaks (defined as enhancers) that have a chromatin accessibility pattern
significantly correlated with a gene’s expression. First, for each scATAC-Seq cell, we
paired it to its nearest scRNA-Seq neighbor in the joint UMAP, establishing links
between 1,186 scATAC-Seq cells and 659 scRNA-Seq cells. Note that not all scRNASeq cells were paired with a scATAC-Seq cell and some scRNA-Seq cells were paired
to multiple scATAC-Seq cells, but the paired scRNA-Seq cells were uniformly distributed
along the EHT trajectory.
To overcome the sparsity in scRNA-Seq and scATAC-Seq data, we expanded
the paired scATAC-Seq and scRNA-Seq neighbors to paired scATAC-Seq and scRNASeq neighborhoods by pooling counts from 10 nearest neighbors. We normalized the
pooled expression and accessibility by regressing out per-meta-cell total counts from
log2 transformed data, followed by z-score transformation. For each expressed gene, we
ran linear regression with its pooled expression against pooled accessibility peaks 200kb
upstream and downstream of its TSS in the paired scATAC-Seq meta-cell. Links with
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Bonferroni corrected p-values < 0.01 and regression coefficients > 0.1 were considered
significant and these called peaks are likely enhancers that contribute to the
corresponding gene’s expression. E-P links for Runx1 shown in Figure 3.5 were called
separately, including additional peaks within 500kb upstream and downstream of Runx1
P1. For genes with multiple promoters (defined as regions 2,000 bp upstream and 500
bp downstream of each TSS), we ran a second regression using the promoter
accessibility as dependent variable and each called peak as independent variable. This
allowed us to link each called enhancer to a specific promoter. We computed “cisregulatory-activity matrix” based on the called E-Ps, and observed consistent pattern
between a gene’s expression and its cis-regulatory-activity score (Supplemental Figure
3.10B).

TF activity assessment using chromVar
We assessed TF binding activity to enhancers with chromVar (246) using its default
setting, but changed the default p.value cutoff in “matchMotifs” function to 0.1 / (2 *
median(enhancer length)) to account for multiple testing. The input TF motifs were
curated from the CIS-BP motif database (286). For each TF motif and each cell, a GCbias and background-corrected deviation score was computed using the
“computeDeviations” function, which represents the relative gain or loss of TF binding
activity. Lastly, to identify TFs with stage-specific binding activity, we ran stage-wise
Mann-Whitney U-test with the deviation scores, and considered those with FDR < 0.05
as significant.
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Figures

Figure 3.1 Experimental design, and overview of single cell RNA-Seq data.
(A) The caudal part of embryos were isolated (boundaries are illustrated with scissors),
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then organs and gut tube removed. Vitelline and umbilical arteries (VU) were isolated
and included in the sample. The tissue was dissociated and cells were isolated by
FACS, then analyzed by scRNA-Seq, scATAC-Seq, or in functional assays. All cell
populations purified and sequenced are listed in Table 3.1, and sort plots are shown in
Supplemental Figures 3.1 and 3.2. (B) The number of cells sequenced (x-axis) and
genes per cell detected for representative samples. (C) UMAP of continuous EHT
trajectory and FL-HSCs, with selected cell populations labeled. (D) Distribution of cells
from each dataset in the UMAP reflecting EHT trajectory. (E) UMAP illustrating the two
streams of E cells expressing high levels of the arterial marker Efnb2 that converge to
form the stem leading to HE and IACs. (F) E+HE+IAC cells separately purified from the
vitelline and umbilical (VU) arteries, and from the dorsal aorta (DA) within the caudal half
of the embryo, highlighted on the global UMAP plot. (G) Cell count along the pseudotime
trajectory. Bar graph quantifies results from a single sort of E10.5 E+HE+IAC cells; heat
maps below the graph show distribution of cells in all sorted cell populations.
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Figure 3.2 Two streams of endothelial cells converge before hemogenic
endothelium.
(A) UMAP of EHT trajectory (from Figure 3.1C, with FL-HSC removed) showing the 7
clusters identified by Louvain clustering in Supplemental Figure 3.5A, with Wnthi E
subdivided into Wnthi AE and Wnthi VE, plus Wntlo E subdivided into Wntlo AE and Wntlo
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VE based on the arterial/venous score determined as shown in panels B and C. (B)
Zoom-in UMAP highlighting the two streams of endothelial cells converging to conflux
AE. Numbers in yellow circles represent pseudotime bins up to the point of convergence.
The dotted gray line represents the boundary between AE and VE. (C) Arterial score vs
venous score over pseudotime bins. Cluster VE from panel A is used as the first
pseudotime bin. Curves are fitted for AE score and VE score of each branch using a
generalized additive model. (D) Violin plots of expression of cluster specific genes,
including venous marker Nr2f2, arterial marker Sox17, Wntlo AE specific gene
Tmem255a, Wnthi AE specific gene Foxq1 and Nkd1, and Notch ligand Dll4. (E) Average
expression of Wntlo E, Wnthi E, and pre-HE-specific genes over pseudotime.
Differentially expressed genes were derived by pairwise expression analysis between
Wntlo E and Wnthi E. Pre-HE specific genes were derived by comparing pre-HE with
Wntlo plus Wnthi E. (F) Heatmap showing stream-specific Reactome pathway activity
over pseudotime. AUCell package(157) was used to compute a pathway activity score
for each cell. One vs the rest Student’s t-test was used to identify group-specific
pathways and the top 6 most significant pathways were plotted.
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Figure 3.3 Developmental bottleneck between pre-HE and HE cells.
(A) UMAP of E10.5 E+HE+IAC cells showing 9 cell types from Figure 3.2A. (B)
Expression of key markers of clusters, including Hey2 in conflux AE and pre-HE, Cd44 in
conflux AE, pre-HE, HE and IACs, Ptprc in IACs, Gfi1 and Runx1 in HE and IACs, and
high levels of Sox17 in conflux AE and pre-HE, with downregulation in HE. Note Runx1
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is expressed at low levels in all subsets of endothelial cells. (C) Velocyto analysis
revealing different differentiation dynamics along the EHT in E10.5 E+HE+IAC cells. To
the right is a zoom-in velocity of pre-HE cells that have accumulated at the bottleneck
between pre-HE and HE. (D) Activity of pathways from Kyoto Encyclopedia of Genes
and Genomes (KEGG) database, computed for each cell using the AUCell method
(157). (E) UMAP of E+HE+IAC cells from E10.5 Runx1+/+ and Runx1+/- littermates. Bars
on the bottom depict the distribution of cells between conflux AE, pre-HE, combined HE,
and IAC populations in E10.5 Runx1+/+ and Runx1+/- littermates. P-values indicate
significant differences in the distributions of cells in pre-HE and HE in Runx1+/+ versus
Runx1+/- samples based on proportion test. (F) UMAP of E+HE+IAC cells from E10.5
control embryos (cR1/+) and littermates ectopically expressing RUNX1 in all endothelial
cells from the Rosa26 locus (Cre;cR1/+) (242). Bars on the bottom as in panel E. (G)
Limiting dilution assay to determine the frequency of HE in the CD44+ fraction of
E+HE+IAC cells isolated from E10.5 embryos (see Supplemental Figure 3.2G for FACS
plots). Shown are frequencies of cells that yielded hematopoietic cells (B220+, CD19+,
Mac1+, Gr1+, and/or CD41 and CD45) ex vivo. Frequencies were calculated by
ELDA(274). Data represent three independent cell purifications and limiting dilution
assays (mean ± SD, unpaired two-tailed Student’s t-test).
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Figure 3.4 Joint scRNA-Seq and scATAC-Seq analysis of bottleneck populations.
(A) UMAP of 1637 cells from scRNA-Seq and 1186 cells from scATAC-Seq, aligned
using Seurat algorithm with a custom defined gene-by-cell activity score matrix (see
Materials and Methods). The number of HE cells was too few to be resolved by UMAP,
and clustered with pre-HE. To gain enough statistical power for predicting E-P, we
pooled reads from 10 nearest neighbors as “meta cells”, and paired scATAC meta cells
to nearby scRNA meta cells. Additional details can be found in the Materials and
Methods section. (B) UCSC genome browser tracks showing open chromatin signal of
Cldn5 promoter and its predicted enhancers. Dots below each aggregated signal track
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represent signal from 50 sampled cells of each type. (C) Linear regression shows high
correlation between Runx1 +23 enhancer chromatin accessibility and Runx1 expression
levels (z-score transformed). Each point represents a paired ATAC-RNA meta cell in
panel A, with pooled RNA expression on the y-axis and pooled enhancer accessibility on
the x-axis. (D) Prediction of enhancer-promoter interaction using linear regression.
Predictions (points in blue shaded area, 5% of total candidate interactions) were made
using p < 0.01 and regression coefficient > 0.1. We recapitulated the majority of known
enhancer-promoter interactions (E-Ps) that function during EHT, with the Runx1 +23
enhancer (287) and Gfi1 enhancer (288) among the top predictions. (E) TF binding
patterns among called scATAC-Seq peaks assessed using chromVar (246), which
defines a deviation score reflecting the accessibility change at binding sites of each TF
across all cells. Binding sites were determined using DNA motif scan on the called
enhancers, which does not discriminate TFs in the same family with very similar motifs.
Top significant TFs based on Mann-Whitney U test are plotted for each stage. (F)
ChromVar deviation score for selected TF motifs plotted on the UMAP, showing specific
binding pattern for Tcf7 in Wnthi E, Sox17 in conflux E, Foxc2 in pre-HE, Gata2 and Klf2
in both pre-HE and IAC. Runx1 binding sites are highly accessible post bottleneck, but
also exhibit medium to high level of chromatin accessibility in some early-stage cells.
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Figure 3.5 Developmental-stage-specific enhancers of Runx1.
(A) UCSC genome browser tracks showing open chromatin signal for each of the
populations. Tracks from E to IAC are cumulative scATAC-Seq signals (per-base unique
fragment coverage) normalized by the number of cells in that population. Tracks for FLHSC are bulk ATAC-Seq data from Chen, C. et al. (252). Experimentally validated
enhancers and E-Ps from Marsman et al. (251) are shown in magenta. Enhancers and
E-P links from Chen, C. et al.(252) are shown in dark green. E-P links were inferred
based on linear regression on paired scRNA-scATAC meta cells (see Materials and
Methods). Placental mammal conservation by PhastCons score is shown as a grey
track. For each of the inferred enhancers, we scanned for known motifs from CIS-BP
database and grouped TFs from the same family having similar motifs. Motif hits of
several previously reported early hematopoietic TFs are highlighted below the track. (B)
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Distribution of linear regression P-values for predicted Runx1 enhancers. Highly
significant peaks include the validated +23 and -371 enhancers. The most significant
peak is ~3.6 kb downstream of P1. (C) Co-accessibility of Runx1 P1 promoter and its
predicted linked enhancers in each cell type. P-values for co-accessibility in each cell
type were computed using Fisher’s exact test with multiple testing correction. (D) Stagespecific chromatin accessibility of Runx1 -371 enhancer and Runx1 expression levels (zscore transformed). Each point in the scatter plot represents a paired ATAC-RNA meta
cell in Figure 3.5A, with pooled RNA expression on the y-axis and pooled enhancer
accessibility on the x-axis. A 2-dimensional density plot is superimposed on the scatter
plot. (E) Co-expression of transcription factors that have binding motifs at Runx1
enhancers and whose expression precedes Runx1. Correlations were computed using
gene expression matrix including conflux E, pre-HE and HE cells. TFs with Pearson
correlation with Runx1 < 0.05 were removed. Hierarchical clustering was performed on
the correlation matrix and a strong TF co-expression module was highlighted.

183

Figure 3.6 Two waves of CD45+ HSPCs in IAC cells.
(A) PCA plot of a subset of data containing IACs, illustrating the trajectory of IAC
differentiation from HE along the PC1 axis. (B) Expression of Gja5, Hey1, and Rac2
illustrating the maturation of IAC cells along the trajectory. (C) PCA plot showing the
separation of E10.5 and E11.5 IAC cells along the PC3 axis. (D) E10.5 and E11.5 IAC
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cells, E10.5 CD45+ IAC cells, and E11.5 pre-HSCs plotted separately to visualize their
relative distribution along the PC3 axis. A K-nearest-neighbor classifier (K = 3 with PC110 as feature input) was trained using E10.5 CD45+ IAC cells and E11.5 pre-HSCs to
determine the fraction of pre-HSCs (labeled in red) in E10.5 and E11.5 IAC cells. (E)
Heatmap showing top differentially expressed genes in E10.5 CD45+ IAC cells versus
E11.5 pre-HSCs. (F) Preferential expression of Mecom in E11.5 pre-HSCs and IAC
cells, versus Myc, Il7r, and Gata1 in E10.5 CD45+ IAC enriched for lympho-myeloidbiased progenitors and in E10.5 IAC cells. (G) Reactome pathway analysis comparing
E11.5 pre-HSC and E10.5 CD45+ IAC cells. Color indicates pathway activity score
computed using the AUCell package (157). (H) Methylcellulose (colony forming unitculture, CFU-C) assay performed in the presence of stem cell factor (SCF), interleukin 3
(IL3), IL6, and erythropoietin (EPO) to measure the frequency of committed erythroid
and myeloid progenitors in E10.5 CD45+ IAC cells, CD45- IAC cells, and E9.5 yolk sac
EMPs. BFU-E, burst forming unit-erythroid; GM, granulocyte/macrophage; Mac,
macrophage; MK, megakaryocyte; GEMM,
granulocyte/erythroid/monocyte/megakaryocyte. Error bars; mean ± SD. Frequencies of
total progenitors are indicated above the bars. n = 3 experiments. (I) Limiting dilution
assays on OP9 stromal cells to determine the frequencies of progenitors in purified
E10.5 CD45+ IAC and E10.5 CD45- IAC cells yielding B (CD45+CD19+B220mid/lo),
myeloid (M) (Gr1+Mac1+or Gr1+Mac1-), and B+myeloid (B/M) cells in culture. Also shown
are frequencies of progenitors in purified E10.5 CD45+ IAC and E10.5 CD45- IAC cells
that produced T cells (CD90+ CD25+) when cultured on OP9 cells expressing the Notch
ligand delta like 1. Error bars; mean ± SD. Frequencies of all progenitors are indicated
above the bars. n = 7 experiments. (J) Percentage of wells at the limiting cell dose
containing B, M, or B/M cells from experiments in panel I. n = 8 experiments.
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Tables
Table 3.1. Summary statistics for collected cell populations.
Dataset/
Cell type1

Surface
Phenotype

#
Embryo
s

Somit
e Pairs

# Cells
Sequenced

Media
n#
Expres
sed
Genes

E9.5 E [1]

CD41- CD45Kit- CD31+
Runx1:GFP-

60

22-27

1582

3454

15703

E9.5 E [2] 2

Ter119- CD41CD45- KitCD144+
ESAM+
Runx1:GFP-

51

25-27

754

3398

12491

E9.5 HE
[1]

CD41- CD45Kitlo/- CD31+
Runx1:GFP+

60

22-27

182

3418

12554

E9.5 HE
[2] 2

Ter119- CD41CD45- Kitlo/CD144+
ESAM+
Runx1:GFP+

51

25-27

686

4094

18223

E9.5
E+HE+IAC

Ter119CD41lo/- Kitlo/CD31+ CD144+
ESAM+

60

23-26

2171

3598

17139

E9.5 EMP

CD41+ Kit+
CD16/32+

30

25-29

1875

4476

25617

E10.5 E [1]

CD41- CD45Kit- CD31+
Runx1:GFP-

43

ND3

1073

1675

5245

E10.5 E [2]

Ter119- CD41CD45- KitCD144+

100

33-38

1017

2672

8131

2
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Median #
UMIs

ESAM+
Runx1:GFPE10.5 HE

Ter119- CD45CD31+ CD144+
ESAM+ Kitlo/
CD41lo/mid/Runx1:GFP+

84

33-38

1795

3431

15518

E10.5
E+HE+IAC

Ter119CD41lo/CD31+CD144+
ESAM+

60

33-36

4776

3208

11991

E10.5 IAC

Ter119CD41lo/- CD31+
CD144+
ESAM+ Kit+

60

33-36

2288

3600

18246

E10.5
CD45+ IAC

CD31+ CD144+
ESAM+ Kit+
CD45+

18

33-37

602

4910

29978

E10.5 VU
E+HE+IAC

Ter119CD41lo/CD31+CD144+
ESAM+

46

35-37

1173

4059

17760

E10.5 DA
E+HE+IAC

Ter119CD41lo/CD31+CD144+
ESAM+

10

33-37

1951

3133

13707

E10.5
Runx1+/+
E+HE+IAC
[1]

Ter119CD41lo/CD31+CD144+
ESAM+

7

34-37

963

4005

17965

E10.5
Runx1+/E+HE+IAC
[1]

Ter119CD41lo/CD31+CD144+
ESAM+

11

34-37

1355

4320

20296

E10.5
Runx1+/+
E+HE+IAC
[2]

Ter119CD41lo/CD31+CD144+
ESAM+

8

32-35

2449

3290

14659

187

E10.5
Runx1+/E+HE+IAC
[2]

Ter119CD41lo/CD31+CD144+
ESAM+

10

32-35

3944

3396

14880

E10.5
CD44+
E+HE+IAC
(paired
scRNA) [1]

Ter119CD41lo/CD31+CD144+
ESAM+
CD44lo/+

56

33-37

2317

3565

15307

E10.5
CD44+
E+HE+IAC
(paired
scATAC)
[1]

Ter119CD41lo/CD31+CD144+
ESAM+
CD44lo/+

56

33-37

2317

3565

15307

E10.5
CD44+
E+HE+IAC
(cR1/+)3

Ter119CD41lo/CD31+CD144+
ESAM+
CD44lo/+

42

30-34

3437

2505

8200

E10.5
CD44+
E+HE+IAC
(Cre;cR1/+
)4

Ter119CD41lo/CD31+CD144+
ESAM+
CD44lo/+

31

30-34

4845

2741

9696

E11.5 IAC
[1]

Ter119- CD31+
CD144+
ESAM+ Kit+

12

ND

1267

3520

16230

E11.5 IAC
[2]

Ter119CD41lo/- CD31+
CD144+
ESAM+ Kit+

71

45-48

299

3304

17188

E11.5 preHSC

CD144+ CD45+
CD27+

41

ND

279

4854

29507

E11.5 FLLMPP5

Ter119- Nk1.1Gr1- CD3eCD19- B220F4/80- Kit+

90

ND

1860

3400

16624

188

CD45+CD135+
IL7ra+
E14.5 FLHSC

Ter119- Gr1B220- CD3eSca1+ Kit+
CD48- CD150+

Total

22

ND

1108

3865

1134

-

44940

-

16500

-

1

Numbers in brackets indicate replicate samples.

2

Markers were adjusted on subsequent sorts to reduce the fraction of contaminating

cells detected by scRNA-Seq.
3

ND, not determined

4

Ectopic RUNX1 expression in endothelial cells in Tg(Cdh5-cre/ERT2)1Rha embryos

(Cre) (273) that contained an activatable Runx1 cDNA in the Rosa26 locus (cR1/+)
(242). Cre was activated by injection of 1 mg tamoxifen into pregnant dams at E9.5.
5

LMPP, lymphoid-primed multipotent progenitor.
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Supplemental Figures

Supplemental Figure 3.1 Purification of endothelial cell populations by FACS.
(A) Quantile contour FACS plots depicting gating strategy for isolating E+HE+IAC cells
(plots are representative sorts from E9.5 embryos). Embryos were collected from
B6C3F1 females mated to C57BL6/J males. Bulk endothelium and clusters were purified
as Ter119-CD41mid/-CD31+CD144+ESAM+cells. Kit was not used to exclude cells in order
to capture IAC cells with the other endothelial cell populations. Fluor-minus-one (FMO)
controls for CD41, Kit, CD144 (vascular endothelial cadherin), and ESAM are shown in
the bottom four panels. Numbers on the x and y-axes are indicated on the first plot on
the left, and unless changed are not depicted on plots to the right of the preceding plot.
190

eF450, eFluorTM-450; APC-e780, APC-eFluor 780; eF450, eFluor 450. (B) Quantile
contour FACS plots depicting gating strategies for isolating endothelial cells (E) (Ter119CD41-CD45-CD31+CD144+ESAM+Kit-Runx1:GFP-) and hemogenic endothelial cells (HE)
(Ter119-CD41-CD45-CD31+CD144+ESAM+Kitlo/-Runx1:GFP+) from E10.5 Runx1-IRESGFP embryos. Embryos were collected from Runx1-IRES-GFP male mice (229) mated
to B6C3F1 females. FMO controls for Kit and CD41 are shown in the two panels below.
(C) Frequency of purified endothelial cells from E9.5 and E10.5 embryos that gave rise
to CD45+cells when cultured in a limiting dilution assay on OP9 stromal cells.
Frequencies are indicated on top of the bars. HE, Runx1:GFP+ endothelial cells, purified
as described in panel B; E, Runx1:GFP- endothelial cells. Error bars, mean ± standard
deviation (SD); n = 5-6 experiments. Frequencies were calculated using ELDA software
(274). (D) Colony forming units (CFU) representing frequency of contaminating
committed HSPCs in purified HE and E populations. Meg, megakaryocyte; Mac,
macrophage; GEMM, granulocyte/erythroid/monocyte/megakaryocyte; BFU-E, burst
forming unit-erythroid; GM, granulocyte/monocyte. Error bars, mean ± SD; n = 2-3
experiments.
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Supplemental Figure 3.2 IAC cell purification by FACS.
(A) Quantile contour FACS plots for purification of E10.5 IAC cells (Ter119-CD41med/192

CD31+Kit+CD144+ESAM+). (B) Quantile contour FACS plots for E11.5 IAC cells. (C)
Quantile contour FACS plots for purification of E10.5 CD45+ IAC cells containing
lympho-myeloid-biased progenitors (Ter119-CD41med/-CD31+Kit+CD144+ESAM+CD45+),
and E10.5 CD45- IAC cells (Ter119-CD41med/-CD31+Kit+CD144+ESAM+CD45-). (D)
Quantile contour FACS plots from purification of E11.5 CD144+CD45+CD27+ IAC cells
containing type II pre-HSCs (E11.5 pre-HSC) (E) Quantile contour FACS plots from
purification of E9.5 yolk sac EMPs (CD16/32+Kit+CD41hi). (F) Quantile contour FACS
plots from purification of E14.5 FL-HSCs [lineage- (Ter119- Gr1- B220- CD3e-)
Kit+Sca1+CD48- CD150+]. (G) Quantile contour FACS plots from purification of E10.5
CD44+ E+HE+IAC cells (Ter119-CD41med/-CD31+CD144+ESAM+CD44+). (H) Quantile
contour FACS plots from purification of yolk sac-derived lymphoid-primed multipotent
progenitors from the E11.5 FL (E11.5 FL-LMPP), which are included in the UMAP plots
in Supplemental Figure 3.3A, B and Supplemental Figure 3.12C.
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Supplemental Figure 3.3 Assignment of cell types, computational filtering of
contaminant cells.
(A) Top: UMAP with all datasets. Labeled populations are contaminant cell types
identified using Louvain clustering and differentially expressed genes (examples shown
below). Populations circled with dashed line were used as input cells for a UMAP
recomputed in panel B. Bottom: expression of representative top differentially expressed
genes, including Col1a2 (mesenchymal-fibroblast cells), Hba-a1 (erythroid
cells/progenitors), Cldn5 (endothelial cells), Lyve1 (combined with Cldn5, marks
lymphatic endothelial or yolk sac endothelial cells). Clusters proximal to the
mesenchymal-fibroblast cluster have distinct gene expression patterns, but are mostly
non-endothelial or non-hematopoietic. (B) Top panel, UMAP with contaminant cells
removed. Example DEGs shown below. E9.5 YS-EMP and E11.4 FL-LMPP are
committed progenitors unrelated to pre-HSCs. Populations circled with a dashed line
represent the continuous EHT trajectory that leads to E10.5 CD45+ IAC cells and E11.5
pre-HSCs. Bottom panel, expression of representative top differentially expressed
194

genes. Bnip3 marks endothelial cells likely undergoing apoptosis, autophagy, or
mitophagy (289); Il7r marks E11.5 FL-LMPP and a subset of IACs, and is low in E9.5
YS-EMPs; Hp (haptoglobin) is expressed in E11.5 FL-LMPP and E9.5 YS-EMP, at low
levels in IAC cells; Gata1 is expressed in the Hp- subset of E9.5 YS-EMPs, a subset of
IAC cells, and at low levels in E11.5 FL-LMPPs. (C) Top panel, UMAP of continuous
EHT trajectory and FL-HSCs, same as Figure 3.2A. Labeled clusters are cell types
determined based on differentially expressed genes (examples shown below). Bottom
panel, expression of representative top differentially expressed genes, including Foxq1
in Wnthi E, Hey2 in conflux AE and pre-HE, Runx1 in HE and IACs, and Ptprc in IACs.
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Supplemental Figure 3.4 Informative feature selection.
(A) Distribution of Gini coefficient for each expressed gene calculated with cells from
Supplemental Figure 3.3A, using the approach described in Materials and Methods.
Genes in the left peak have low Gini coefficients and ubiquitous expression patterns.
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Genes in the right tail show unequal expression across clusters, and were chosen as
IFFs for downstream dimensionality reduction analysis. (B) GO enrichment results for
ubiquitous genes in panel A. Redundant terms were removed and top 15 enriched GO
terms were plotted using clusterProfiler (281). Bar height represents gene counts for
each enriched term. (C) GO enrichment results for IFFs in panel A. (D) IFF selection
applied to two scRNA-Seq batches, E10.5 E+HE+IAC and E10.5 E+HE+IAC for paired
scATAC, sampled under similar biological conditions. Panel 1 shows UMAP with top
2000 VEG from Seurat, 2 shows Seurat clusters, 3 shows UMAP with IFF selected
based on Seurat clustering, 4 shows the UMAP colored by cell type. (E) Intersection of
top 2000 IFFs selected across different Seurat clustering results with varied resolution.
Intersections with less than 30 genes are not plotted. Seurat resolution parameters
under which overlap is observed are indicated by a series of dots in a column below the
x-axis. (F) Gini coefficient distribution of open chromatin peaks when applying IFF
method to scATAC-Seq data. Peaks with Gini coefficient greater than the 85th percentile
were selected as IFFs for analysis in panel F. (G) UMAP computed with EHT cells using
variable features defined by Seurat (279). (H) UMAP computed using IFFs derived
based on Gini coefficient distribution in panel F. Louvain clustering on the UMAP
revealed finer endothelial cell subtypes compared to result in panel E.
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Supplemental Figure 3.5 Unsupervised clustering and dimension reduction on
EHT cells.
(A) UMAP of continuous EHT trajectory and FL-HSCs colored by Louvain clustering
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result. (B) UMAP, same as in A, colored by Seurat clustering result. (C) Heatmap
showing overlap of cells between Seurat clusters and Louvain clusters (number of cells
in each Seurat cluster divided by number of cells in corresponding Louvain cluster). (D)
Heatmap of expression of Wnt pathway genes (based on GO annotation) that are
differentially expressed between Wntlo E and Wnthi E. (E) PHATE low dimensional
embedding of EHT trajectory and FL-HSCs colored by cell type. (F) UMAP, same as in
A, colored by Seurat predicted cell cycle phases. (G) Bar plot showing cell cycle phase
composition for each cell type.
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Supplemental Figure 3.6 RNA velocity estimate with scVelo dynamic model.
(A) scVelo estimated velocity embedded on the same UMAP as in Figure 3.3C. (B)
Velocity estimation for genes induced at different stages of EHT, including Kitl in E,
Vegfc in conflux AE, Meis2 in pre-HE and Runx1 in HE and subset of E cells. For each
gene, the phase plot shows unspliced versus spliced transcript counts and the scVelo
fitted model. The velocity and expression are plotted on the same UMAP in panel A.
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Supplemental Figure 3.7 Reactome pathway analysis for the transitions between
conflux AE, pre-HE, and HE.
Top stage-wise differentially activated pathways were plotted. Rows were clustered
using hierarchical clustering with Ward’s method.
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Supplemental Figure 3.8 RUNX1 haploinsufficiency reduces phenotypic
hemogenic endothelial cells in the dorsal aorta.
(A) Confocal z-projection stacks of dorsal aortas with z-intervals of 2 μM of E9.5
embryos immunostained with antibodies against RUNX1 and SOX17. Scale bar: 100μM.
Enlargement of outlined area shown below. Scale bar: 50μM. Runx1+/+ n=6, Runx1+/n=3 (23-27 somite pairs). Representative images are shown for each genotype. (B)
Quantification of absolute number of AE cells (RUNX1+SOX17-) and HE cells
(RUNX1+SOX17low/-) per mm of dorsal aorta. Two-way ANOVA and Tukey’s test. (C)
Proportion of HE and AE cells [(# of HE or AE)/(total # of AE+HE)] in E9.5 embryos.
Two-way ANOVA and Tukey’s test. **p<0.01.
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Supplemental Figure 3.9 Quality assessment of scATAC-Seq data.
Quality assessment was performed using the scATAC-pro software. (A) Enrichment
profile of scATAC-seq reads around the transcription start site (TSS). Scores were
calculated based on the aggregate read distribution centered on the TSSs, extending
1000 bp in both directions. (B) Distribution of ATAC-Seq insert size for all unique
fragments. (C) Scatter plot (with points down-sampled) of the fraction of unique
fragments in peaks versus total number of unique fragments per cell barcode,
discriminating cells from non-cells. (D) Box plots of the fraction of unique fragments
overlapping with annotated genomic regions from Ensemble regulatory build release 95.
Mito, mitochondrial genome.
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Supplemental Figure 3.10 Mapping between scRNA and scATAC data.
(A) Signature matching of scATAC-Seq and scRNA-Seq data. Differentially accessible
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peaks (DAPs) and differentially expressed genes (DEGs) were separately derived, and
hypergeometric test was performed on DAPs and DEGs within predefined genomic
windows around DEG/DAP (10k bp, 100k bp and 500k bp) for each pair of scATAC-Seq
(labeled as C1-6) and scRNA-Seq clusters (labeled by cell type names). We did not
obtain enough DAPs for C2 and C4 for this matching. (B) Heatmap of stage-wise
differentially expressed genes and their corresponding cis-regulatory-activity score.
Values are log2 transformed and scaled across cells.
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Supplemental Figure 3.11 Transition from HE to IAC and fate probability analysis.
(A) Differentially expressed genes in HE to IAC cell transition. Expression heatmap is
plotted for top genes ranked by PC1 loading (PCA shown in Figure 3.6A). Cells are
ordered based on PC1 score. Expression values are log2 transformed and z-score
scaled. (B) Expression pattern of Sox17, Nupr1, Spn (CD43) and Ptprc (CD45) on the
PC1 vs PC2 PCA plot. Values are log2 transformed normalized UMI counts. (C) T-SNE
plot generated with the Palantir package (260), colored by cell population. (D) Fate
probability of becoming pre-HSC versus lympho-myeloid-biased progenitors predicted by
FateID and Palantir for each cell in the T-SNE plot. (E) Cumulative distribution of preHSC fate probability for each cell population. One-sided Kolmogorov–Smirnov test was
carried out between E9.5 HE and E10.5 HE, E10.5 IAC and E11.5 IAC for probabilities
computed with both methods. ***p<0.001. (F) Transcription factors expressed in HE that
show bifurcation in expression along the trajectory. Expression is imputed with MAGIC
(290). Gene expression trends are modeled with a generalized additive model, using
cells with probability greater than 0.5 for each fate branch.
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Supplemental Figure 3.12 Comparison with previously published scRNA-Seq data.
(A) Left panel shows UMAP of EHT trajectory computed with genes shared with Zhou et
al. (39), with the same cells in Figure 3.1C. Middle panel shows projection of Zhou et al.
(39) data to the same UMAP (see Methods). Right panel shows heatmap for the fraction
of each cell population from Zhou et al. mapped to each of the cell types from this study.
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(B) Projection of E10 (left panel) and E11 (right panel) cells from Baron et al. (226) to
those from this study. The UMAP is slightly different from those in panel A, due to
differences in shared genes, but each cell type has an almost identical relative position.
Heatmap shows the fraction of each cell population from Baron et al. mapped to each of
the cell types from this study. (C) Top panel: UMAP of EMP, macrophage precursors
and macrophage single cell data highlighting the EMP signature score (average
expression level of signature genes listed in Supplemental Table 2 from Mass et al.
(282)). Bottom panel: UMAP of indicated populations from this study (circles). E9.5
EMPs form a separate cluster from IAC cells and other cell types. Cells with a high EMP
signature score from Mass et al. (282) (brown triangles) were projected onto the same
UMAP (see Materials and Methods). 64 out of 91 E10.25 EMP cells projected onto the
E9.5 YS-EMP cluster, and none overlapped with E10.5 CD45+ IAC cells. Yolk sacderived lymphoid-primed multipotent progenitors purified from the E11.5 fetal liver
(E11.5 FL-LMPP) are also separated from E10.5 CD45+ IAC cells. Heatmap shows top
differentially expressed genes of each cell population.
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CHAPTER 4 SOFTWARE FOR SINGLE CELL TRANSCRIPTOMICS DATA
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Introduction
Technologies such as single cell RNA-sequencing measure gene expressions and
present them as high-dimensional expression matrixes for downstream analyses. In
recent years, many methods have been developed for the statistical analysis of
transcriptomics data, such as edgeR (291) and DESeq (292) for differential expression
testing, and monocle (131), Seurat (293), SC3 (123) and SCDE (294) for single cell
RNA-Seq data analysis. Besides these, the Comprehensive R Archive Network (CRAN)
(295) and Bioconductor (296) host various statistical packages addressing different
aspects of transcriptomics study and provides recipes for a multitude of analysis
workflows. Making use of these R analysis packages requires expertise in R and often
custom scripts to integrate the results of different packages. In addition, many
exploratory analyses of transcriptomics data involve repeated data manipulations such
as normalizations, filtering, merging, etc., each step generating a derived dataset whose
version and provenance must be tracked. Previous efforts to address these problems
include designing standardized workflows (297), building a comprehensive package
(293) or assembling pipelines into integrative platforms such as Galaxy (298). Designing
workflows or using large packages still requires a significant amount of programming
skills and it can be difficult to make various components compatible or applicable to
specific datasets. Integrative platforms offer greater usability but trade off flexibility,
functionality and efficiency due to limitations on data size, parameter choice and
computing power. For example, the Galaxy platform is designed as discrete functional
modules which require separate file inputs for different analysis. This design not only
makes user-end file format conversion complicated and time-consuming, but also breaks
the integrity of the analysis workflow, limiting the sharing of global parameters, filtering
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criteria and analysis results between modules. Tools such as RNASeqGUI (299),
START (300), ASAP (301) and DEApp (302) provide an interactive graphical interface
for a small number of packages. But these and other similar packages all adopt a rigid
workflow design, have limited data provenance tracking, and none of the packages
provide mechanisms for tracking, saving and sharing analysis results. Furthermore,
many web-based applications require users to upload data to a server, which might be
prohibited by HIPPA (Health Insurance Portability and Accountability Act of 1996) for
clinical data analysis.
Here we developed PIVOT, an R-based platform for exploratory transcriptomics
data analysis. We leverage the Shiny framework (303) to bridge open source R
packages and JavaScript-based web applications, and to design a user-friendly
graphical interface that is consistent across statistical packages. The Shiny framework
translates user-driven events (e.g. pressing buttons) into R interpretable reactive data
objects, and present results as dynamic web content. PIVOT incorporates four key
features that assists user interactions, integrative analysis and provenance
management:
• PIVOT directly integrates existing open-source packages by wrapping the
packages with a uniform user-interface and visual output displays. The user
interface replaces command line options of many packages with menus, sliders,
and other option controls, while the visual outputs provide extra interactive
features such as change of view, active objects, and other user selectable tools.
• PIVOT provides many tools to manipulate a dataset to derive new datasets
including different ways to normalize a dataset, subset a dataset, etc. In
particular, PIVOT supports manipulating the datasets using the results of an
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analysis; for example, a user might use the results of differential gene expression
analysis to select all gene satisfying some p-value filter. PIVOT implements a
visual data management system, which allows users to create multiple data
views and graphically display the linked relationship between data variants,
allowing navigation through derived data objects and automated re-analysis.
• PIVOT dynamically bridges analysis packages to allow results from one package
to be used as inputs to another. Thus, it provides a flexible framework for users
to combine tools into customizable pipelines for various analysis purposes.
• PIVOT provides facilities to automatically generate reports, publication-quality
figures, and reproducible computations. All analyses and data generated in an
interactive session can be packaged as a single R object that can be shared to
exactly reproduce any results.
Recently, we extended PIVOT to a new tool, VisCello, which supports analysis and
hosting of large-scale single cell data. VisCello preserves key functions of PIVOT,
incorporates several latest single cell analysis packages, and have multiple function and
speed optimizations.

Results and Discussion
We describe the general workflow of PIVOT and demonstrate its versatile and practical
use in the following sections. We also briefly describe VisCello, an extension of PIVOT
which facilitates large-scale single cell data analysis.
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Data input and transformations
Read counts obtained from RNA-Seq quantification tools such as HTSeq (304) or
featureCounts (305) can be directly uploaded into PIVOT as text, csv or Excel files. Data
generated using the 10x Genomics Cell Ranger pipeline can also be readily read in and
processed by PIVOT. PIVOT automatically performs user selected data transformations
including normalization, log transformation, or standardization. We have included
multiple RNA-Seq data normalization methods including DESeq normalization (306),
trimmed mean of M-values (TMM) (307), quantile normalization (308), RPKM/TPM
(309), Census normalization (181), and Remove Unwanted Variation (RUVg) (310)
(Table 4.1). If samples contain spike-in control mixes such as ERCC (311), PIVOT will
also separately analyze the ERCC count distribution and allow users to normalize the
data using the ERCC control. Existing methods can be customized by the user by setting
detailed normalization parameters. For example, we implement a modification of the
DESeq method by making the inclusion criterion a user set parameter, making it more
applicable to sparse expression matrices such as single cell RNA-Seq data (312).
Users can upload experiment design information such as conditions and batches,
which can be visualized as annotation attributes (e.g., color points/sidebars) or used as
model specification variables for downstream analyses such as differential expression.
PIVOT supports flexible operations to filter data for row and column subsets as well as
for merging datasets, creating new derived datasets. Multiple summary statistics and
quality control plots are automatically generated to help users identify possible outliers.
Users can manually select samples for analysis, or specify statistical criteria on analysis
results such as expression threshold, dropout rate cutoff, Cook’s distance or size factor
range to remove unwanted features and samples.
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Visual data management with data map
When analyzing large datasets, a common procedure is to first perform quality control to
remove low quality elements, then normalize the data and finally generate different data
subsets for various analysis purposes. Some analyses require filtering out genes with
low expressions, while others are designed to be performed on a subset of the genes
such as transcription factors. During secondary analyses, outliers may be detected
requiring additional scrutiny. All these data manipulations generate a network of derived
datasets from the original data and require a significant amount of effort to track. Failure
to track the data lineage could affect the reproducibility and reliability of the study.
Furthermore, an investigator might wish to repeat an analysis over a variety of derived
datasets, which may be tedious and error-prone to carry out manually. To address this
problem, we implemented a graphical data management system in PIVOT.
As the user generates derived datasets with various data manipulations, PIVOT
records and presents the data provenance in an interactive tree graph, the "Data Map".
As shown in Figure 4.1, each node in the data map represents a derived dataset and the
edges contain information about the details of the derivation operation. Users can attach
analysis results to the data nodes as interactive R markdown reports (313) and switch
between different datasets or retrieve analysis reports by simply clicking the nodes.
Upon switch to a new dataset selected from the Data Map, PIVOT automatically re-runs
analyses and updates parameter choices when needed. Thus, a user can easily
compare results of a workflow across derived datasets. The data map is generated with
the visNetwork package (314) and can be directly edited, so that users can rename
nodes, add notes, or delete data subsets and analysis reports that are no longer useful.
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The full data history is also presented as downloadable tables with all sample and
feature information as well as data manipulation details.

Comprehensive toolset for exploratory analysis
PIVOT is designed to aid exploratory analysis for both single cell and bulk RNA-Seq
data, thus we have incorporated a large set of commonly used tools (see Table 4.1).
PIVOT supports many visual data analytics including QC plots (number of detected
genes, total read counts, dropout rates and estimated size factors; Figure 4.2A, data
from (100)), transcriptome statistics plots (e.g., rank-frequency plots, mean-variability
plots, etc; Figure 4.2B), and sample and feature correlation plots (e.g., heatmaps,
smoothened scatter plots, etc.). All visual plots feature interactive options and a query
function is provided which allows users to search for features sharing similar expression
patterns with a target feature. PIVOT provides users extensive control over parameter
choices. Each analysis module contains multiple visual controls allowing users to adjust
parameters and obtain updated results on the fly.

Integrative analysis and interactive visualization
PIVOT transparently bridges multiple sequences of analyses to form customizable
analysis pipelines. For example, with single cell data collected from heterogeneous
tissues, a user can first perform PCA or t-SNE (115) (Figure 4.2C) to visualize the low
dimensional embedding of the data. If there is clear clustering pattern, possibly
originated from different cell types, the user can directly specify cell clusters by dragging
216

selection boxes on the graph, or perform K-means or hierarchical clustering with the
projection matrix. One can proceed to run DE or penalized LDA (315) to identify clusterspecific marker genes, which can then be used to filter the datasets for generating a
heatmap showing distinctive expression pattern across cell types (Figure 4.2D). Within
each determined cell type, a user may further apply the walk-trap community detection
method (316) to identify densely connected network of cells, which are indicative of
potential subpopulations.
As another example, for time-series data such as cells collected at different
stages of development or differentiation, one can use diffusion pseudotime (DPT) (317),
which reconstructs the lineage branching pattern based on the diffusion map algorithm
(136), or Monocle (131), which implements an unsupervised algorithm for pseudotemporal ordering of single cells (130). We have incorporated the latest Monocle 2
workflow in PIVOT, including cell state ordering, unsupervised cell clustering, gene
clustering by pseudo-temporal expression pattern and cell trajectory analysis. Besides
the DE method implemented in monocle, one can also run DESeq, edgeR, SCDE or the
Mann-Whitney U test. A user can specify whether to perform basic DE analysis or a
multi-factorial DE analysis with customized formula for complex experimental designs
such as time-series or controlling for batch effects. Results are presented as dynamic
tables including all essential statistics such as maximum likelihood estimation and
confidence intervals. Each gene entry in the table can be clicked and visualized as violin
plots or box plots, showing the actual expression level across conditions. Once DE
results are obtained, the user can further explore the connections between DE genes
and identify potential trans-differentiation factors as introduced in the Mogrify algorithm
(318). PIVOT provides several extensions of functionality from the original Mogrify
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method. The network analysis module allows users to plot the log fold changes (LFC) of
DE genes in a protein-protein interaction network obtained from the STRING database
(Figure 4.3A) (319) or a directed regulatory network graph constructed from the
Regnetwork repository (Figure 4.3B) (320). With scoring based on the p-value and log
fold change, the graph can be filtered to only include top-rank genes, showing the
regulatory "hot spot" of the network. PIVOT provides users with multiple options for
defining the network influence score of transcription factors, and will produce lists of
potential trans-differentiation factors based on the final ranking. As shown in Figure
4.3C, with the FANTOM5 expression data of fibroblasts and ES cells (321), PIVOT
correctly reports OCT4 (POU5F1), NANOG and SOX2 as key factors for transdifferentiation (322). In addition to the DESeq results used by the original Mogrify
algorithm, a user can choose to use SCDE or edgeR results to perform transdifferentiation analysis on single cell datasets.
Another useful feature of PIVOT is that it provides users multiple visualization
options by exploiting the power of various plotting packages. For example, users can
either generate publication-quality heatmap graphs (implemented in gplots package
[43]), or interactively explore the heatmap with the heatmaply view (323). For principal
component analysis, PIVOT uses three different packages to present the 2D and 3D
projections. The plotly package (324) displays sample names and relevant information
as mouse-over labels, while the ggbiplot (325) presents the loadings of each gene on
the graph as vectors. The threejs package (326) fully utilizes the power of WebGL and
outputs rotatable 3D projections. In the network analysis module, we utilize both igraph
(327) and networkD3 (328) package to plot the transcription factor centered local
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network. The latter provides a force directed layout, which allows users to drag the
nodes and visualize the physical simulation of the network response.

Reproducible research and complete provenance capture
PIVOT automatically records all data manipulations and analysis steps. Once an
analysis has been performed, users will have the option of pasting related R markdown
code to a shinyAce report editor (329), or download the report as either a pdf or
interactive html document. All results and associated parameters will be captured and
saved to the report along with user-provided comments. PIVOT states are automatically
saved in cases of browser refresh, crash or user exit, and can also be manually
exported, shared and loaded. Thus, all analyses performed in PIVOT are fully
encapsulated and can be shared or disseminated as a single data+provenance object,
allowing universally reproducible research.

VisCello: extending PIVOT for large-scale single cell data
We extended PIVOT to VisCello for distributing single cell analyses and providing
interactive visualizations (Figure 4.4). VisCello can be installed as an R package
(https://github.com/qinzhu/VisCello) or hosted as an interactive web app. Compared to
PIVOT, VisCello had multiple optimizations, including the adoption of the sparse matrix
format (330), which significantly improves the speed and reduces memory use. VisCello
hosts dimensionality reductions (e.g. UMAPs), cell annotations, and marker gene tables
for different subsets of the data. Users can visualize gene expression on UMAP or PCA
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plots, on a lineage tree diagram, or as box/violin plots grouped by cell type or lineage.
The plots are interactive, allowing users to zoom in on subsets of cells, define new cell
annotation groups, and run differential expression analysis and GO/KEGG enrichment
with these newly defined groups. Program state can be downloaded and shared,
facilitating collaboration. VisCello has been used to host and disseminate various single
cell datasets (170, 331, 332).

Conclusions
We developed PIVOT and VisCello for easy, fast, and exploratory analysis of single cell
transcriptomics data. Toward this goal we have automated the analysis procedures and
data management, and we provide users with detailed explanations both in tooltips and
user manuals. PIVOT and VisCello exploits the power of multiple plotting packages and
gives users full control of key analysis and plotting parameters. Given user input that
leads to function errors, PIVOT and VisCello will alert the user and provide corrective
suggestions. Program states and reports can be shared between researchers to
facilitate the discussion of expression analysis and future experimental design. Future
versions of the software will continue to integrate popular transcriptome analysis routines
as they are made available to the research community.

220

Figures

Figure 4.1 Data management with data map.
The map shows the history of the data change and the association between analysis
and data nodes. Users can hover over edges to see operation details, or click nodes to
get analysis reports or switch active subsets.
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Figure 4.2 Selected analysis modules in PIVOT.
(A) The table on the left lists basic sample statistics. The selected statistics are plotted
below the table, and clicking a sample in the table will plot its count
distribution. (B) Mean-Standard deviation plot (top left, with vsn package), rank
frequency plot (top right) and mean variability plot (bottom, with Seurat
package). (C) The t-SNE module plots 1D, 2D and 3D projections (3D not shown due to
space). (D) Feature heatmap with the top 100 differentially expressed genes reported by
DESeq2 likelihood ratio test.
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Figure 4.3 Network analysis for the identification of potential transdifferentiation
factors.
(A, B) Graphs showing the connection between transcription factors differentially
expressed between fibroblasts and ES cells. A is an undirected graph showing the
protein-protein interaction relationship based on the STRING database, and B is
constructed based on the Regnetwork repository, showing the regulatory relationship.
The size of the nodes and the color gradient indicate the log fold change of the genes.
The graphs have been zoomed in to only include the genes with large LFC and small pvalue. (C) Predicted transdifferentiation factor lists based on the network score ranking.
The table includes information such as the center transcription factor score, the total
number of vertices in its direct neighborhood, and the number of activated neighbors
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with gene score above a user-specified threshold. Clicking entries on the table will plot
the local neighborhood network centered on that TF.
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Figure 4.4 Screenshots of VisCello.
(A) Screenshot of the cell type explorer, which enables interactive visualization of 2D
and 3D UMAPs and PCA plots for different subsets of the data. The view shown in the
panel is a 3D UMAP for all cells colored by estimated embryo time. Users can overlay
gene expression, cell type, number of expressed genes and other statistics on this plot.
The cell type explorer also features box/violin plots for gene expression across cell
types, lineages or time, summarized gene expression tables, and marker gene tables.
(B) Screenshot of the early cell lineage explorer, which enables interactive visualization
and comparison of the sc-RNA-seq data and summarized live imaging data. Panel
shows a radiograph of average fluorescent intensity (log10 scaled) of pha-4, measured
by live imaging.
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Tables
Table 4.1. List of tools currently integrated/implemented in PIVOT.

PIVOT Modules

Tools Integrated

Normalization

DESeq, Modified DESeq, TMM, Upper quartile,
CPM/RPKM/TPM, RUV, Spike-in regression, Census

Feature/Sample Filtering

List based, Expression based and Quality based filters

Basic Analysis Modules

Data distribution plots, Dispersion analysis, Rankfrequency plot, Spike-in analysis, Feature heatmap, etc.

Differential Expression

DESeq2, edgeR, SCDE, Monocle, Mann-Whitney U test

Clustering/Classification
Dimensionality
Reduction
Correlation Analysis
Gene Set Enrichment
Analysis
Network Analysis

Other Utilities

Hierarchical, K-means, SC3, Community detection,
Classification with caret, Cell state ordering with
Monocle2/Diffusion pseudotime
PCA, t-SNE, Metric/Non-Metric MDS, penalized LDA,
Diffusion Map
Pairwise scatter plots, Sample/feature correlation
heatmap,
Co-expression analysis
KEGG pathway analysis, Gene ontology analysis
STRING protein association network, Regnetwork
visualization, Mogrify based transcription factor
prediction
Data map, Gene ID/Name conversion, BioMart gene
annotation query, Venn diagram, Report generation,
State saving
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CHAPTER 5 CONCLUSION AND FUTURE DIRECTIONS

Conclusion
In this thesis I have presented two investigations of gene regulation in development and
differentiation. The first study examines cell type transitions and gene expression
change at whole-organism scale using the nematode Caenorhabditis elegans. The
second study aims to understand a specific developmental process, endothelial to
hematopoietic transition, which leads to the formation of pre-HSCs. For both studies, I
have developed computational methods that facilitate sophisticated statistical analysis of
single cell data.
In the C. elegans study described in Chapter 2, we profiled the transcriptome
of >80,000 single cells across C. elegans developmental stages ranging from ~100-600
minutes post-fertilization. Using the scRNA-Seq data, a known C. elegans lineage tree,
and imaging of fluorescent reporter genes, we generated a lineage-resolved single-cell
atlas of embryonic development with 93% cells annotated with a cell type or a cell lineage.
This atlas covers early events starting from initial diversification of founder lineages
through the specification of terminal cell fates. It enables us to make several unique
discoveries about the gene regulatory programs underly development and differentiation.
First, by modeling the bifurcating differentiation in neuron development, we identified the
widespread presence of ‘multilineage priming’, where the regulators of multiple alternative
fates are co-expressed in a progenitor cell and were selectively inherited by its
descendants. Second, by tracing the development of AB lineage, we found a timedependent association between a cell’s transcriptome with its lineage history and fate
choice. Gene expression associated with lineage identity is rapidly lost at the time of the
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terminal division and is replaced by transcriptional program related to the terminal fate.
Lastly, we identified several types of convergent development, where distinct lineages
converge to a homogeneous transcriptomic state before differentiating to the same cell
type.
In Chapter 3, we studied the process of pre-HSC formation in the mouse embryo.
By profiling ~40,000 single cells from early mouse embryos, we were able to capture the
entire developmental trajectory from arterial endothelial cells to lympho-myeloid biased
progenitors and pre-HSCs. Using this dataset, we discovered an endothelial cell precursor
of HE cells that we termed pre-HE, in which multiple signaling pathways known to be
important for the specification of HE cells are active. Furthermore, through trajectory
modeling and RNA velocity analysis, we identified a developmental bottleneck between
pre-HE and HE cells. We observed Runx1, a key regulator of EHT (33, 41), is expressed
in approximately 7% of pre-HE cells and hypothesized that its expression level regulates
the cell passage through the bottleneck. We validated the hypothesis by performing
scRNA-Seq on Runx1+/- and Runx1+/+ littermates and observed a 68% reduction in the
proportion of HE and IAC cells in Runx1 haploinsufficient mice. To investigate the
epigenetic mechanism regulating Runx1 expression at the bottleneck, we performed
paired scRNA-Seq and scATAC-Seq on E10.5 CD44+ E+HE+IAC cells and developed a
computational pipeline for integrative analysis of these two data modalities. We identified
a candidate enhancer 371 kb upstream of the Runx1 P1 promoter that first becomes
accessible in pre-HE cells and contains motifs of TFs that are downstream of signaling
pathways active in pre-HE. We also found that after cells pass the bottleneck, they follow
distinct developmental trajectories leading to an initial wave of lympho-myeloid-biased
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progenitors at E10.5, followed by precursors of HSCs at E11.5. The findings of this study
will inform efforts to generate HSCs from human ESCs and iPSCs in vitro.
Interestingly, we observed recurrent gene regulatory patterns in both
developmental systems. For example, both systems involve convergence in cellular
differentiation that give rise to a common progenitor population. In C. elegans
embryogenesis, transcriptome state of three sets of distinct cell lineages converges over
time and give rise to IL1/IL2 neuroblasts (Figure 2.4A-D). Similarly, two streams of
arterial endothelial cells with different Wnt signaling level converge to form conflux AE
(Figure 3.2). This phenomenon, known as developmental homoplasy, has been reported
for other developmental systems (333). The exact mechanism driving the convergence
is unknown, but in both cases, we observed coordinated up-regulation of a set of
transcription factors in the converging cells, suggesting TFs (and upstream signaling
pathways) likely play a key role in homogenizing the transcriptome of distinct cell
populations (Figure 2.4A-D and Figure 3.2).
In addition, we observed discontinuous trajectories for many cell types in the
UMAP of C. elegans embryogenesis, suggesting sudden changes in the transcriptome.
In contrast, a developmental bottleneck was found in the trajectory leading to HE, where
most cells are blocked at the pre-HE stage. These observations suggest that rate of
transcriptome changes may vary during differentiation. Therefore, analysis of the RNA
velocity and acceleration will likely reveal important regulatory points in cellular
differentiation.
Finally, we found during C. elegans embryogenesis, terminal cell fate is specified
through a series of lineage bifurcations, each involving multiple differentially expressed
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TFs (Figure 2.5C-E). Similarly, analysis of scATAC-Seq data reveals sequential
activation of TFs during EHT (Figure 3.4E). Taken together, these results highlight the
incremental nature of cell fate decisions and the coordination of the transcriptional
regulatory program underlie development and differentiation.
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Future direction: Comparative analysis of embryogenesis across
species
Comparative analysis of gene expression across species has enabled discovery of
conserved gene expression patterns and coordinated evolution of regulators (334). With
the increasing amount of single cell data for various developmental systems such as our
C. elegans single cell atlas and those listed in Table 1.1, it is now possible to investigate
evolutionary conserved gene regulatory mechanism at single cell resolution.
For example, using the single cell developmental datasets, one can test the
“hourglass” model of development, which predicts that the most conserved
developmental period of animal phyla is not the early and late embryonic stage, but a
mid-embryonic period, or “phylotypic period” (335). The hourglass model is supported by
many morphological evidence as well as molecular evidence (336), but has never been
examined at the single cell resolution, where both cell type and embryonic time can be
resolved. Using single cell analysis, one can test this model through a cell-centric
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approach and a gene-centric approach. In the first approach, homology between cell
types across species can be established by comparing the gene expression profile.
Then, differentiation trajectories of homologous cell types can be aligned through
dynamic time warping (DTW), such that the transcriptome divergence across
developmental timepoints can be compared. In the second gene-centric approach, one
can perform TRN inference for each species and search for conserved TRN modules,
and check if these modules are activated at specific developmental stage.
One potential caveat is that most published single cell data on development are
from evolutionarily distant species, making it difficult to establish homology between cells
from these species. The Caenorhabditis genus of nematodes includes ~50 species with
almost identical cell lineage structure, and thus provides an ideal system for comparative
study of embryogenesis. Furthermore, for one of these species, C. elegans, we have
generated a lineage-resolved single cell atlas, which can be used as a reference
dataset. Therefore, single cell sequencing on other closely related species, such as C.
remanei, C. brenneri and C. briggsae, will likely enable a comprehensive survey of
evolutionarily conserved gene regulatory principles during embryogenesis.

Future direction: Uncover gene regulatory mechanisms underlie EHT
Understanding how HSC form in vivo is essential for producing HSCs from other cell
sources ex vivo. Our recent work expanded our knowledge about EHT, but the complete
gene regulatory mechanisms underlie EHT has not been resolved.
For example, in Chapter 3, we showed using single cell analysis that a
developmental bottleneck exists between pre-HE and HE, and Runx1 dosage regulates
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cell passage through the bottleneck. We further showed, using scATAC analysis, that a
distal enhancer 371 kb upstream of Runx1 is transiently accessible in pre-HE cells.
However, we do not yet know if the Runx1 -371 enhancer is required to activate Runx1
expression at the bottleneck. Some evidence from zebrafish suggest that this enhancer
is capable of driving reporter gene expression in the intermediate cell mass and
posterior blood island of zebrafish embryos (251), but it remains to be shown that the
enhancer directly regulates Runx1 expression in pre-HE and HE cells. To answer this
question, one can use the CRISPR/Cas9 system to delete this enhancer in mouse
models and observe the effect on Runx1 expression. Furthermore, to test which
transcription factors bind to the enhancer to activate its activity, point mutations can be
introduced to destroy the GATA/TAL1, STAT, JUN, and RAR/RXR motifs at the
enhancer site. A significant reduction of enhancer activity in these mutants would
suggest the requirement for the corresponding transcription factor. Finally, one can
perform circular chromosome conformation capture sequencing (4C-seq) to identify the
changes in enhancer-promoter looping during pre-HE to HE transition. It is possible that
the -371 enhancer is required to initiate Runx1 expression through a long-range
interaction with Runx1 promoter but is no longer required thereafter as other Runx1
enhancers take over.
Another unsolved problem is what regulates the pre-HSC production from HE
cells. Our single cell data suggest that at E10.5, most of the HE cells differentiate into
lympho-myeloid progenitors, and only 2% of the IAC cells are pre-HSCs. However, at
E11.5, the proportion shifts dramatically, where 67% of the IAC cells are found to be preHSCs. The fate probability analysis shown in Supplemental Figure 3.11 provides some
clue, as we observe down-regulation of Myc and up-regulation of Smad7, Mecom, Meis2
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and Nfix in the trajectory leading to pre-HSC. Myc is a proto-oncogene which drives cell
proliferation (337), and previous study have shown that cell cycle is slowed down
considerably as pre-HSC mature (338). On the other hand, Mecom encodes the
transcription factors Evi1 and Mds1-Evi1, which are known to promote stemness and
quiescence of adult HSCs (339, 340). These suggest that regulation of cell cycle may
play an important role in the specification of the pre-HSC fate. Future experiments that
perturb expression level of these transcription factors may reveal the underlying gene
regulatory network controlling the fate choice of HE cells.

Future direction: In silico modeling of development and
differentiation
The pace and volume of single cell data collection across a variety of developmental
systems is exploding, giving the hope that we now have the data density to meaningfully
apply latest machine learning technologies to model complex organismal development.
First, at the single-cell level, development involves cell differentiation where each
cell adopts a series of molecular changes and differentiates into the terminal cell type,
such as a neuron or a blood cell. Although significant progress has been made to
discover molecular switches regulating differentiation, we do not yet know how the
control fully works even for a small part of the process. For example, in this thesis I
showed that the Runx1 is a key regulator helping endothelial cells (blood vessel cells)
overcome a developmental bottleneck to become hematopoietic stem cells (HSCs). Yet
little is known about which genes activate Runx1 expression in the first place. To decode
the regulatory program of cell differentiation, a different approach from that described in
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previous section is to build an in silico cell differentiation model using deep learning.
Deep learning has demonstrated great power in solving problems in dynamical domain
such as autonomous driving (341). Self-driving cars uses information about a car’s
current state, such as speed, direction, and surroundings, to make decisions on the
adjustments to speed and direction. Like self-driving cars, a deep neural network can
take the cell’s molecular state at each time point, as measured by single-cell
sequencing, and make predictions about the cell’s future state. The model can be
trained with currently available 104-106 single cell data points along the differentiation
trajectory, such that it can robustly predict the series of molecular changes happening
inside a developing cell. One caveat of using deep neural network is that the learned
model is presented as a black box and is hard to interpret (342). But recent advances
such as SHAP (SHapley Additive exPlanations) (343) have made it possible to look
inside the black box and examine which genes contribute most to the prediction result.
Therefore, we might use the model as an in silico hypothesis generating platform to
query the potential role of a gene during differentiation.
Second, development is a multi-cellular process involving different types of cells
interacting with each other in a spatial context and organizing into intricate tissue
structures. So far, efforts to re-create functional tissues in vitro by organoid culture
systems have largely failed, as the organoids cannot recapitulate the cell type diversity
and cell-cell interaction in vivo (344). Recently, multi-agent reinforcement learning has
achieved great success in modeling multi-component systems such as real-time strategy
games (345) and drone systems (346). Therefore, it might be possible to expand the
single cell models into a multi-agent system to simulate cell-cell communications in
silico. One of the best ground truth datasets for benchmarking is our embryogenesis
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atlas of C. elegans, which is a simple organism with only 558 cells at hatching and
spatial location of every cell known. Building on top of this, it might be possible to use
multi-agent learning to simulate the interactions between spatially adjacent cells and the
development of a “virtual embryo” over time.
Finally, to make the models trained using data from model organisms applicable
for understanding human developmental processes, transfer learning techniques can be
applied. The Human Cell Atlas project has by far collected millions of cells from human
post-mortem tissues. However, the majority of the cells come from adults. In other
words, we only have information from the end point of human development. These
existing data can be used as “anchor points” for establishing the connections between
human and mouse. With these anchor points, a model trained in mouse can be adapted
using transfer learning to make predictions for matched human developmental stages.
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